BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 019568
(339 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 155 bits (392), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 105/309 (33%), Positives = 156/309 (50%), Gaps = 15/309 (4%)
Query: 17 PSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNL 76
P+ + + + FS EL A+D FS N++G+GGFG VYK RL DG VAVK
Sbjct: 13 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE 72
Query: 77 QCGRALK-SFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---SS 132
+ + + F E EM+ HRNL+++ C + LV YM +GS+ L S
Sbjct: 73 ERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 132
Query: 133 NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
LD +R I + A L YLH IIH D+K +N+LLD+ A + DF +AKL+
Sbjct: 133 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 192
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF---N 249
+D + TIG++APEY G+ S DV+ +G+ML+E TG++ D +
Sbjct: 193 DYKDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 251
Query: 250 GEMTLKHWVNDWLPISTLE-VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308
++ L WV L LE +VD +L K++ V + +A+ C SP +R
Sbjct: 252 DDVMLLDWVKGLLKEKKLEALVDVDLQGN------YKDEEVEQLIQVALLCTQSSPMERP 305
Query: 309 NAKEIVKKL 317
E+V+ L
Sbjct: 306 KMSEVVRML 314
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 151 bits (382), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 102/308 (33%), Positives = 152/308 (49%), Gaps = 13/308 (4%)
Query: 17 PSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNL 76
P+ + + + FS EL A+D F N++G+GGFG VYK RL DG VAVK
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKE 64
Query: 77 QCGRALK-SFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---SS 132
+ + + F E EM+ HRNL+++ C + LV YM +GS+ L S
Sbjct: 65 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 124
Query: 133 NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
LD +R I + A L YLH IIH D+K +N+LLD+ A + DF +AKL+
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIF---N 249
+D + IG++APEY G+ S DV+ +G+ML+E TG++ D +
Sbjct: 185 DYKDXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 250 GEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN 309
++ L WV L LE L D+ K++ V + +A+ C SP +R
Sbjct: 244 DDVMLLDWVKGLLKEKKLEA-----LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298
Query: 310 AKEIVKKL 317
E+V+ L
Sbjct: 299 MSEVVRML 306
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 136 bits (342), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 97/299 (32%), Positives = 155/299 (51%), Gaps = 17/299 (5%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKS 94
++L +AT+ F LIG G FG VYK L DG +VA+K + + ++ F E E +
Sbjct: 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASA 151
RH +L+ +I C L+ +YM +G+L+++LY S+ + QRL I I A
Sbjct: 92 CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L YLH + IIH D+K N+LLD+N V ++DF I+K DQ+ T+GY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT-LKHWVNDWLPISTLE-V 269
PEY +GR++ DVYSFG++L E + + EM L W + LE +
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL---LKIRDSLL 325
VD NL + + + + + A+ C S E R + +++ KL L++++S++
Sbjct: 269 VDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 133 bits (335), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 96/299 (32%), Positives = 154/299 (51%), Gaps = 17/299 (5%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKS 94
++L +AT+ F LIG G FG VYK L DG +VA+K + + ++ F E E +
Sbjct: 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASA 151
RH +L+ +I C L+ +YM +G+L+++LY S+ + QRL I I A
Sbjct: 92 CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L YLH + IIH D+K N+LLD+N V ++DF I+K Q+ T+GY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT-LKHWVNDWLPISTLE-V 269
PEY +GR++ DVYSFG++L E + + EM L W + LE +
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL---LKIRDSLL 325
VD NL + + + + + A+ C S E R + +++ KL L++++S++
Sbjct: 269 VDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 76/233 (32%), Positives = 122/233 (52%), Gaps = 23/233 (9%)
Query: 29 WRTFSYLELCQATDEFSE------NNLIGKGGFGSVYKARLGDGMEVAVK----VFNLQC 78
+ +FS+ EL T+ F E N +G+GGFG VYK + + VAVK + ++
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 70
Query: 79 GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--- 135
+ F+ E ++M +H NL++++ S+ + LV YMP+GSL L +C+
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGT 127
Query: 136 --LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193
L R I A+ + +LH + IH D+K +N+LLD+ A +SDF +A+
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
Q++ ++ T YMAPE R G ++ D+YSFG++L+E TG DE
Sbjct: 185 KFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 112 bits (280), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 23/233 (9%)
Query: 29 WRTFSYLELCQATDEFSE------NNLIGKGGFGSVYKARLGDGMEVAVK----VFNLQC 78
+ +FS+ EL T+ F E N +G+GGFG VYK + + VAVK + ++
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 70
Query: 79 GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--- 135
+ F+ E ++M +H NL++++ S+ + LV YMP+GSL L +C+
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGT 127
Query: 136 --LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193
L R I A+ + +LH + IH D+K +N+LLD+ A +SDF +A+
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
Q++ + T YMAPE R G ++ D+YSFG++L+E TG DE
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 111 bits (277), Expect = 6e-25, Method: Compositional matrix adjust.
Identities = 76/233 (32%), Positives = 120/233 (51%), Gaps = 23/233 (9%)
Query: 29 WRTFSYLELCQATDEFSE------NNLIGKGGFGSVYKARLGDGMEVAVK----VFNLQC 78
+ +FS+ EL T+ F E N +G+GGFG VYK + + VAVK + ++
Sbjct: 6 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 64
Query: 79 GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--- 135
+ F+ E ++M +H NL++++ S+ + LV YMP+GSL L +C+
Sbjct: 65 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL---SCLDGT 121
Query: 136 --LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193
L R I A+ + +LH + IH D+K +N+LLD+ A +SDF +A+
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
Q + + T YMAPE R G ++ D+YSFG++L+E TG DE
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 230
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 45/290 (15%)
Query: 50 IGKGGFGSVYKAR------LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V+ A D M VAVK A K F E E++ +++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYS---------------SNCILDIFQRLNIMIDV 148
C + + +V EYM HG L K+L + + L + Q L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
AS + YL S +H DL N L+ N++ + DF +++ + D T I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTL 267
+M PE + + DV+SFG++L E FT GK+P W +S
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------------WFQLSNT 242
Query: 268 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
EV++ ++Q + C V+++ + C P+QR+N KEI K L
Sbjct: 243 EVIEC--ITQGRV-LERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 105 bits (262), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 67/198 (33%), Positives = 105/198 (53%), Gaps = 8/198 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRA--LKSFNVECEMMKSIRHRNLIKVISSC 107
IG G FG+V++A G +VAVK+ Q A + F E +MK +RH N++ + +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+ ++V EY+ GSL + L+ S LD +RL++ DVA + YLH + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DLK N+L+D + DF +++L + T +MAPE R+ +
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 226 DVYSFGIMLMETFTGKKP 243
DVYSFG++L E T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 104 bits (259), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 73/233 (31%), Positives = 117/233 (50%), Gaps = 23/233 (9%)
Query: 29 WRTFSYLELCQATDEFSE------NNLIGKGGFGSVYKARLGDGMEVAVK----VFNLQC 78
+ +FS+ EL T+ F E N G+GGFG VYK + + VAVK + ++
Sbjct: 3 FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 79 GRALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--- 135
+ F+ E ++ +H NL++++ S+ + LV Y P+GSL L +C+
Sbjct: 62 EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL---SCLDGT 118
Query: 136 --LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV 193
L R I A+ + +LH + IH D+K +N+LLD+ A +SDF +A+
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 194 GEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
Q + ++ T Y APE R G ++ D+YSFG++L+E TG DE
Sbjct: 176 KFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 227
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 104 bits (259), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 66/198 (33%), Positives = 106/198 (53%), Gaps = 8/198 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRA--LKSFNVECEMMKSIRHRNLIKVISSC 107
IG G FG+V++A G +VAVK+ Q A + F E +MK +RH N++ + +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+ ++V EY+ GSL + L+ S LD +RL++ DVA + YLH + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
+LK N+L+D + DF +++L ++ T +MAPE R+ +
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 226 DVYSFGIMLMETFTGKKP 243
DVYSFG++L E T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVF----NLQCGRALKSFNVECEMMKSIRH 97
E + +IG GGFG VY+A +GD EVAVK + + +++ E ++ ++H
Sbjct: 8 ELTLEEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N+I + C E LV+E+ G L + L DI +N + +A + YLH
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHD 123
Query: 158 GYSAPIIHCDLKPSNVLLDD--------NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209
PIIH DLK SN+L+ N + ++DF +A+ E T+
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYA 179
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+MAPE R S DV+S+G++L E TG+ P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 99.0 bits (245), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 79/278 (28%), Positives = 129/278 (46%), Gaps = 28/278 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
IG G FG V+ + +VA+K + + + F E E+M + H L+++ C
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ LV E+M HG L YL + + L + +DV + YL A +IH DL
Sbjct: 77 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 133
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L+ +N V +SDF + + ++ +DQ + T T + + +PE R S+ DV+S
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST-LEVVDANLLSQEDIHFVAKEQ 287
FG+++ E F+ GK P + N E+ V D IST + L S
Sbjct: 193 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 233
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ V+ + C E PE R ++++L +I +S L
Sbjct: 234 --THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 79/278 (28%), Positives = 129/278 (46%), Gaps = 28/278 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
IG G FG V+ + +VA+K + + + F E E+M + H L+++ C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ LV E+M HG L YL + + L + +DV + YL A +IH DL
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L+ +N V +SDF + + ++ +DQ + T T + + +PE R S+ DV+S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST-LEVVDANLLSQEDIHFVAKEQ 287
FG+++ E F+ GK P + N E+ V D IST + L S
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 228
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ V+ + C E PE R ++++L +I +S L
Sbjct: 229 --THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 264
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 98.6 bits (244), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 38/293 (12%)
Query: 45 SENNLIGKGGFGSVYKARLGDG---MEVAVKVFNLQCGRALKS---FNVECEMMKSIRHR 98
+ +IG G FG VYK L EV V + L+ G K F E +M H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HF 157
N+I++ S + ++ EYM +G+L+K+L + + Q + ++ +A+ ++YL +
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG--YMAPEY 215
Y +H DL N+L++ N+V +SDF ++++L +D T T + I + APE
Sbjct: 167 NY----VHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTAPEA 221
Query: 216 GREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
+ ++ DV+SFGI++ E T G++P E+ N E+ +ND + T
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--INDGFRLPT-------- 271
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK---KLLKIRDSL 324
C S ++ L M C + +R +IV KL++ DSL
Sbjct: 272 ----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 98.6 bits (244), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 79/278 (28%), Positives = 129/278 (46%), Gaps = 28/278 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
IG G FG V+ + +VA+K + + + F E E+M + H L+++ C
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ LV E+M HG L YL + + L + +DV + YL A +IH DL
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 130
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L+ +N V +SDF + + ++ +DQ + T T + + +PE R S+ DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST-LEVVDANLLSQEDIHFVAKEQ 287
FG+++ E F+ GK P + N E+ V D IST + L S
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 230
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ V+ + C E PE R ++++L +I +S L
Sbjct: 231 --THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 266
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 98.2 bits (243), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 79/278 (28%), Positives = 129/278 (46%), Gaps = 28/278 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
IG G FG V+ + +VA+K + + + F E E+M + H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ LV E+M HG L YL + + L + +DV + YL A +IH DL
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L+ +N V +SDF + + ++ +DQ + T T + + +PE R S+ DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST-LEVVDANLLSQEDIHFVAKEQ 287
FG+++ E F+ GK P + N E+ V D IST + L S
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 231
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ V+ + C E PE R ++++L +I +S L
Sbjct: 232 --THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 98.2 bits (243), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 50/292 (17%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V+ A D M VAVK A + F E E++ ++H+++++
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYS--------------SNCILDIFQRLNIMIDVA 149
C+ +V EYM HG L ++L S + L + Q L + VA
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 150 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
+ + YL HF +H DL N L+ +V + DF +++ + D +T
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 265
I +M PE + + DV+SFG++L E FT GK+P W +S
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYQLS 242
Query: 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
E +D +E C V+ + C P+QR + K++ +L
Sbjct: 243 NTEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 97.8 bits (242), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 50/292 (17%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V+ A D M VAVK A + F E E++ ++H+++++
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYS--------------SNCILDIFQRLNIMIDVA 149
C+ +V EYM HG L ++L S + L + Q L + VA
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 150 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
+ + YL HF +H DL N L+ +V + DF +++ + D +T
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 265
I +M PE + + DV+SFG++L E FT GK+P W +S
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYQLS 236
Query: 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
E +D +E C V+ + C P+QR + K++ +L
Sbjct: 237 NTEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 97.8 bits (242), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 50/292 (17%)
Query: 50 IGKGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V+ A D M VAVK A + F E E++ ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYS--------------SNCILDIFQRLNIMIDVA 149
C+ +V EYM HG L ++L S + L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 150 SALEYL---HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
+ + YL HF +H DL N L+ +V + DF +++ + D +T
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIS 265
I +M PE + + DV+SFG++L E FT GK+P W +S
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-----------------WYQLS 265
Query: 266 TLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
E +D +E C V+ + C P+QR + K++ +L
Sbjct: 266 NTEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 97.4 bits (241), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 81/282 (28%), Positives = 122/282 (43%), Gaps = 40/282 (14%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIKVISSC 107
IG+G FG V+ RL D VAVK LK+ F E ++K H N++++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+ ++ +V+E + G +L + L + L ++ D A+ +EYL S IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ + V +SDF +++ + + + + APE GR S+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK- 285
+SFGI+L ETF+ G P NL +Q+ FV K
Sbjct: 299 WSFGILLWETFSLGASPY---------------------------PNLSNQQTREFVEKG 331
Query: 286 ------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
E C VF L C P QR + I ++L IR
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 97.4 bits (241), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 28/278 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
IG G FG V+ + +VA+K + + F E E+M + H L+++ C
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ LV E+M HG L YL + + L + +DV + YL A +IH DL
Sbjct: 94 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 150
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L+ +N V +SDF + + ++ +DQ + T T + + +PE R S+ DV+S
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST-LEVVDANLLSQEDIHFVAKEQ 287
FG+++ E F+ GK P + N E+ V D IST + L S
Sbjct: 210 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 250
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ V+ + C E PE R ++++L +I +S L
Sbjct: 251 --THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 286
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
IG G FG V+ + +VA+K + + + F E E+M + H L+++ C
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ LV E+M HG L YL + + L + +DV + YL A +IH DL
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L+ +N V +SDF + + ++ +DQ + T T + + +PE R S+ DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST-LEVVDANLLSQEDIHFVAKEQ 287
FG+++ E F+ GK P + N E+ V D IST + L S
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 230
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ V+ + C E PE R ++++L I S L
Sbjct: 231 --THVYQIMNHCWKERPEDRPAFSRLLRQLAAIAASGL 266
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 97.1 bits (240), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 81/282 (28%), Positives = 122/282 (43%), Gaps = 40/282 (14%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIKVISSC 107
IG+G FG V+ RL D VAVK LK+ F E ++K H N++++I C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+ ++ +V+E + G +L + L + L ++ D A+ +EYL S IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ + V +SDF +++ + + + + APE GR S+ DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAK- 285
+SFGI+L ETF+ G P NL +Q+ FV K
Sbjct: 299 WSFGILLWETFSLGASPY---------------------------PNLSNQQTREFVEKG 331
Query: 286 ------EQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIR 321
E C VF L C P QR + I ++L IR
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 96.7 bits (239), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 10 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 69
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 70 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 129
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 130 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 186
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 187 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 246
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 247 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 291
Query: 319 KIRDSL 324
+IRD++
Sbjct: 292 QIRDNM 297
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 42/283 (14%)
Query: 50 IGKGGFGSVYKARL------GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V+ A D + VAVK A K F+ E E++ +++H +++K
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCI----------LDIFQRLNIMIDVASA 151
C + +V EYM HG L K+L + + + L Q L+I +A+
Sbjct: 81 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ YL S +H DL N L+ +N++ + DF +++ + D T I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVV 270
PE + + DV+S G++L E FT GK+P W +S EV+
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------------WYQLSNNEVI 240
Query: 271 DANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI 313
+ ++Q + C V+ L + C P R N K I
Sbjct: 241 EC--ITQGRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI 280
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 5 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 64
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 65 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 124
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 125 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 181
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 182 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 241
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 242 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 286
Query: 319 KIRDSL 324
+IRD++
Sbjct: 287 QIRDNM 292
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 24 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 84 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 144 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 260
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 261 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 305
Query: 319 KIRDSL 324
+IRD++
Sbjct: 306 QIRDNM 311
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 243 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 319 KIRDSL 324
+IRD++
Sbjct: 288 QIRDNM 293
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 24 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 84 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 144 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 260
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 261 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 305
Query: 319 KIRDSL 324
+IRD++
Sbjct: 306 QIRDNM 311
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 12 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 71
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 72 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 131
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 132 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 188
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 189 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 248
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 249 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 293
Query: 319 KIRDSL 324
+IRD++
Sbjct: 294 QIRDNM 299
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 11 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 70
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 71 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 130
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 131 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 187
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 188 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 247
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 248 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 292
Query: 319 KIRDSL 324
+IRD++
Sbjct: 293 QIRDNM 298
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 243 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 319 KIRDSL 324
+IRD++
Sbjct: 288 QIRDNM 293
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 138/306 (45%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 9 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL + +D + L +
Sbjct: 69 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICK 128
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 246 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 319 KIRDSL 324
+IRD++
Sbjct: 291 QIRDNM 296
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 13 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 72
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 73 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 132
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 133 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 189
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 190 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 249
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 250 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 294
Query: 319 KIRDSL 324
+IRD++
Sbjct: 295 QIRDNM 300
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 136/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 4 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 64 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 124 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 180
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 240
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 241 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 285
Query: 319 KIRDSL 324
+IRD +
Sbjct: 286 QIRDQM 291
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 9 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 69 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 128
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 246 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 319 KIRDSL 324
+IRD++
Sbjct: 291 QIRDNM 296
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 96.3 bits (238), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 136/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 157 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 213
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 274 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
Query: 319 KIRDSL 324
+IRD +
Sbjct: 319 QIRDQM 324
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 109 NEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L + L + Q +++ +AS + Y+ +H D
Sbjct: 74 EEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 129
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDV 188
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 189 WSFGILLTELTTKGRVPYPGMVNREV 214
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 95.9 bits (237), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 243 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 319 KIRDSL 324
+IRD++
Sbjct: 288 QIRDNM 293
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 85/336 (25%), Positives = 154/336 (45%), Gaps = 55/336 (16%)
Query: 30 RTF----SYLELCQATDEFSE---------NNLIGKGGFGSVYKARLG--DGMEVAVKVF 74
RTF +Y + Q EF++ + ++G G FG V RL E++V +
Sbjct: 20 RTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 75 NLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 131
L+ G + + F E +M H N+I++ + + +V EYM +GSL+ +L
Sbjct: 80 TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 132 SNCILDIFQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+ + Q + ++ +AS ++YL GY +H DL N+L++ N+V +SDF +++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 191 LLVGEDQSMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248
+L + ++ T+ I + +PE + ++ DV+S+GI+L E + G++P E+
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 249 NGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308
N ++ ++ VD E C + ++ L + C + R
Sbjct: 256 NQDV--------------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295
Query: 309 NAKEIVKKLLKIRDSLLRNVGGRCI------RQSNL 338
++IV I D L+RN G I R SNL
Sbjct: 296 KFEQIV----SILDKLIRNPGSLKIITSAAARPSNL 327
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 95.5 bits (236), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 80/306 (26%), Positives = 138/306 (45%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 9 QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++E++P+GSL +YL +D + L +
Sbjct: 69 KSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICK 128
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH DL N+L+++ + DF + K+L + + + + I
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 246 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290
Query: 319 KIRDSL 324
+IRD++
Sbjct: 291 QIRDNM 296
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V+EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 84 EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV 224
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 85/336 (25%), Positives = 154/336 (45%), Gaps = 55/336 (16%)
Query: 30 RTF----SYLELCQATDEFSE---------NNLIGKGGFGSVYKARLG--DGMEVAVKVF 74
RTF ++ + Q EF++ + ++G G FG V RL E++V +
Sbjct: 20 RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 75 NLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 131
L+ G + + F E +M H N+I++ + + +V EYM +GSL+ +L
Sbjct: 80 TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 132 SNCILDIFQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+ + Q + ++ +AS ++YL GY +H DL N+L++ N+V +SDF +A+
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLAR 195
Query: 191 LLVGEDQSMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248
+L + ++ T+ I + +PE + ++ DV+S+GI+L E + G++P E+
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 249 NGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308
N ++ ++ VD E C + ++ L + C + R
Sbjct: 256 NQDV--------------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295
Query: 309 NAKEIVKKLLKIRDSLLRNVGGRCI------RQSNL 338
++IV I D L+RN G I R SNL
Sbjct: 296 KFEQIV----SILDKLIRNPGSLKIITSAAARPSNL 327
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 95.1 bits (235), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 109 NEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L + L + Q +++ +AS + Y+ +H D
Sbjct: 77 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 191
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 192 WSFGILLTELTTKGRVPYPGMVNREV 217
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 94.7 bits (234), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK IRH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 84 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV 224
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 94.7 bits (234), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 26/274 (9%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VAVK+ + + F E + M + H L+K CS
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
E +V EY+ +G L YL S L+ Q L + DV + +L S IH DL
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L+D ++ +SDF + + ++ +DQ ++ T + + APE + S+ DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
FGI++ E F+ GK P D N E+ LK V + L + +
Sbjct: 191 FGILMWEVFSLGKMPYDLYTNSEVVLK-------------VSQGHRLYRPHL-------A 230
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
++ + +C E PE+R ++++ + +R+
Sbjct: 231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 94.7 bits (234), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V+EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 84 EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV 224
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNL--QCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ + ++F E +++ RH N++ +
Sbjct: 44 IGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL K+L+ +FQ ++I A ++YLH + IIH
Sbjct: 101 MTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHR 156
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
D+K +N+ L + + + DF +A + S Q ++ +MAPE R S
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVYS+GI+L E TG+ P I N
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHINN 242
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 109 NEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L + L + Q +++ +AS + Y+ +H D
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 364
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREV 390
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 40/293 (13%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNL-------QCGRALKSFNVECEM 91
A +E IGKGGFG V+K RL D VA+K L + + F E +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
M ++ H N++K+ N +V+E++P G L L + +L +M+D+A
Sbjct: 77 MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 152 LEYLHFGYSAPIIHCDLKPSNVL---LDDN--MVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
+EY+ + PI+H DL+ N+ LD+N + A ++DFS+++ V + +
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV-----HSVSGLLG 188
Query: 207 TIGYMAPEY--GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+MAPE E + D YSF ++L TG+ P DE G++
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------- 238
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
N++ +E + E C + N+ C P++R + IVK+L
Sbjct: 239 -------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 82/329 (24%), Positives = 151/329 (45%), Gaps = 51/329 (15%)
Query: 33 SYLELCQATDEFSE---------NNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG-- 79
+Y + Q EF++ + ++G G FG V RL E++V + L+ G
Sbjct: 25 TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 80 -RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 138
+ + F E +M H N+I++ + + +V EYM +GSL+ +L + +
Sbjct: 85 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 144
Query: 139 FQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
Q + ++ +AS ++YL GY +H DL N+L++ N+V +SDF ++++L + +
Sbjct: 145 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 200
Query: 198 SMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 255
+ T+ I + +PE + ++ DV+S+GI+L E + G++P E+ N ++
Sbjct: 201 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--- 257
Query: 256 HWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
++ VD E C + ++ L + C + R ++IV
Sbjct: 258 -----------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV- 299
Query: 316 KLLKIRDSLLRNVGGRCI------RQSNL 338
I D L+RN G I R SNL
Sbjct: 300 ---SILDKLIRNPGSLKIITSAAARPSNL 325
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 82/329 (24%), Positives = 151/329 (45%), Gaps = 51/329 (15%)
Query: 33 SYLELCQATDEFSE---------NNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG-- 79
+Y + Q EF++ + ++G G FG V RL E++V + L+ G
Sbjct: 27 TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 80 -RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 138
+ + F E +M H N+I++ + + +V EYM +GSL+ +L + +
Sbjct: 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 139 FQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
Q + ++ +AS ++YL GY +H DL N+L++ N+V +SDF ++++L + +
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 198 SMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 255
+ T+ I + +PE + ++ DV+S+GI+L E + G++P E+ N ++
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--- 259
Query: 256 HWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
++ VD E C + ++ L + C + R ++IV
Sbjct: 260 -----------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV- 301
Query: 316 KLLKIRDSLLRNVGGRCI------RQSNL 338
I D L+RN G I R SNL
Sbjct: 302 ---SILDKLIRNPGSLKIITSAAARPSNL 327
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 94.4 bits (233), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 109 NEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L + L + Q +++ +AS + Y+ +H D
Sbjct: 81 EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP-IKWTAPEAALYGRFTIKSDV 195
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 196 WSFGILLTELTTKGRVPYPGMVNREV 221
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 94.4 bits (233), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 109 NEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L + L + Q +++ +AS + Y+ +H D
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 364
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREV 390
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 75 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 189
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 190 WSFGILLTELTTKGRVPYPGMVNREV 215
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 73 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 187
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 188 WSFGILLTELTTKGRVPYPGMVNREV 213
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 73/203 (35%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 50 IGKGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
IGKG FG V LGD G +VAVK ++ ++F E +M +RH NL++++
Sbjct: 14 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 108 SNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
E+ +V EYM GSL YL S +L L +DV A+EYL +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 125
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DL NVL+ ++ VA +SDF + K + S TQ + + APE RE + S
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 226 DVYSFGIMLMETFT-GKKPTDEI 247
DV+SFGI+L E ++ G+ P I
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRI 203
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 109 NEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L + L + Q +++ +AS + Y+ +H D
Sbjct: 81 EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 195
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 196 WSFGILLTELTTKGRVPYPGMVNREV 221
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 80/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMM 92
+F E +L +GKG FGSV R L D G VAVK L+ F E E++
Sbjct: 7 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 66
Query: 93 KSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
KS++H N++K C + + L++EY+P+GSL YL +D + L +
Sbjct: 67 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 126
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIG 209
+EYL + IH +L N+L+++ + DF + K+L + + + + I
Sbjct: 127 GMEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 183
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFT----GKKPTDEIF-------NGEMTLKHWV 258
+ APE E + S DV+SFG++L E FT K P E G+M + H +
Sbjct: 184 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 243
Query: 259 NDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLL 318
L + + + C ++ + C + QR + +++ ++
Sbjct: 244 E---------------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 288
Query: 319 KIRDSL 324
+IRD++
Sbjct: 289 QIRDNM 294
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 84/336 (25%), Positives = 154/336 (45%), Gaps = 55/336 (16%)
Query: 30 RTF----SYLELCQATDEFSE---------NNLIGKGGFGSVYKARLG--DGMEVAVKVF 74
RTF ++ + Q EF++ + ++G G FG V RL E++V +
Sbjct: 20 RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 75 NLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 131
L+ G + + F E +M H N+I++ + + +V EYM +GSL+ +L
Sbjct: 80 TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 132 SNCILDIFQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+ + Q + ++ +AS ++YL GY +H DL N+L++ N+V +SDF +++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 191 LLVGEDQSMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248
+L + ++ T+ I + +PE + ++ DV+S+GI+L E + G++P E+
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 249 NGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308
N ++ ++ VD E C + ++ L + C + R
Sbjct: 256 NQDV--------------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295
Query: 309 NAKEIVKKLLKIRDSLLRNVGGRCI------RQSNL 338
++IV I D L+RN G I R SNL
Sbjct: 296 KFEQIV----SILDKLIRNPGSLKIITSAAARPSNL 327
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 73/203 (35%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 50 IGKGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
IGKG FG V LGD G +VAVK ++ ++F E +M +RH NL++++
Sbjct: 29 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 108 SNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
E+ +V EYM GSL YL S +L L +DV A+EYL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DL NVL+ ++ VA +SDF + K + S TQ + + APE RE + S
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 226 DVYSFGIMLMETFT-GKKPTDEI 247
DV+SFGI+L E ++ G+ P I
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRI 218
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 84 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV 224
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 84/336 (25%), Positives = 153/336 (45%), Gaps = 55/336 (16%)
Query: 30 RTF----SYLELCQATDEFSE---------NNLIGKGGFGSVYKARLG--DGMEVAVKVF 74
RTF ++ + Q EF++ + ++G G FG V RL E++V +
Sbjct: 20 RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 75 NLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 131
L+ G + + F E +M H N+I++ + + +V EYM +GSL+ +L
Sbjct: 80 TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 132 SNCILDIFQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+ + Q + ++ +AS ++YL GY +H DL N+L++ N+V +SDF + +
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGR 195
Query: 191 LLVGEDQSMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248
+L + ++ T+ I + +PE + ++ DV+S+GI+L E + G++P E+
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 249 NGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308
N ++ ++ VD E C + ++ L + C + R
Sbjct: 256 NQDV--------------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295
Query: 309 NAKEIVKKLLKIRDSLLRNVGGRCI------RQSNL 338
++IV I D L+RN G I R SNL
Sbjct: 296 KFEQIV----SILDKLIRNPGSLKIITSAAARPSNL 327
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 109 NEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L + L + Q +++ +AS + Y+ +H D
Sbjct: 250 EEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 364
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREV 390
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 79/309 (25%), Positives = 144/309 (46%), Gaps = 42/309 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHR 98
S + ++G G FG V RL E++V + L+ G + + F E +M H
Sbjct: 35 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-F 157
N+I++ + + +V EYM +GSL+ +L + + Q + ++ +AS ++YL
Sbjct: 95 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 154
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYG 216
GY +H DL N+L++ N+V +SDF ++++L + ++ T+ I + +PE
Sbjct: 155 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 210
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275
+ ++ DV+S+GI+L E + G++P E+ N ++ ++ VD
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD---- 252
Query: 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGRCI-- 333
E C + ++ L + C + R ++IV I D L+RN G I
Sbjct: 253 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV----SILDKLIRNPGSLKIIT 306
Query: 334 ----RQSNL 338
R SNL
Sbjct: 307 SAAARPSNL 315
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 79/309 (25%), Positives = 144/309 (46%), Gaps = 42/309 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHR 98
S + ++G G FG V RL E++V + L+ G + + F E +M H
Sbjct: 18 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HF 157
N+I++ + + +V EYM +GSL+ +L + + Q + ++ +AS ++YL
Sbjct: 78 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYG 216
GY +H DL N+L++ N+V +SDF ++++L + ++ T+ I + +PE
Sbjct: 138 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275
+ ++ DV+S+GI+L E + G++P E+ N ++ ++ VD
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD---- 235
Query: 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGRCI-- 333
E C + ++ L + C + R ++IV I D L+RN G I
Sbjct: 236 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV----SILDKLIRNPGSLKIIT 289
Query: 334 ----RQSNL 338
R SNL
Sbjct: 290 SAAARPSNL 298
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 84 EEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV 224
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 79/309 (25%), Positives = 144/309 (46%), Gaps = 42/309 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHR 98
S + ++G G FG V RL E++V + L+ G + + F E +M H
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HF 157
N+I++ + + +V EYM +GSL+ +L + + Q + ++ +AS ++YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYG 216
GY +H DL N+L++ N+V +SDF ++++L + ++ T+ I + +PE
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275
+ ++ DV+S+GI+L E + G++P E+ N ++ ++ VD
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD---- 264
Query: 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGRCI-- 333
E C + ++ L + C + R ++IV I D L+RN G I
Sbjct: 265 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV----SILDKLIRNPGSLKIIT 318
Query: 334 ----RQSNL 338
R SNL
Sbjct: 319 SAAARPSNL 327
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 13/212 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 20 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L++S ++ + ++I A ++YLH + IIH
Sbjct: 77 STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 132
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L ++ + DF +A + S Q +I +MAPE R S
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
DVY+FGI+L E TG+ P I N + ++
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 224
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 73/203 (35%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 50 IGKGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
IGKG FG V LGD G +VAVK ++ ++F E +M +RH NL++++
Sbjct: 201 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 108 SNEEFK-ALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
E+ +V EYM GSL YL S +L L +DV A+EYL +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DL NVL+ ++ VA +SDF + K + S TQ + + APE RE + S
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 226 DVYSFGIMLMETFT-GKKPTDEI 247
DV+SFGI+L E ++ G+ P I
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRI 390
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 109 NEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L + L + Q +++ +AS + Y+ +H D
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 447
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREV 473
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 16 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L+ ++ + ++I A ++YLH + IIH
Sbjct: 73 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L +++ + DF +A + S Q +I +MAPE R + S
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINN 214
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 73/203 (35%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 50 IGKGGFGSVYKARLGD--GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSC 107
IGKG FG V LGD G +VAVK ++ ++F E +M +RH NL++++
Sbjct: 20 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 108 SNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
E+ +V EYM GSL YL S +L L +DV A+EYL +H
Sbjct: 75 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 131
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DL NVL+ ++ VA +SDF + K + S TQ + + APE RE S
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKS 186
Query: 226 DVYSFGIMLMETFT-GKKPTDEI 247
DV+SFGI+L E ++ G+ P I
Sbjct: 187 DVWSFGILLWEIYSFGRVPYPRI 209
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 21 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L+ ++ + ++I A ++YLH + IIH
Sbjct: 78 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 133
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L +++ + DF +A + S Q +I +MAPE R + S
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINN 219
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 18 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L+ ++ + ++I A ++YLH + IIH
Sbjct: 75 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 130
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L +++ + DF +A + S Q +I +MAPE R + S
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNINN 216
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 43 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L+ ++ + ++I A ++YLH + IIH
Sbjct: 100 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 155
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L +++ + DF +A + S Q +I +MAPE R + S
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNINN 241
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 21 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L+ ++ + ++I A ++YLH + IIH
Sbjct: 78 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 133
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L +++ + DF +A + S Q +I +MAPE R + S
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINN 219
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 78/293 (26%), Positives = 130/293 (44%), Gaps = 40/293 (13%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNL-------QCGRALKSFNVECEM 91
A +E IGKGGFG V+K RL D VA+K L + + F E +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
M ++ H N++K+ N +V+E++P G L L + +L +M+D+A
Sbjct: 77 MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 152 LEYLHFGYSAPIIHCDLKPSNVL---LDDN--MVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
+EY+ + PI+H DL+ N+ LD+N + A ++DF +++ V + +
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLG 188
Query: 207 TIGYMAPEY--GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+MAPE E + D YSF ++L TG+ P DE G++
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------- 238
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
N++ +E + E C + N+ C P++R + IVK+L
Sbjct: 239 -------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V+EYM G L +L L + Q +++ +AS + Y+ +H D
Sbjct: 84 EEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV 224
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 44 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L+ ++ + ++I A ++YLH + IIH
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L +++ + DF +A + S Q +I +MAPE R + S
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINN 242
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 84 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV 224
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 16 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L+ ++ + ++I A ++YLH + IIH
Sbjct: 73 STAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L +++ + DF +A + S Q +I +MAPE R + S
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINN 214
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 83/336 (24%), Positives = 154/336 (45%), Gaps = 55/336 (16%)
Query: 30 RTF----SYLELCQATDEFSE---------NNLIGKGGFGSVYKARLG--DGMEVAVKVF 74
RTF ++ + Q EF++ + ++G G FG V RL E++V +
Sbjct: 20 RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 75 NLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 131
L+ G + + F E +M H N+I++ + + +V EYM +GSL+ +L
Sbjct: 80 TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK 139
Query: 132 SNCILDIFQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+ + Q + ++ +AS ++YL G+ +H DL N+L++ N+V +SDF +++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGF----VHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 191 LLVGEDQSMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248
+L + ++ T+ I + +PE + ++ DV+S+GI+L E + G++P E+
Sbjct: 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 249 NGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRI 308
N ++ ++ VD E C + ++ L + C + R
Sbjct: 256 NQDV--------------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRP 295
Query: 309 NAKEIVKKLLKIRDSLLRNVGGRCI------RQSNL 338
++IV I D L+RN G I R SNL
Sbjct: 296 KFEQIV----SILDKLIRNPGSLKIITSAAARPSNL 327
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 194
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 234
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 235 CPEELYQLMRLCWKERPEDR 254
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 194
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 234
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 235 CPEELYQLMRLCWKERPEDR 254
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 92.4 bits (228), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L L + Q +++ +AS + Y+ +H D
Sbjct: 251 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF + +L+ + + Q F I + APE GR + DV
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 365
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 366 WSFGILLTELTTKGRVPYPGMVNREV 391
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 86 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 200
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 240
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 241 CPEELYQLMRLCWKERPEDR 260
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 81 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 136
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 195
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 196 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 235
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 236 CPEELYQLMRLCWKERPEDR 255
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 89 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 144
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 203
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 204 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 243
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 244 CPEELYQLMRLCWKERPEDR 263
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 82 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 137
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 196
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 197 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 236
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 237 CPEELYQLMRLCWKERPEDR 256
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 88 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 143
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 202
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 203 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 242
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 243 CPEELYQLMRLCWKERPEDR 262
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 78/293 (26%), Positives = 129/293 (44%), Gaps = 40/293 (13%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNL-------QCGRALKSFNVECEM 91
A +E IGKGGFG V+K RL D VA+K L + + F E +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
M ++ H N++K+ N +V+E++P G L L + +L +M+D+A
Sbjct: 77 MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 152 LEYLHFGYSAPIIHCDLKPSNVL---LDDN--MVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
+EY+ + PI+H DL+ N+ LD+N + A ++DF ++ V + +
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV-----HSVSGLLG 188
Query: 207 TIGYMAPEY--GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+MAPE E + D YSF ++L TG+ P DE G++
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------- 238
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
N++ +E + E C + N+ C P++R + IVK+L
Sbjct: 239 -------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 86 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 200
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 240
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 241 CPEELYQLMRLCWKERPEDR 260
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 85 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 140
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 199
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 200 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 239
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 240 CPEELYQLMRLCWKERPEDR 259
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 194
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 234
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 235 CPEELYQLMRLCWKERPEDR 254
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 92.0 bits (227), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L++S ++ + ++I A ++YLH + IIH
Sbjct: 89 STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L ++ + DF +A S Q +I +MAPE R S
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINN 230
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 20/229 (8%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNL---QCGRALKSFNVECEMMKSIRHRNLIKVIS 105
+G GG +VY A ++VA+K + + LK F E + H+N++ +I
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
++ LV+EY+ +L +Y+ S+ L + +N + +++ H I+H
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRIVH 134
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT-QTFATIGYMAPEYGREGRVSAN 224
D+KP N+L+D N + DF IAK L + S+TQT T+ Y +PE +
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLPISTLEV 269
D+YS GI+L E G+ P FNGE + +KH + D +P T +V
Sbjct: 193 TDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDV 236
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V+ VA+K L+ G + ++F E ++MK +RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 109 NEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM G L +L L + Q +++ +AS + Y+ +H D
Sbjct: 84 EEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ +N+V ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP-IKWTAPEAALYGRFTIKSDV 198
Query: 228 YSFGIMLME-TFTGKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREV 224
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 91.7 bits (226), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 16 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L+ ++ + ++I A ++YLH + IIH
Sbjct: 73 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L +++ + DF +A S Q +I +MAPE R + S
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINN 214
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 36 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L+ ++ + ++I A ++YLH + IIH
Sbjct: 93 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 148
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L +++ + DF +A S Q +I +MAPE R + S
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 209 QSDVYAFGIVLYELMTGQLPYSNINN 234
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 90 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 145
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 146 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 204
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 205 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 244
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 245 CPEELYQLMRLCWKERPEDR 264
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 91.7 bits (226), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 81/329 (24%), Positives = 150/329 (45%), Gaps = 51/329 (15%)
Query: 33 SYLELCQATDEFSE---------NNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG-- 79
+Y + Q EF++ + ++G G FG V RL E++V + L+ G
Sbjct: 27 TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 80 -RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 138
+ + F E +M H N+I++ + + +V E M +GSL+ +L + +
Sbjct: 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
Query: 139 FQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
Q + ++ +AS ++YL GY +H DL N+L++ N+V +SDF ++++L + +
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 198 SMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 255
+ T+ I + +PE + ++ DV+S+GI+L E + G++P E+ N ++
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--- 259
Query: 256 HWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
++ VD E C + ++ L + C + R ++IV
Sbjct: 260 -----------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV- 301
Query: 316 KLLKIRDSLLRNVGGRCI------RQSNL 338
I D L+RN G I R SNL
Sbjct: 302 ---SILDKLIRNPGSLKIITSAAARPSNL 327
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 75 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 130
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 189
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 190 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 229
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 230 CPEELYQLMRLCWKERPEDR 249
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L++S ++ + ++I A ++YLH + IIH
Sbjct: 89 STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L ++ + DF +A S Q +I +MAPE R S
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINN 230
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 91.3 bits (225), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 13/206 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G FG+VYK + GD VAVK+ N+ + L++F E +++ RH N++ +
Sbjct: 44 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + A+V ++ SL +L+ ++ + ++I A ++YLH + IIH
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR---EGRVSA 223
DLK +N+ L +++ + DF +A S Q +I +MAPE R + S
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 224 NGDVYSFGIMLMETFTGKKPTDEIFN 249
DVY+FGI+L E TG+ P I N
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINN 242
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 21/238 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---SFNVECEMMKSIR 96
+D + ++G GG V+ AR L D +VAVKV R F E + ++
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 97 HRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
H ++ V + E +V+EY+ +L +++ + + I + +A A
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYM 211
+ L+F + IIH D+KP+N+++ + DF IA+ + S+TQT T Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLPIS 265
+PE R V A DVYS G +L E TG+ P F G+ + +H D +P S
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 90.5 bits (223), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 21/238 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---SFNVECEMMKSIR 96
+D + ++G GG V+ AR L D +VAVKV R F E + ++
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 97 HRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
H ++ V + E +V+EY+ +L +++ + + I + +A A
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYM 211
+ L+F + IIH D+KP+N+++ + DF IA+ + S+TQT T Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLPIS 265
+PE R V A DVYS G +L E TG+ P F G+ + +H D +P S
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPDSVAYQHVREDPIPPS 240
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 90.1 bits (222), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 78/309 (25%), Positives = 143/309 (46%), Gaps = 42/309 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHR 98
S + ++G G FG V RL E++V + L+ G + + F E +M H
Sbjct: 18 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-F 157
N+I++ + + +V E M +GSL+ +L + + Q + ++ +AS ++YL
Sbjct: 78 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYG 216
GY +H DL N+L++ N+V +SDF ++++L + ++ T+ I + +PE
Sbjct: 138 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLL 275
+ ++ DV+S+GI+L E + G++P E+ N ++ ++ VD
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV--------------IKAVD---- 235
Query: 276 SQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGGRCI-- 333
E C + ++ L + C + R ++IV I D L+RN G I
Sbjct: 236 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV----SILDKLIRNPGSLKIIT 289
Query: 334 ----RQSNL 338
R SNL
Sbjct: 290 SAAARPSNL 298
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 90.1 bits (222), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 36/288 (12%)
Query: 48 NLIGKGGFGSVYKARL--GDGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIK 102
+IG G G V RL +V V + L+ G R + F E +M H N+I+
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGYSA 161
+ + +V EYM +GSL+ +L + + I Q + ++ V + + YL GY
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE-DQSMTQTQTFATIGYMAPEYGREGR 220
+H DL NVL+D N+V +SDF ++++L + D + T T I + APE
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 221 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
S+ DV+SFG+++ E G++P + N ++ IS++E E
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----------ISSVE---------EG 270
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327
A C + L + C + QR +IV L D+L+R+
Sbjct: 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 36/288 (12%)
Query: 48 NLIGKGGFGSVYKARL--GDGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIK 102
+IG G G V RL +V V + L+ G R + F E +M H N+I+
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGYSA 161
+ + +V EYM +GSL+ +L + + I Q + ++ V + + YL GY
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE-DQSMTQTQTFATIGYMAPEYGREGR 220
+H DL NVL+D N+V +SDF ++++L + D + T T I + APE
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 221 VSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
S+ DV+SFG+++ E G++P + N ++ IS++E E
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----------ISSVE---------EG 270
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327
A C + L + C + QR +IV L D+L+R+
Sbjct: 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 69/260 (26%), Positives = 120/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH +L
Sbjct: 76 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNL 131
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 190
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 191 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 230
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 231 CPEELYQLMRLCWKERPEDR 250
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 89.7 bits (221), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 72/260 (27%), Positives = 122/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ A +VAVK ++++F E +MK+++H L+K+ + +
Sbjct: 23 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDL 168
E ++ E+M GSL +L S Q L +ID ++ + E + F IH DL
Sbjct: 82 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ ++V ++DF +A+++ + + + F I + APE G + DV+
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDVW 196
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+LME T G+ P + N E+ I LE E
Sbjct: 197 SFGILLMEIVTYGRIPYPGMSNPEV-----------IRALE---------RGYRMPRPEN 236
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++N+ M C PE+R
Sbjct: 237 CPEELYNIMMRCWKNRPEER 256
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 82/291 (28%), Positives = 124/291 (42%), Gaps = 35/291 (12%)
Query: 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
E ++G+G FG V KA+ +VA+K + R K+F VE + + H N++K
Sbjct: 9 EIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK 65
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGYS 160
+ +C N LV+EY GSL L+ + + ++ + + + YLH
Sbjct: 66 LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 161 APIIHCDLKPSNVLL-DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
+IH DLKP N+LL V + DF A D T + +MAPE
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS 178
Query: 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
S DV+S+GI+L E T +KP DEI + V++ T + NL
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN----GTRPPLIKNLPKP-- 232
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGG 330
+ +L C + P QR + +EIV KI L+R G
Sbjct: 233 ------------IESLMTRCWSKDPSQRPSMEEIV----KIMTHLMRYFPG 267
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 89.4 bits (220), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 21/238 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---SFNVECEMMKSIR 96
+D + ++G GG V+ AR L D +VAVKV R F E + ++
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 97 HRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
H ++ V + E +V+EY+ +L +++ + + I + +A A
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYM 211
+ L+F + IIH D+KP+N+L+ + DF IA+ + S+ QT T Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLPIS 265
+PE R V A DVYS G +L E TG+ P F G+ + +H D +P S
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 89.0 bits (219), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 82/291 (28%), Positives = 124/291 (42%), Gaps = 35/291 (12%)
Query: 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
E ++G+G FG V KA+ +VA+K + R K+F VE + + H N++K
Sbjct: 10 EIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK 66
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGYS 160
+ +C N LV+EY GSL L+ + + ++ + + + YLH
Sbjct: 67 LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 161 APIIHCDLKPSNVLL-DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
+IH DLKP N+LL V + DF A D T + +MAPE
Sbjct: 125 KALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS 179
Query: 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQED 279
S DV+S+GI+L E T +KP DEI + V++ T + NL
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN----GTRPPLIKNLPKP-- 233
Query: 280 IHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGG 330
+ +L C + P QR + +EIV KI L+R G
Sbjct: 234 ------------IESLMTRCWSKDPSQRPSMEEIV----KIMTHLMRYFPG 268
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 120/266 (45%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +++E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 81 REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 196
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 197 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 237
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 72/260 (27%), Positives = 122/260 (46%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ A +VAVK ++++F E +MK+++H L+K+ + +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDL 168
E ++ E+M GSL +L S Q L +ID ++ + E + F IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ ++V ++DF +A+++ + + + F I + APE G + DV+
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGSFTIKSDVW 369
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+LME T G+ P + N E+ I LE E
Sbjct: 370 SFGILLMEIVTYGRIPYPGMSNPEV-----------IRALE---------RGYRMPRPEN 409
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++N+ M C PE+R
Sbjct: 410 CPEELYNIMMRCWKNRPEER 429
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 89.0 bits (219), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 28/260 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G G V+ +VAVK Q + +F E +MK ++H+ L+++ + +
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E ++ EYM +GSL +L + + I L I + L++ +A + ++ IH DL
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ D + ++DF +A+L+ + + + F I + APE G + DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP-IKWTAPEAINYGTFTIKSDVW 194
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+L E T G+ P + N E+ I LE V +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEV-----------IQNLE---------RGYRMVRPDN 234
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++ L C E PE R
Sbjct: 235 CPEELYQLMRLCWKERPEDR 254
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 88.6 bits (218), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 120/266 (45%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +++E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 85 REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 200
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 201 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 241
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 88.6 bits (218), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 81/335 (24%), Positives = 151/335 (45%), Gaps = 53/335 (15%)
Query: 30 RTF----SYLELCQATDEFSE---------NNLIGKGGFGSVYKARL--GDGMEVAVKVF 74
RTF ++ + Q EF++ + ++G G FG V RL E++V +
Sbjct: 20 RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 75 NLQCG---RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS 131
L+ G + + F E +M H N+I++ + + +V E M +GSL+ +L
Sbjct: 80 TLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRK 139
Query: 132 SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191
+ + Q + ++ +AS ++YL +H DL N+L++ N+V +SDF ++++
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 192 LVGEDQSMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFN 249
L + ++ T+ I + +PE + ++ DV+S+GI+L E + G++P E+ N
Sbjct: 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256
Query: 250 GEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRIN 309
++ ++ VD E C + ++ L + C + R
Sbjct: 257 QDV--------------IKAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPK 296
Query: 310 AKEIVKKLLKIRDSLLRNVGGRCI------RQSNL 338
++IV I D L+RN G I R SNL
Sbjct: 297 FEQIV----SILDKLIRNPGSLKIITSAAARPSNL 327
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 88.2 bits (217), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 10/206 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG V+ +VA+K L+ G + +SF E ++MK ++H L+++ + S
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKT--LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYM GSL +L L + +++ VA+ + Y+ IH D
Sbjct: 75 EEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +N+L+ + ++ ++DF +A+L+ + + Q F I + APE GR + DV
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFP-IKWTAPEAALYGRFTIKSDV 189
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEM 252
+SFGI+L E T G+ P + N E+
Sbjct: 190 WSFGILLTELVTKGRVPYPGMNNREV 215
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 88.2 bits (217), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 72/267 (26%), Positives = 121/267 (45%), Gaps = 28/267 (10%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +++E+M +G+L YL N + L + ++SA+EYL IH D
Sbjct: 78 REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 193
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKE 286
++FG++L E T G P I P E++ ++D E
Sbjct: 194 WAFGVLLWEIATYGMSPYPGI--------------DPSQVYELL------EKDYRMERPE 233
Query: 287 QCVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 234 GCPEKVYELMRACWQWNPSDRPSFAEI 260
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 88.2 bits (217), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 73/267 (27%), Positives = 120/267 (44%), Gaps = 28/267 (10%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 19 LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N + L + ++SA+EYL IH D
Sbjct: 78 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 193
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKE 286
++FG++L E T G P I P E++ ++D E
Sbjct: 194 WAFGVLLWEIATYGMSPYPGI--------------DPSQVYELL------EKDYRMERPE 233
Query: 287 QCVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 234 GCPEKVYELMRACWQWNPSDRPSFAEI 260
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 81 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFP-IKWTAPESLAYNKFSIKSDV 196
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 197 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 237
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 238 CPEKVYELMRACWQWNPSDRPSFAEI 263
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 87.8 bits (216), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +++E+M +G+L YL N + L + ++SA+EYL IH D
Sbjct: 80 REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 195
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 87.8 bits (216), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 195
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 87.8 bits (216), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +++E+M +G+L YL N + L + ++SA+EYL IH D
Sbjct: 80 REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 195
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 87.8 bits (216), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 200
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 201 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 241
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 87.8 bits (216), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 195
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 87.8 bits (216), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFP-IKWTAPESLAYNKFSIKSDV 197
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 198 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 238
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 87.8 bits (216), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 200
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 201 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 241
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 87.8 bits (216), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFN-----VECEMMKSIRHRNLIKV 103
+G GGFG V + D G +VA+K QC + L N +E ++MK + H N++
Sbjct: 23 LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 104 ------ISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYL 155
+ + + L +EY G L KYL + + C L ++ D++SAL YL
Sbjct: 79 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 138
Query: 156 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
H IIH DLKP N++L ++ + D AK L DQ T+ T+ Y+A
Sbjct: 139 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 192
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
PE + + + D +SFG + E TG +P
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 223
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 87.8 bits (216), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 84 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 140
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 199
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 200 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 240
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEI 266
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 87.4 bits (215), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 77/312 (24%), Positives = 143/312 (45%), Gaps = 45/312 (14%)
Query: 33 SYLELCQATDEFSEN---------NLIGKGGFGSVYKARL--GDGMEVAVKVFNLQCG-- 79
+Y + QA EF++ +IG G FG V RL E+ V + L+ G
Sbjct: 4 TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 80 -RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 138
+ + F E +M H N+I + + + +V EYM +GSL+ +L ++ +
Sbjct: 64 EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 139 FQRLNIMIDVASALEYL-HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
Q + ++ +++ ++YL GY +H DL N+L++ N+V +SDF ++++L + +
Sbjct: 124 IQLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 198 SMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLK 255
+ T+ I + APE + ++ DV+S+GI++ E + G++P E+ N ++
Sbjct: 180 AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDV--- 236
Query: 256 HWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
I +E E + C + ++ L + C + R EIV
Sbjct: 237 --------IKAVE---------EGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVN 279
Query: 316 KLLKIRDSLLRN 327
L D L+RN
Sbjct: 280 ML----DKLIRN 287
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 87.4 bits (215), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFN-----VECEMMKSIRHRNLIKV 103
+G GGFG V + D G +VA+K QC + L N +E ++MK + H N++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 104 ------ISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYL 155
+ + + L +EY G L KYL + + C L ++ D++SAL YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 156 HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
H IIH DLKP N++L ++ + D AK L DQ T+ T+ Y+A
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 191
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
PE + + + D +SFG + E TG +P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 87.4 bits (215), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 197
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 198 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 238
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 197
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 198 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 238
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 239 CPEKVYELMRACWQWNPSDRPSFAEI 264
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 200
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 201 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 241
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEI 267
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 77/266 (28%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 40 LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E +V EYMP+G+L YL N + L + ++SA+EYL IH D
Sbjct: 99 LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N V ++DF +++L+ G+ + F I + APE S DV
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNTFSIKSDV 214
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKE 286
++FG++L E T G P + G I +V D L ++ E
Sbjct: 215 WAFGVLLWEIATYGMSP----YPG-------------IDLSQVYD---LLEKGYRMEQPE 254
Query: 287 QCVSFVFNLAMACAVESPEQRINAKE 312
C V+ L AC SP R + E
Sbjct: 255 GCPPKVYELMRACWKWSPADRPSFAE 280
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 34 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH D
Sbjct: 93 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 149
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 208
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 209 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 249
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 250 CPEKVYELMRACWQWNPSDRPSFAEI 275
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N + L + ++SA+EYL IH D
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 195
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEI 262
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 32/290 (11%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N + L + ++SA+EYL IH D
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 195
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 196 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 236
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKL------LKIRDSLLRNVGGR 331
C V+ L AC +P R + EI + I D + + +G R
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 286
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 87.0 bits (214), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 32/290 (11%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N + L + ++SA+EYL IH D
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 200
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 201 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 241
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKL------LKIRDSLLRNVGGR 331
C V+ L AC +P R + EI + I D + + +G R
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 291
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 21/238 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---SFNVECEMMKSIR 96
+D + ++G GG V+ AR L +VAVKV R F E + ++
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 97 HRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
H ++ V ++ E +V+EY+ +L +++ + + I + +A A
Sbjct: 71 HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYM 211
+ L+F + IIH D+KP+N+++ + DF IA+ + S+TQT T Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLPIS 265
+PE R V A DVYS G +L E TG+ P F G+ + +H D +P S
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 65/274 (23%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VA+K+ + + F E ++M ++ H L+++ C+
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ ++ EYM +G L YL Q L + DV A+EYL S +H DL
Sbjct: 76 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L++D V +SDF +++ ++ ++ + ++ F + + PE + S+ D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFP-VRWSPPEVLMYSKFSSKSDIWA 191
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
FG+++ E ++ GK P + N E T +H L + +L S++
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSE-TAEHIAQG------LRLYRPHLASEK---------- 234
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
V+ + +C E ++R K ++ +L + D
Sbjct: 235 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 265
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 86.3 bits (212), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 11/217 (5%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RALKSFNVECEMMKSIR 96
E ++G G FG+VYK + +G + VA+K+ N G +A F E +M S+
Sbjct: 39 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H +L++++ C + + LV + MPHG L +Y++ + LN + +A + YL
Sbjct: 99 HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +A+LL G+++ I +MA E
Sbjct: 158 ---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
+ + DV+S+G+ + E T G KP D I E+
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 251
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 21/238 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---SFNVECEMMKSIR 96
+D + ++G GG V+ AR L +VAVKV R F E + ++
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 97 HRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
H ++ V + E +V+EY+ +L +++ + + I + +A A
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYM 211
+ L+F + IIH D+KP+N+++ + DF IA+ + S+TQT T Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLPIS 265
+PE R V A DVYS G +L E TG+ P F G+ + +H D +P S
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 15/221 (6%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMK 93
LE DE + ++GKG +G VY R L + + +A+K + R + + E + K
Sbjct: 1 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 94 SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI-DVASA 151
++H+N+++ + S S F + +E +P GSL L S + D Q + +
Sbjct: 61 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIG 209
L+YLH I+H D+K NVL++ + V +SDF +K L G + T+TF T+
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQ 174
Query: 210 YMAPEY---GREGRVSANGDVYSFGIMLMETFTGKKPTDEI 247
YMAPE G G A D++S G ++E TGK P E+
Sbjct: 175 YMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYEL 214
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N + L + ++SA+EYL IH D
Sbjct: 78 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 193
Query: 228 YSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKE 286
++FG++L E T G P I P E++ ++D E
Sbjct: 194 WAFGVLLWEIATYGMSPYPGI--------------DPSQVYELL------EKDYRMERPE 233
Query: 287 QCVSFVFNLAMACAVESPEQRINAKEIVKKL------LKIRDSLLRNVGGR 331
C V+ L AC +P R + EI + I D + + +G R
Sbjct: 234 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 284
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 50 IGKGGFGSVY-----KARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIKV 103
+G+G FG V G G VAVK CG L+S + E E+++++ H +++K
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 104 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
C ++ K+ LV+EY+P GSL YL +C+ + Q L + + YLH +
Sbjct: 76 KGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLH---AQ 130
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREGR 220
IH L NVLLD++ + + DF +AK + G + + + + + APE +E +
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 221 VSANGDVYSFGIMLMETFT 239
DV+SFG+ L E T
Sbjct: 191 FYYASDVWSFGVTLYELLT 209
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 15/221 (6%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMK 93
LE DE + ++GKG +G VY R L + + +A+K + R + + E + K
Sbjct: 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 74
Query: 94 SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI-DVASA 151
++H+N+++ + S S F + +E +P GSL L S + D Q + +
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDD-NMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIG 209
L+YLH I+H D+K NVL++ + V +SDF +K L G + T+TF T+
Sbjct: 135 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTGTLQ 188
Query: 210 YMAPEY---GREGRVSANGDVYSFGIMLMETFTGKKPTDEI 247
YMAPE G G A D++S G ++E TGK P E+
Sbjct: 189 YMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYEL 228
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 65/274 (23%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VA+K+ + + F E ++M ++ H L+++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ ++ EYM +G L YL Q L + DV A+EYL S +H DL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L++D V +SDF +++ ++ ++++ + F + + PE + S+ D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFP-VRWSPPEVLMYSKFSSKSDIWA 206
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
FG+++ E ++ GK P + N E T +H L + +L S++
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSE-TAEHIAQG------LRLYRPHLASEK---------- 249
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
V+ + +C E ++R K ++ +L + D
Sbjct: 250 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 280
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 21/239 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK---SFNVECEMMKSIR 96
+D + ++G GG V+ AR L +VAVKV R F E + ++
Sbjct: 28 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 97 HRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
H ++ V + E +V+EY+ +L +++ + + I + +A A
Sbjct: 88 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 143
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYM 211
+ L+F + IIH D+KP+N+++ + DF IA+ + S+TQT T Y+
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE----MTLKHWVNDWLPIST 266
+PE R V A DVYS G +L E TG+ P F G+ + +H D +P S
Sbjct: 204 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSA 258
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 50 IGKGGFGSVY-----KARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIKV 103
+G+G FG V G G VAVK CG L+S + E E+++++ H +++K
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 104 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
C ++ K+ LV+EY+P GSL YL +C+ + Q L + + YLH +
Sbjct: 77 KGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCV-GLAQLLLFAQQICEGMAYLH---AQ 131
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREGR 220
IH L NVLLD++ + + DF +AK + G + + + + + APE +E +
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 221 VSANGDVYSFGIMLMETFT 239
DV+SFG+ L E T
Sbjct: 192 FYYASDVWSFGVTLYELLT 210
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 85.9 bits (211), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 11/217 (5%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RALKSFNVECEMMKSIR 96
E ++G G FG+VYK + +G + VA+K+ N G +A F E +M S+
Sbjct: 16 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H +L++++ C + + LV + MPHG L +Y++ + LN + +A + YL
Sbjct: 76 HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +A+LL G+++ I +MA E
Sbjct: 135 ---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
+ + DV+S+G+ + E T G KP D I E+
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG V+ + +VAVK L+ G ++++F E +MK+++H L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL-NIMIDVASALEYLHFGYSAPIIHCD 167
EE ++ EYM GSL +L S + +L + +A + Y+ IH D
Sbjct: 79 REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +NVL+ ++++ ++DF +A+++ + + + F I + APE G + DV
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGCFTIKSDV 194
Query: 228 YSFGIMLMETFT-GKKP 243
+SFGI+L E T GK P
Sbjct: 195 WSFGILLYEIVTYGKIP 211
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 34 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA ++YL S
Sbjct: 94 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 251
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 252 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 65/274 (23%), Positives = 126/274 (45%), Gaps = 26/274 (9%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VA+K+ + + F E ++M ++ H L+++ C+
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ ++ EYM +G L YL Q L + DV A+EYL S +H DL
Sbjct: 76 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L++D V +SDF +++ ++ ++ + + F + + PE + S+ D+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VRWSPPEVLMYSKFSSKSDIWA 191
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
FG+++ E ++ GK P + N E T +H L + +L S++
Sbjct: 192 FGVLMWEIYSLGKMPYERFTNSE-TAEHIAQG------LRLYRPHLASEK---------- 234
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
V+ + +C E ++R K ++ +L + D
Sbjct: 235 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 265
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 85.1 bits (209), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 65/274 (23%), Positives = 126/274 (45%), Gaps = 26/274 (9%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VA+K+ + + F E ++M ++ H L+++ C+
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ ++ EYM +G L YL Q L + DV A+EYL S +H DL
Sbjct: 75 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 131
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L++D V +SDF +++ ++ ++ + + F + + PE + S+ D+++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VRWSPPEVLMYSKFSSKSDIWA 190
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
FG+++ E ++ GK P + N E T +H L + +L S++
Sbjct: 191 FGVLMWEIYSLGKMPYERFTNSE-TAEHIAQG------LRLYRPHLASEK---------- 233
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
V+ + +C E ++R K ++ +L + D
Sbjct: 234 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 264
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 85.1 bits (209), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 65/274 (23%), Positives = 126/274 (45%), Gaps = 26/274 (9%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VA+K+ + + F E ++M ++ H L+++ C+
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ ++ EYM +G L YL Q L + DV A+EYL S +H DL
Sbjct: 82 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 138
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L++D V +SDF +++ ++ ++ + + F + + PE + S+ D+++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VRWSPPEVLMYSKFSSKSDIWA 197
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
FG+++ E ++ GK P + N E T +H L + +L S++
Sbjct: 198 FGVLMWEIYSLGKMPYERFTNSE-TAEHIAQG------LRLYRPHLASEK---------- 240
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
V+ + +C E ++R K ++ +L + D
Sbjct: 241 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 271
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 84.7 bits (208), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 65/274 (23%), Positives = 126/274 (45%), Gaps = 26/274 (9%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VA+K+ + + F E ++M ++ H L+++ C+
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ ++ EYM +G L YL Q L + DV A+EYL S +H DL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L++D V +SDF +++ ++ ++ + + F + + PE + S+ D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VRWSPPEVLMYSKFSSKSDIWA 206
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
FG+++ E ++ GK P + N E T +H L + +L S++
Sbjct: 207 FGVLMWEIYSLGKMPYERFTNSE-TAEHIAQG------LRLYRPHLASEK---------- 249
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
V+ + +C E ++R K ++ +L + D
Sbjct: 250 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 280
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 84.7 bits (208), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 65/274 (23%), Positives = 126/274 (45%), Gaps = 26/274 (9%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V + +VA+K+ + + F E ++M ++ H L+++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLK 169
+ ++ EYM +G L YL Q L + DV A+EYL S +H DL
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127
Query: 170 PSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYS 229
N L++D V +SDF +++ ++ ++ + + F + + PE + S+ D+++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VRWSPPEVLMYSKFSSKSDIWA 186
Query: 230 FGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
FG+++ E ++ GK P + N E T +H L + +L S++
Sbjct: 187 FGVLMWEIYSLGKMPYERFTNSE-TAEHIAQG------LRLYRPHLASEK---------- 229
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
V+ + +C E ++R K ++ +L + D
Sbjct: 230 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 260
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 84.7 bits (208), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 225 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 283
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH +
Sbjct: 284 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 340
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 341 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 399
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 400 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 440
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 441 CPEKVYELMRACWQWNPSDRPSFAEI 466
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 27 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA ++YL S
Sbjct: 87 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 143
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 244
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 245 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 291
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA ++YL S
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 148
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 249
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA ++YL S
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 247
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA ++YL S
Sbjct: 95 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 252
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 253 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA ++YL S
Sbjct: 95 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 252
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 253 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 54 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA ++YL S
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 170
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 271
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 272 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 318
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 33 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA ++YL S
Sbjct: 93 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 149
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 250
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 251 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 84.3 bits (207), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 34 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA ++YL S
Sbjct: 94 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 251
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 252 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 84.3 bits (207), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 69/287 (24%), Positives = 138/287 (48%), Gaps = 36/287 (12%)
Query: 49 LIGKGGFGSVYKARL--GDGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKV 103
+IG G FG V RL +VAV + L+ G + + F E +M H N++ +
Sbjct: 50 VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAP 162
+ + +V+E+M +G+L+ +L + + Q + ++ +A+ + YL GY
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY--- 166
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM-TQTQTFATIGYMAPEYGREGRV 221
+H DL N+L++ N+V +SDF +++++ + +++ T T + + APE + +
Sbjct: 167 -VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 222 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDI 280
++ DV+S+GI++ E + G++P +W +S +V+ A +E
Sbjct: 226 TSASDVWSYGIVMWEVMSYGERP------------YW-----DMSNQDVIKA---IEEGY 265
Query: 281 HFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327
A C + + L + C + +R ++IV I D ++RN
Sbjct: 266 RLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIV----GILDKMIRN 308
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 84.3 bits (207), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 50 IGKGGFGSVY-----KARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIKV 103
+G+G FG V G G VAVK CG +S + E ++++++ H ++IK
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 104 ISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
C ++ K+L V+EY+P GSL YL + + + Q L + + YLH S
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREGR 220
IH +L NVLLD++ + + DF +AK + G + + + + + APE +E +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 221 VSANGDVYSFGIMLMETFT 239
DV+SFG+ L E T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 84.3 bits (207), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 53 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA ++YL S
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 169
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 270
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 271 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 317
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/266 (25%), Positives = 121/266 (45%), Gaps = 26/266 (9%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N ++ L + ++SA+EYL IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 441
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T M+ P +++ L ++D E
Sbjct: 442 WAFGVLLWEIATYG----------MS---------PYPGIDLSQVYELLEKDYRMERPEG 482
Query: 288 CVSFVFNLAMACAVESPEQRINAKEI 313
C V+ L AC +P R + EI
Sbjct: 483 CPEKVYELMRACWQWNPSDRPSFAEI 508
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/289 (23%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 49 LIGKGGFGSVYKARL--GDGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKV 103
+IG G FG V + RL E V + L+ G R + F E +M H N+I++
Sbjct: 23 VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAP 162
+N ++ E+M +G+L+ +L ++ + Q + ++ +AS + YL Y
Sbjct: 83 EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSY--- 139
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA---TIGYMAPEYGREG 219
+H DL N+L++ N+V +SDF +++ L T+T + I + APE
Sbjct: 140 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ ++ D +S+GI++ E + G++P +W +S +V++A ++
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERP------------YW-----DMSNQDVINA---IEQ 238
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327
D C + + L + C + R ++V L D ++RN
Sbjct: 239 DYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL----DKMIRN 283
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 84.0 bits (206), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 32/290 (11%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G +G VY+ + VAVK + ++ F E +MK I+H NL++++ C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
E ++ E+M +G+L YL N + L + ++SA+EYL IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L N L+ +N + ++DF +++L+ G+ + F I + APE + S DV
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IKWTAPESLAYNKFSIKSDV 402
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
++FG++L E T P +++ L ++D E
Sbjct: 403 WAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYRMERPEG 443
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKL------LKIRDSLLRNVGGR 331
C V+ L AC +P R + EI + I D + + +G R
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 493
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 27/217 (12%)
Query: 48 NLIGKGGFGSVYKARLG-DG--MEVAVKVFNLQCGRA-LKSFNVECEMM-KSIRHRNLIK 102
++IG+G FG V KAR+ DG M+ A+K + + F E E++ K H N+I
Sbjct: 21 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 147
++ +C + + L +EY PHG+L +L S + L Q L+ D
Sbjct: 81 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA ++YL IH DL N+L+ +N VA ++DF +++ G++ + +T
Sbjct: 141 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 194
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MA E + N DV+S+G++L E + G P
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 231
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 38 CQATDEFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNV 87
CQ F E +L +GKG FGSV R LGD G VAVK + F
Sbjct: 1 CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 88 ECEMMKSIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 145
E +++K++ ++K +S + LV+EY+P G L +L LD + L
Sbjct: 61 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 120
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQT 204
+ +EYL S +H DL N+L++ ++DF +AKLL + +D + +
Sbjct: 121 SQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 177
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+ I + APE + S DV+SFG++L E FT
Sbjct: 178 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 36 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA +++L S
Sbjct: 96 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ ++ ++ +T A + +MA E +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 253
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 254 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 27/217 (12%)
Query: 48 NLIGKGGFGSVYKARLG-DG--MEVAVKVFNLQCGRA-LKSFNVECEMM-KSIRHRNLIK 102
++IG+G FG V KAR+ DG M+ A+K + + F E E++ K H N+I
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 147
++ +C + + L +EY PHG+L +L S + L Q L+ D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA ++YL IH DL N+L+ +N VA ++DF +++ G++ + +T
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MA E + N DV+S+G++L E + G P
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 35 LELCQATDEFSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKS 84
L CQ F E +L +GKG FGSV R LGD G VAVK +
Sbjct: 11 LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 85 FNVECEMMKSIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 142
F E +++K++ ++K +S + LV+EY+P G L +L LD + L
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 143 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQ 201
+ +EYL S +H DL N+L++ ++DF +AKLL + +D + +
Sbjct: 131 LYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 202 TQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+ I + APE + S DV+SFG++L E FT
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 74/316 (23%), Positives = 143/316 (45%), Gaps = 49/316 (15%)
Query: 32 FSYLELCQATDEFSEN---------NLIGKGGFGSVYKA--RLGDGMEVAVKVFNLQCG- 79
F++ + +A EF++ +IG G FG V +L E+ V + L+ G
Sbjct: 14 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 80 --RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 137
+ + F E +M H N+I + + ++ E+M +GSL+ +L ++
Sbjct: 74 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
+ Q + ++ +A+ ++YL +H DL N+L++ N+V +SDF +++ L ED
Sbjct: 134 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDD 188
Query: 198 SMTQTQTFA-----TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGE 251
+ T T A I + APE + + ++ DV+S+GI++ E + G++P
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------- 240
Query: 252 MTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAK 311
+W ++ +V++A ++D C S + L + C + R
Sbjct: 241 ----YW-----DMTNQDVINA---IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 288
Query: 312 EIVKKLLKIRDSLLRN 327
+IV L D ++RN
Sbjct: 289 QIVNTL----DKMIRN 300
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 90 DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E S + D+++ G ++ + G P
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAGLPP 233
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 82.8 bits (203), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 50 IGKGGFGSVY-----KARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIKV 103
+G+G FG V G G VAVK CG +S + E ++++++ H ++IK
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 104 ISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
C ++ K+L V+EY+P GSL YL + + + Q L + + YLH +
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREGR 220
IH +L NVLLD++ + + DF +AK + G + + + + + APE +E +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 221 VSANGDVYSFGIMLMETFT 239
DV+SFG+ L E T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 69/289 (23%), Positives = 130/289 (44%), Gaps = 38/289 (13%)
Query: 49 LIGKGGFGSVYKARL--GDGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKV 103
+IG G FG V + RL E V + L+ G R + F E +M H N+I++
Sbjct: 21 VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAP 162
+N ++ E+M +G+L+ +L ++ + Q + ++ +AS + YL Y
Sbjct: 81 EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSY--- 137
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA---TIGYMAPEYGREG 219
+H DL N+L++ N+V +SDF +++ L T T + I + APE
Sbjct: 138 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ ++ D +S+GI++ E + G++P +W +S +V++A ++
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERP------------YW-----DMSNQDVINA---IEQ 236
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327
D C + + L + C + R ++V L D ++RN
Sbjct: 237 DYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL----DKMIRN 281
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 33 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA +++L S
Sbjct: 93 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 149
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 250
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 251 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 36 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA +++L S
Sbjct: 96 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 253
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 254 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA +++L S
Sbjct: 95 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 252
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 253 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 35 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA +++L S
Sbjct: 95 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 252
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 253 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 82.4 bits (202), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
N +IG+G FG VY L G + AVK N + + F E +MK H N++
Sbjct: 40 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 102 KVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
++ C E LV L YM HG L ++ + + + + VA +++L S
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 156
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
+ + DV+SFG++L E T P P + D + +
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 257
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ E C ++ + + C E R + E+V ++ I + +
Sbjct: 258 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 304
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 71/283 (25%), Positives = 128/283 (45%), Gaps = 41/283 (14%)
Query: 43 EFSENNLIGKGGFGSVYKARL----GDGMEVAVKVF--NLQCGRALKSFNVECEMMKSIR 96
+F+ ++GKG FGSV +A+L G ++VAVK+ ++ ++ F E MK
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 97 HRNLIKVISSCSNEEFKA------LVLEYMPHGSLEKYLYSSNCILDIFQR-----LNIM 145
H ++ K++ K ++L +M HG L +L +S + F + M
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+D+A +EYL S IH DL N +L ++M ++DF +++ + D +
Sbjct: 144 VDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPI 264
+ ++A E + + + DV++FG+ + E T G+ P I N E + ++L
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYL-- 252
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR 307
+ N L Q +C+ V++L C P+QR
Sbjct: 253 -----IGGNRLKQ-------PPECMEEVYDLMYQCWSADPKQR 283
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 59/237 (24%), Positives = 118/237 (49%), Gaps = 19/237 (8%)
Query: 32 FSYLELCQATDEFSEN---------NLIGKGGFGSVYKARL--GDGMEVAVKVFNLQCG- 79
F++ + QA EF++ +IG G FG V RL E+ V + L+ G
Sbjct: 10 FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 80 --RALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 137
+ + F E +M H N+I + + + ++ EYM +GSL+ +L ++
Sbjct: 70 TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
+ Q + ++ + S ++YL +H DL N+L++ N+V +SDF ++++L + +
Sbjct: 130 VIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 198 SMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
+ T+ I + APE + ++ DV+S+GI++ E + G++P ++ N ++
Sbjct: 187 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 243
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 73/260 (28%), Positives = 118/260 (45%), Gaps = 38/260 (14%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G G FG V+ A +VAVK ++++F E +MK+++H L+K+ + +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL-EYLHFGYSAPIIHCDL 168
E ++ E+M GSL +L S Q L +ID ++ + E + F IH DL
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+ +N+L+ ++V ++DF +A+ VG I + APE G + DV+
Sbjct: 305 RAANILVSASLVCKIADFGLAR--VGAK---------FPIKWTAPEAINFGSFTIKSDVW 353
Query: 229 SFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
SFGI+LME T G+ P + N E+ I LE E
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEV-----------IRALE---------RGYRMPRPEN 393
Query: 288 CVSFVFNLAMACAVESPEQR 307
C ++N+ M C PE+R
Sbjct: 394 CPEELYNIMMRCWKNRPEER 413
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 82.0 bits (201), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 68/288 (23%), Positives = 119/288 (41%), Gaps = 32/288 (11%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNL 100
N +IG+G FG VY L G + AVK N G + F E +MK H N+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-VSQFLTEGIIMKDFSHPNV 152
Query: 101 IKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+ ++ C E LV L YM HG L ++ + + + + VA +++L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGR 217
S +H DL N +LD+ ++DF +A+ + ++ +T A + +MA E +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
+ + DV+SFG++L E T P P + D +
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 310
Query: 278 EDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
+ + E C ++ + + C E R + E+V ++ I + +
Sbjct: 311 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 9 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 66
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 67 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 125
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 126 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 182
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 183 LTEKSACKSSDLWALGCIIYQLVAGLPP 210
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 82.0 bits (201), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 65
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 66 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 124
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 181
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPP 209
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 14 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 71
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 72 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 130
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 131 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 188 LTEKSACKSSDLWALGCIIYQLVAGLPP 215
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 7 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 64
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 65 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 123
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 124 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 180
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 181 LTEKSACKSSDLWALGCIIYQLVAGLPP 208
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 29 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 86
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 87 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 145
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPP 230
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 29 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 86
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 87 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 145
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 202
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLPP 230
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 81.6 bits (200), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 10 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 67
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 68 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 126
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 127 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 183
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 184 LTEKSACKSSDLWALGCIIYQLVAGLPP 211
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 27/217 (12%)
Query: 48 NLIGKGGFGSVYKARLG-DG--MEVAVKVFNLQCGRA-LKSFNVECEMM-KSIRHRNLIK 102
++IG+G FG V KAR+ DG M+ A+K + + F E E++ K H N+I
Sbjct: 28 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQRLNIMID 147
++ +C + + L +EY PHG+L +L S + L Q L+ D
Sbjct: 88 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA ++YL IH +L N+L+ +N VA ++DF +++ G++ + +T
Sbjct: 148 VARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 201
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MA E + N DV+S+G++L E + G P
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 238
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 81.6 bits (200), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 90 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAGLPP 233
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 81.3 bits (199), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 90 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 90 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 90 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 33 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 90
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 91 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 149
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPP 234
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 33 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 90
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 91 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 149
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLPP 234
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 56/197 (28%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG V+ + +VAVK L+ G ++++F E +MK+++H L+++ + +
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL-NIMIDVASALEYLHFGYSAPIIHCD 167
EE ++ E+M GSL +L S + +L + +A + Y+ IH D
Sbjct: 78 KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L+ +NVL+ ++++ ++DF +A+++ + + + F I + APE G + +V
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP-IKWTAPEAINFGCFTIKSNV 193
Query: 228 YSFGIMLMETFT-GKKP 243
+SFGI+L E T GK P
Sbjct: 194 WSFGILLYEIVTYGKIP 210
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 81.3 bits (199), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 90 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLPP 233
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 35 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 92
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 93 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 151
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 152 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLPP 236
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 80.9 bits (198), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++EY G+L +YL Y N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 258
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 259 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 317 LLKI 320
L +I
Sbjct: 313 LDRI 316
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 44 FSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMMK 93
F E +L +GKG FGSV R LGD G VAVK + F E +++K
Sbjct: 4 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 94 SIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
++ ++K +S LV+EY+P G L +L LD + L +
Sbjct: 64 ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGY 210
+EYL S +H DL N+L++ ++DF +AKLL + +D + + + I +
Sbjct: 124 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT 239
APE + S DV+SFG++L E FT
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFT 209
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++EY G+L +YL Y N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 258
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 259 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 317 LLKI 320
L +I
Sbjct: 313 LDRI 316
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 80.5 bits (197), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++EY G+L +YL Y N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 258
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 259 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 317 LLKI 320
L +I
Sbjct: 313 LDRI 316
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 80.1 bits (196), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 44 FSENNL-----IGKGGFGSVYKAR---LGD--GMEVAVKVFNLQCGRALKSFNVECEMMK 93
F E +L +GKG FGSV R LGD G VAVK + F E +++K
Sbjct: 8 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 94 SIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
++ ++K +S + LV+EY+P G L +L LD + L +
Sbjct: 68 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGY 210
+EYL S +H DL N+L++ ++DF +AKLL + +D + + + I +
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT 239
APE + S DV+SFG++L E FT
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYELFT 213
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++EY G+L +YL Y N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 258
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 259 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 317 LLKI 320
L +I
Sbjct: 313 LDRI 316
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F +V AR L E A+K+ L+ +K V E ++M +
Sbjct: 37 EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 94
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 95 DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 153
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 154 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 211 LTEKSACKSSDLWALGCIIYQLVAGLPP 238
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++EY G+L +YL Y N + +
Sbjct: 95 KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 258
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 259 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 317 LLKI 320
L +I
Sbjct: 313 LDRI 316
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 58/230 (25%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 39 QATDEFSEN---------NLIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKS 84
QA EF++ +IG G FG V RL E+ V + L+ G + +
Sbjct: 2 QAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD 61
Query: 85 FNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 144
F E +M H N+I + + + ++ EYM +GSL+ +L ++ + Q + +
Sbjct: 62 FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGM 121
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
+ + S ++YL +H DL N+L++ N+V +SDF ++++L + ++ T+
Sbjct: 122 LRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRG 178
Query: 205 FA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
I + APE + ++ DV+S+GI++ E + G++P ++ N ++
Sbjct: 179 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 228
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-----ECEMMKSI 95
++F ++G+G F + AR L E A+K+ L+ +K V E ++M +
Sbjct: 30 EDFKFGKILGEGSFSTTVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H +K+ + ++E L Y +G L KY+ + R ++ SALEYL
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H IIH DLKP N+LL+++M ++DF AK+L E + T Y++PE
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKP 243
E + D+++ G ++ + G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 80.1 bits (196), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++EY G+L +YL Y N + +
Sbjct: 95 KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 258
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 259 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 317 LLKI 320
L +I
Sbjct: 313 LDRI 316
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 50 IGKGGFGSVYKARL---GD--GMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V R GD G +VAVK + G + E E+++++ H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 104 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
C+ + L++E++P GSL++YL + +++ Q+L + + ++YL S
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT-QTQTFATIGYMAPEYGREGR 220
+H DL NVL++ + DF + K + + + T + + + + APE + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 221 VSANGDVYSFGIMLMETFT 239
DV+SFG+ L E T
Sbjct: 206 FYIASDVWSFGVTLHELLT 224
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 50 IGKGGFGSVYKARL---GD--GMEVAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIKV 103
+G+G FG V R GD G +VAVK + G + E E+++++ H N++K
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 104 ISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
C+ + L++E++P GSL++YL + +++ Q+L + + ++YL S
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT-QTQTFATIGYMAPEYGREGR 220
+H DL NVL++ + DF + K + + + T + + + + APE + +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 221 VSANGDVYSFGIMLMETFT 239
DV+SFG+ L E T
Sbjct: 194 FYIASDVWSFGVTLHELLT 212
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 22 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++EY G+L +YL Y N + +
Sbjct: 82 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 142 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 245
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 246 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 299
Query: 317 LLKI 320
L +I
Sbjct: 300 LDRI 303
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCGRA-LKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ L E EMM
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++EY G+L +YL Y N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 258
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 259 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 317 LLKI 320
L +I
Sbjct: 313 LDRI 316
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 83/333 (24%), Positives = 142/333 (42%), Gaps = 50/333 (15%)
Query: 16 RPSNDASMPLVAMWRTFSYLELCQ---ATDEFSENNLIGKGGFGSVY--------KARLG 64
R S+ A P++A + E + D+ + +G+G FG V K +
Sbjct: 52 RLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPK 111
Query: 65 DGMEVAVKVFNLQCG-RALKSFNVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 122
+ + VAVK+ + L E EMMK I +H+N+I ++ +C+ + +++EY
Sbjct: 112 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 171
Query: 123 GSLEKYL-----------YSSNCILD---IFQRL-NIMIDVASALEYLHFGYSAPIIHCD 167
G+L +YL Y N + + F+ L + +A +EYL S IH D
Sbjct: 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRD 228
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDV 227
L NVL+ +N V ++DF +A+ + D T + +MAPE + + DV
Sbjct: 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
+SFG+++ E FT G P + V + L +E
Sbjct: 289 WSFGVLMWEIFT--------LGGS-----------PYPGIPVEELFKLLKEGHRMDKPAN 329
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C + ++ + C P QR K++V+ L +I
Sbjct: 330 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 108/212 (50%), Gaps = 10/212 (4%)
Query: 48 NLIGKGGFGSVYKARLG--DGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIK 102
+IG G FG V RL E+ V + L+ G + + F E +M H N+I
Sbjct: 14 KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ + + ++ EYM +GSL+ +L ++ + Q + ++ + S ++YL
Sbjct: 74 LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMS 130
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGREGRV 221
+H DL N+L++ N+V +SDF ++++L + ++ T+ I + APE +
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 222 SANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
++ DV+S+GI++ E + G++P ++ N ++
Sbjct: 191 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 222
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 70/291 (24%), Positives = 133/291 (45%), Gaps = 42/291 (14%)
Query: 49 LIGKGGFGSVYKA--RLGDGMEVAVKVFNLQCG---RALKSFNVECEMMKSIRHRNLIKV 103
+IG G FG V +L E+ V + L+ G + + F E +M H N+I +
Sbjct: 14 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGYSAP 162
+ ++ E+M +GSL+ +L ++ + Q + ++ +A+ ++YL Y
Sbjct: 74 EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY--- 130
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA-----TIGYMAPEYGR 217
+H L N+L++ N+V +SDF +++ L ED + T T A I + APE +
Sbjct: 131 -VHRALAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 218 EGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLS 276
+ ++ DV+S+GI++ E + G++P +W ++ +V++A
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERP------------YW-----DMTNQDVINA---I 227
Query: 277 QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRN 327
++D C S + L + C + R +IV L D ++RN
Sbjct: 228 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRN 274
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 24 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++EY G+L +YL Y N + +
Sbjct: 84 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 144 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 247
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 248 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 301
Query: 317 LLKI 320
L +I
Sbjct: 302 LDRI 305
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 79.0 bits (193), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 27 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++EY G+L +YL Y N + +
Sbjct: 87 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 147 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 250
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 251 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 304
Query: 317 LLKI 320
L +I
Sbjct: 305 LDRI 308
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 50 IGKGGFGSVY-----KARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIKV 103
+G+G FG V G G VAVK G +S + E ++++++ H ++IK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 104 ISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
C + +L V+EY+P GSL YL + + + Q L + + YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREGR 220
IH DL NVLLD++ + + DF +AK + G + + + + + APE +E +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 221 VSANGDVYSFGIMLMETFT 239
DV+SFG+ L E T
Sbjct: 214 FYYASDVWSFGVTLYELLT 232
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 78.6 bits (192), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 72/267 (26%), Positives = 113/267 (42%), Gaps = 26/267 (9%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G +GSVYKA G VA+K ++ L+ E +M+ +++K S
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+V+EY GS+ + N L + I+ LEYLHF IH D+
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K N+LL+ A L+DF +A L D + T +MAPE +E + D++
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
S GI +E GK P +I P+ + ++ N F E
Sbjct: 210 SLGITAIEMAEGKPPYADIH--------------PMRAIFMIPTNPPPT----FRKPELW 251
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVK 315
+ C V+SPEQR A ++++
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQ 278
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 78.2 bits (191), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 47/296 (15%)
Query: 50 IGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSI-RHRN 99
+G+G FG V K + +VAVK+ + L E EMMK I +H+N
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLN------I 144
+I ++ +C+ + +++EY G+L +YL YS N + ++L+
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGS-----------PY 242
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ V + L +E C + ++ + C P QR K++V+ L +I
Sbjct: 243 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 78.2 bits (191), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 77/323 (23%), Positives = 136/323 (42%), Gaps = 59/323 (18%)
Query: 43 EFSENNL-----IGKGGFGSVYKARLGDGME------VAVKVFNLQCGRALKS-FNVECE 90
E+ NN+ IG+G FG V++AR + VAVK+ + +++ F E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----C------------ 134
+M + N++K++ C+ + L+ EYM +G L ++L S + C
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 135 -------ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187
L ++L I VA+ + YL +H DL N L+ +NMV ++DF
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDE 246
+++ + D I +M PE R + DV+++G++L E F+ G +P
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 247 IFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ 306
+ + E+ V D N+L+ E C ++NL C + P
Sbjct: 280 MAHEEVIYY-------------VRDGNILA-------CPENCPLELYNLMRLCWSKLPAD 319
Query: 307 RINAKEIVKKLLKIRDSLLRNVG 329
R + I + L ++ + VG
Sbjct: 320 RPSFCSIHRILQRMCERAEGTVG 342
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 47/296 (15%)
Query: 50 IGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSI-RHRN 99
+G+G FG V K + +VAVK+ + L E EMMK I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLN------I 144
+I ++ +C+ + +++EY G+L +YL YS N + ++L+
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGS-----------PY 253
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ V + L +E C + ++ + C P QR K++V+ L +I
Sbjct: 254 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 47/296 (15%)
Query: 50 IGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSI-RHRN 99
+G+G FG V K + +VAVK+ + L E EMMK I +H+N
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLN------I 144
+I ++ +C+ + +++EY G+L +YL YS N + ++L+
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGS-----------PY 246
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ V + L +E C + ++ + C P QR K++V+ L +I
Sbjct: 247 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 77.8 bits (190), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 47/296 (15%)
Query: 50 IGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSI-RHRN 99
+G+G FG V K + +VAVK+ + L E EMMK I +H+N
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLN------I 144
+I ++ +C+ + +++EY G+L +YL YS N + ++L+
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGS-----------PY 245
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ V + L +E C + ++ + C P QR K++V+ L +I
Sbjct: 246 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 77.8 bits (190), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 76/304 (25%), Positives = 130/304 (42%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++ Y G+L +YL Y N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 258
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 259 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 317 LLKI 320
L +I
Sbjct: 313 LDRI 316
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 77.8 bits (190), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQ-CGRALKSFNV--ECEMMKSIRH 97
D F IGKG FG V + D ++ A+K N Q C + NV E ++M+ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+ + S +EE +V++ + G L +L + + +L + ++ AL+YL
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICELVMALDYLQ- 132
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY-- 215
+ IIH D+KP N+LLD++ H++DF+IA +L E Q T T YMAPE
Sbjct: 133 --NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFS 187
Query: 216 GREGR-VSANGDVYSFGIMLMETFTGKKP 243
R+G S D +S G+ E G++P
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 77.8 bits (190), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 47/296 (15%)
Query: 50 IGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSI-RHRN 99
+G+G FG V K + +VAVK+ + L E EMMK I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLN------I 144
+I ++ +C+ + +++EY G+L +YL YS N + ++L+
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGS-----------PY 253
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ V + L +E C + ++ + C P QR K++V+ L +I
Sbjct: 254 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 77.4 bits (189), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 47/296 (15%)
Query: 50 IGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSI-RHRN 99
+G+G FG V K + +VAVK+ + L E EMMK I +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLN------I 144
+I ++ +C+ + +++EY G+L +YL YS N + ++L+
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGS-----------PY 294
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ V + L +E C + ++ + C P QR K++V+ L +I
Sbjct: 295 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRALKSFNVECEMMKSIRHRNLIKVISSC 107
IG GGF V A + G VA+K+ + G L E E +K++RH+++ ++
Sbjct: 18 IGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVL 77
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+VLEY P G L Y+ S + + + R+ + + SA+ Y+H S H D
Sbjct: 78 ETANKIFMVLEYCPGGELFDYIISQDRLSEEETRV-VFRQIVSAVAYVH---SQGYAHRD 133
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR-EGRVSANGD 226
LKP N+L D+ L DF + G QT ++ Y APE + + + + D
Sbjct: 134 LKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQT-CCGSLAYAAPELIQGKSYLGSEAD 192
Query: 227 VYSFGIMLMETFTGKKPTDE-----IFNGEMTLKHWVNDWLPISTL 267
V+S GI+L G P D+ ++ M K+ V WL S++
Sbjct: 193 VWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSI 238
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 76/304 (25%), Positives = 130/304 (42%), Gaps = 47/304 (15%)
Query: 42 DEFSENNLIGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMM 92
D+ + +G+G FG V K + + + VAVK+ + L E EMM
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 93 KSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCILD--- 137
K I +H+N+I ++ +C+ + +++ Y G+L +YL Y N + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 138 IFQRL-NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
F+ L + +A +EYL S IH DL NVL+ +N V ++DF +A+ + D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKH 256
T + +MAPE + + DV+SFG+++ E FT G
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGS----- 258
Query: 257 WVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKK 316
P + V + L +E C + ++ + C P QR K++V+
Sbjct: 259 ------PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 317 LLKI 320
L +I
Sbjct: 313 LDRI 316
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 39 QATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC-------GRALKSFNVECE 90
+ ++F NL+GKG F VY+A + G+EVA+K+ + + R + C+
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
+ +H +++++ + + + LVLE +G + +YL + + + M + +
Sbjct: 68 L----KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG- 209
+ YLH S I+H DL SN+LL NM ++DF +A L M + + G
Sbjct: 124 GMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL-----KMPHEKHYTLCGT 175
Query: 210 --YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTD 245
Y++PE DV+S G M G+ P D
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 71/318 (22%), Positives = 139/318 (43%), Gaps = 48/318 (15%)
Query: 23 MPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARL-----GDGME-VAVKVFNL 76
MPL+ + E+ + F E +G+ FG VYK L G+ + VA+K
Sbjct: 9 MPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 77 QCGRALKS-FNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----- 130
+ L+ F E + ++H N++ ++ + ++ +++ Y HG L ++L
Sbjct: 67 KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 126
Query: 131 ----------SSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMV 180
+ L+ ++++ +A+ +EYL S ++H DL NVL+ D +
Sbjct: 127 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183
Query: 181 AHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT- 239
+SD + + + D + I +MAPE G+ S + D++S+G++L E F+
Sbjct: 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 243
Query: 240 GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 299
G +P + S +VV+ ++ + + C ++V+ L + C
Sbjct: 244 GLQP-----------------YCGYSNQDVVE--MIRNRQV-LPCPDDCPAWVYALMIEC 283
Query: 300 AVESPEQRINAKEIVKKL 317
E P +R K+I +L
Sbjct: 284 WNEFPSRRPRFKDIHSRL 301
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 47/296 (15%)
Query: 50 IGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSI-RHRN 99
+G+G FG V K + +VAVK+ + L E EMMK I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLN------I 144
+I ++ +C+ + +++EY G+L +YL +S N + ++L+
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGS-----------PY 253
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ V + L +E C + ++ + C P QR K++V+ L +I
Sbjct: 254 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDG----MEVAVKVFNLQCGRALKSFNVECEMM---KS 94
E + ++G G FG+V+K + +G + V +KV + GR +SF + M S
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGS 71
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+ H ++++++ C + LV +Y+P GSL ++ L LN + +A + Y
Sbjct: 72 LDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
L ++H +L NVLL ++DF +A LL +D+ + ++ I +MA E
Sbjct: 131 LE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 215 YGREGRVSANGDVYSFGIMLMETFT-GKKP 243
G+ + DV+S+G+ + E T G +P
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 40/295 (13%)
Query: 47 NNLIGKGGFGSVYKARL----GDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNL 100
++G+G FGSV + L G ++VAVK L R ++ F E MK H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 101 IKVISSCSNEEFKAL-----VLEYMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVAS 150
I+++ C + + +L +M +G L YL S + + L M+D+A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
+EYL + +H DL N +L D+M ++DF ++K + D + +
Sbjct: 159 GMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
+A E + ++ DV++FG+ + E T G P + N EM D+L
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY------DYL------- 262
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSL 324
+ + L Q E C+ ++ + +C P R + +L K+ +SL
Sbjct: 263 LHGHRLKQ-------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAV--KVFNLQCGRALKSFNVECEMM---KS 94
E + ++G G FG+V+K G+ +++ V KV + GR +SF + M S
Sbjct: 32 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGS 89
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+ H ++++++ C + LV +Y+P GSL ++ L LN + +A + Y
Sbjct: 90 LDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
L ++H +L NVLL ++DF +A LL +D+ + ++ I +MA E
Sbjct: 149 LE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 215 YGREGRVSANGDVYSFGIMLMETFT-GKKP 243
G+ + DV+S+G+ + E T G +P
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 36/288 (12%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G FG V + A G + VAVK L A+ F E M S+ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ K +V E P GSL L + + +L R + VA + YL S
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREG 219
IH DL N+LL + + DF + + L +D + Q + APE +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
S D + FG+ L E FT G++P W+ ++ +++ + + +E
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 240
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326
E C ++N+ + C PE R + LL+ + + +R
Sbjct: 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 76.3 bits (186), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 72/275 (26%), Positives = 118/275 (42%), Gaps = 40/275 (14%)
Query: 49 LIGKGGFGSVYKARLGDGMEVAVKV----FNLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
++GKG FG K + EV V F+ + R +F E ++M+ + H N++K I
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR---TFLKEVKVMRCLEHPNVLKFI 73
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
++ + EY+ G+L + S + QR++ D+AS + YLH S II
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED---------QSMTQTQTFATIG---YMA 212
H DL N L+ +N ++DF +A+L+V E + + + + +G +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
PE DV+SFGI+L E G+ D D+LP +D
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCE-IIGRVNADP-------------DYLP----RTMDF 232
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQR 307
L + + C F + + C PE+R
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 36/288 (12%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G FG V + A G + VAVK L A+ F E M S+ HRNLI+
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ K +V E P GSL L + + +L R + VA + YL S
Sbjct: 80 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREG 219
IH DL N+LL + + DF + + L +D + Q + APE +
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
S D + FG+ L E FT G++P W+ ++ +++ + + +E
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 234
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326
E C ++N+ + C PE R + LL+ + + +R
Sbjct: 235 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 282
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 71/269 (26%), Positives = 110/269 (40%), Gaps = 36/269 (13%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G FG V + A G + VAVK L A+ F E M S+ HRNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ K +V E P GSL L + + +L R + VA + YL S
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREG 219
IH DL N+LL + + DF + + L +D + Q + APE +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
S D + FG+ L E FT G++P W+ ++ +++ + + +E
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 230
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQR 307
E C ++N+ + C PE R
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 47/296 (15%)
Query: 50 IGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSI-RHRN 99
+G+G FG V K + +VAVK+ + L E EMMK I +H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLN------I 144
+I ++ +C+ + +++EY G+L +YL Y N + ++L+
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGS-----------PY 238
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ V + L +E C + ++ + C P QR K++V+ L +I
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 47/296 (15%)
Query: 50 IGKGGFGSVY--------KARLGDGMEVAVKVFNLQCG-RALKSFNVECEMMKSI-RHRN 99
+G+G FG V K + +VAVK+ + L E EMMK I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQRLN------I 144
+I ++ +C+ + +++EY G+L +YL Y N + ++L+
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
VA +EYL S IH DL NVL+ ++ V ++DF +A+ + D T
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPI 264
+ +MAPE + + DV+SFG++L E FT G P
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGS-----------PY 253
Query: 265 STLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
+ V + L +E C + ++ + C P QR K++V+ L +I
Sbjct: 254 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 54 GFGSVYKARLGD----GMEVAVKVFNLQCGRALK---SFNVECEMMKSIRHRNLIKVISS 106
G G+ K ++G+ G +VAVK+ N Q R+L E + +K RH ++IK+
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
S +V+EY+ G L Y+ + ++ R + + SA++Y H ++H
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVVHR 135
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG- 225
DLKP NVLLD +M A ++DF ++ ++ D +T + Y APE GR+ A
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTSC-GSPNYAAPEV-ISGRLYAGPE 191
Query: 226 -DVYSFGIMLMETFTGKKPTDE 246
D++S G++L G P D+
Sbjct: 192 VDIWSCGVILYALLCGTLPFDD 213
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 71/269 (26%), Positives = 110/269 (40%), Gaps = 36/269 (13%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G FG V + A G + VAVK L A+ F E M S+ HRNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ K +V E P GSL L + + +L R + VA + YL S
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREG 219
IH DL N+LL + + DF + + L +D + Q + APE +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
S D + FG+ L E FT G++P W+ ++ +++ + + +E
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 230
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQR 307
E C ++N+ + C PE R
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 71/269 (26%), Positives = 110/269 (40%), Gaps = 36/269 (13%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G FG V + A G + VAVK L A+ F E M S+ HRNLI+
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ K +V E P GSL L + + +L R + VA + YL S
Sbjct: 80 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREG 219
IH DL N+LL + + DF + + L +D + Q + APE +
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
S D + FG+ L E FT G++P W+ ++ +++ + + +E
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 234
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQR 307
E C ++N+ + C PE R
Sbjct: 235 GERLPRPEDCPQDIYNVMVQCWAHKPEDR 263
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 36/288 (12%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G FG V + A G + VAVK L A+ F E M S+ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ K +V E P GSL L + + +L R + VA + YL S
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREG 219
IH DL N+LL + + DF + + L +D + Q + APE +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
S D + FG+ L E FT G++P W+ ++ +++ + + +E
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 240
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLR 326
E C ++N+ + C PE R + LL+ + + +R
Sbjct: 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 75.5 bits (184), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 71/269 (26%), Positives = 110/269 (40%), Gaps = 36/269 (13%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G FG V + A G + VAVK L A+ F E M S+ HRNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ K +V E P GSL L + + +L R + VA + YL S
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQSMTQTQTFATIGYMAPEYGREG 219
IH DL N+LL + + DF + + L +D + Q + APE +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
S D + FG+ L E FT G++P W+ ++ +++ + + +E
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQIL--HKIDKE 230
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQR 307
E C ++N+ + C PE R
Sbjct: 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR-LGDGME-----VAVKVFNLQCGRALK-SFNVECE 90
EF NNL +G G FG V +A G G E VAVK+ K + E +
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
+M + +H N++ ++ +C++ ++ EY +G L +L + +L+ I A
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 150 SALEYLHFG----------YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199
S + LHF S IH D+ NVLL + VA + DF +A+ ++ + +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+ + +MAPE + + DV+S+GI+L E F+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 74.7 bits (182), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 50 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 110 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 169 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+++ MP G L Y+ + LN + +A + YL
Sbjct: 77 NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 136 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G + K L D + + ++A+AL Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYC 129
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 182
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 183 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 65/291 (22%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 50 IGKGGFGSVYKARL-----GDGME-VAVKVFNLQCGRALKS-FNVECEMMKSIRHRNLIK 102
+G+ FG VYK L G+ + VA+K + L+ F E + ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR---------------LNIMID 147
++ + ++ +++ Y HG L ++L + D+ ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
+A+ +EYL S ++H DL NVL+ D + +SD + + + D +
Sbjct: 137 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 266
I +MAPE G+ S + D++S+G++L E F+ G +P + S
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----------------YCGYSN 236
Query: 267 LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
+VV+ ++ + + C ++V+ L + C E P +R K+I +L
Sbjct: 237 QDVVE--MIRNRQV-LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 21/221 (9%)
Query: 37 LCQATDE------FSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNV 87
+ ATDE + IGKG F V AR + G EVAVK+ + +L+
Sbjct: 4 ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR 63
Query: 88 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 147
E +MK + H N++K+ E+ LV+EY G + YL + + + R
Sbjct: 64 EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-Q 122
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTF- 205
+ SA++Y H Y I+H DLK N+LLD +M ++DF + + VG + TF
Sbjct: 123 IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG-----NKLDTFC 174
Query: 206 ATIGYMAPEYGREGRVSANG-DVYSFGIMLMETFTGKKPTD 245
+ Y APE + + DV+S G++L +G P D
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+++ MP G L Y+ + LN + +A + YL
Sbjct: 79 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+++ MP G L Y+ + LN + +A + YL
Sbjct: 78 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 74.7 bits (182), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+++ MP G L Y+ + LN + +A + YL
Sbjct: 76 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+++ MP G L Y+ + LN + +A + YL
Sbjct: 80 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 139 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+++ MP G L Y+ + LN + +A + YL
Sbjct: 77 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 136 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 74.3 bits (181), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+++ +IG G FG VY+A+L D E+ V + + G+A K N E ++M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFK--NRELQIMRKLDHCNIVRL 78
Query: 104 ------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+E + LVL+Y+P + Y + + I+ +L M + +L Y
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 155 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
PE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 72/284 (25%), Positives = 121/284 (42%), Gaps = 31/284 (10%)
Query: 40 ATDEFSENNLIGKGGFGSVYKA----RLGDGMEVAVKVFNLQCGRALK-SFNVECEMMKS 94
A ++ N ++G+G FG VY+ G+ + VAVK C K F E +MK+
Sbjct: 22 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+ H +++K+I EE +++E P+G L YL + L + + + + A+ Y
Sbjct: 82 LDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 140
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
L S +H D+ N+L+ L DF +++ + ED + T I +M+PE
Sbjct: 141 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPE 196
Query: 215 YGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273
R + DV+ F + + E + GK+P W+ + I LE D
Sbjct: 197 SINFRRFTTASDVWMFAVCMWEILSFGKQPF-----------FWLENKDVIGVLEKGDR- 244
Query: 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L + D+ C ++ L C P R E+V L
Sbjct: 245 -LPKPDL-------CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 280
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T+ T+ Y+ PE
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTELCGTLDYLPPEM 177
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 72/284 (25%), Positives = 120/284 (42%), Gaps = 31/284 (10%)
Query: 40 ATDEFSENNLIGKGGFGSVYKA----RLGDGMEVAVKVFNLQCGRALK-SFNVECEMMKS 94
A ++ N ++G+G FG VY+ G+ + VAVK C K F E +MK+
Sbjct: 6 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+ H +++K+I EE +++E P+G L YL + L + + + + A+ Y
Sbjct: 66 LDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
L S +H D+ N+L+ L DF +++ + ED T I +M+PE
Sbjct: 125 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLPIKWMSPE 180
Query: 215 YGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273
R + DV+ F + + E + GK+P W+ + I LE D
Sbjct: 181 SINFRRFTTASDVWMFAVCMWEILSFGKQPF-----------FWLENKDVIGVLEKGDR- 228
Query: 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L + D+ C ++ L C P R E+V L
Sbjct: 229 -LPKPDL-------CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 264
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 72/284 (25%), Positives = 120/284 (42%), Gaps = 31/284 (10%)
Query: 40 ATDEFSENNLIGKGGFGSVYKA----RLGDGMEVAVKVFNLQCGRALK-SFNVECEMMKS 94
A ++ N ++G+G FG VY+ G+ + VAVK C K F E +MK+
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+ H +++K+I EE +++E P+G L YL + L + + + + A+ Y
Sbjct: 70 LDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
L S +H D+ N+L+ L DF +++ + ED T I +M+PE
Sbjct: 129 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV-TRLPIKWMSPE 184
Query: 215 YGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDAN 273
R + DV+ F + + E + GK+P W+ + I LE D
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPF-----------FWLENKDVIGVLEKGDR- 232
Query: 274 LLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L + D+ C ++ L C P R E+V L
Sbjct: 233 -LPKPDL-------CPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 64/287 (22%), Positives = 121/287 (42%), Gaps = 30/287 (10%)
Query: 47 NNLIGKGGFGSVYKARLGDG----MEVAVKVFN-LQCGRALKSFNVECEMMKSIRHRNLI 101
+ +IGKG FG VY D ++ A+K + + + +++F E +M+ + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 102 KVIS-SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+I E ++L YM HG L +++ S + ++ + VA +EYL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA--TIGYMAPEYGRE 218
+H DL N +LD++ ++DF +A+ ++ + Q A + + A E +
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
R + DV+SFG++L E T P P ++ D +
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAP-------------------PYRHIDPFDLTHFLAQ 243
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLL 325
E C ++ + C P R + +V ++ +I +LL
Sbjct: 244 GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+++ +IG G FG VY+A+L D E+ V + + G+A K N E ++M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFK--NRELQIMRKLDHCNIVRL 78
Query: 104 ------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+E + LVL+Y+P + Y + + I+ +L M + +L Y
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 155 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
PE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAELLLGQP----IFPGDSGVDQLV 233
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 29/228 (12%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+++ +IG G FG VY+A+L D E+ V + + G+A K N E ++M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQGKAFK--NRELQIMRKLDHCNIVRL 78
Query: 104 ------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+E + LVL+Y+P + Y + + I+ +L M + +L Y
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 155 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
PE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G+VY A + G EVA++ NLQ + E +M+ ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+EY+ GSL + + C +D Q + + ALE+LH S +IH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K N+LL + L+DF + E +++ T +MAPE D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 229 SFGIMLMETFTGKKP 243
S GIM +E G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 26 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 86 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 145 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 202 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 65 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 123
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 176
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 177 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 204
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L + D + + ++A+AL Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEM 177
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 40/285 (14%)
Query: 50 IGKGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+G+G FG VY+ D ++ VAVK N R F E +MK ++++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS---------SNCILDIFQRLNIMIDVASALE 153
++ S + +V+E M HG L+ YL S + + + + ++A +
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL+ + +H DL N ++ + + DF + + + D + + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 214 EYGREGRVSANGDVYSFGIMLME-TFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
E ++G + + D++SFG++L E T ++P + N E LK V+D
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF------------VMDG 248
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L Q D C V +L C +P+ R EIV L
Sbjct: 249 GYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEM 177
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 70 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 13 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 73 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 132 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 189 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 73.6 bits (179), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 79 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 54 GFGSVYKARLGD----GMEVAVKVFNLQCGRALK---SFNVECEMMKSIRHRNLIKVISS 106
G G+ K ++G+ G +VAVK+ N Q R+L E + +K RH ++IK+
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
S +V+EY+ G L Y+ + ++ R + + SA++Y H ++H
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMVVHR 135
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG- 225
DLKP NVLLD +M A ++DF ++ ++ D + + + Y APE GR+ A
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLR-DSCGSPNYAAPEV-ISGRLYAGPE 191
Query: 226 -DVYSFGIMLMETFTGKKPTDE 246
D++S G++L G P D+
Sbjct: 192 VDIWSCGVILYALLCGTLPFDD 213
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 79 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 78 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L + D + + ++A+AL Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 180
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 181 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTXLCGTLDYLPPEM 177
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 39 QATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVF-NLQCGRALKSFNV-ECEMMKSI 95
Q+ +++ L+G+G +G V K R D G VA+K F + +K + E +++K +
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEY 154
RH NL+ ++ C ++ LV E++ H L+ L+ + + Q+ I +
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----ING 136
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ F +S IIH D+KP N+L+ + V L DF A+ L + AT Y APE
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPE 194
Query: 215 -------YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 254
YG+ V A G + + M F G D++++ M L
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL 241
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 40/285 (14%)
Query: 50 IGKGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+G+G FG VY+ D ++ VAVK N R F E +MK ++++
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS---------SNCILDIFQRLNIMIDVASALE 153
++ S + +V+E M HG L+ YL S + + + + ++A +
Sbjct: 82 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL+ + +H DL N ++ + + DF + + + D + + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 214 EYGREGRVSANGDVYSFGIMLME-TFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
E ++G + + D++SFG++L E T ++P + N E LK V+D
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF------------VMDG 245
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L Q D C V +L C +P+ R EIV L
Sbjct: 246 GYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 23 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 83 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 22 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 82 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 141 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 198 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 70 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 128
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 181
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 182 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 19 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 79 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----CHAPSSRRTTLSGTLDYLPPEM 178
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 179 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 206
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEM 178
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 179 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 206
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 14/232 (6%)
Query: 17 PSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-F 74
P N+ L + + + A ++F +GKG FG+VY AR + A+KV F
Sbjct: 9 PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF 68
Query: 75 NLQCGRA--LKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 132
Q +A E E+ +RH N++++ + L+LEY P G++ + L
Sbjct: 69 KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 128
Query: 133 NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
+ D + + ++A+AL Y H S +IH D+KP N+LL ++DF +
Sbjct: 129 SK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-- 182
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANG-DVYSFGIMLMETFTGKKP 243
S +T T+ Y+ PE EGR+ D++S G++ E GK P
Sbjct: 183 --HAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPP 231
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G + K L D + + ++A+AL Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYITELANALSYC 129
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S + T+ Y+ PE
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLXGTLDYLPPEM 182
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 183 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 40/285 (14%)
Query: 50 IGKGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+G+G FG VY+ D ++ VAVK N R F E +MK ++++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS---------SNCILDIFQRLNIMIDVASALE 153
++ S + +V+E M HG L+ YL S + + + + ++A +
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL+ + +H DL N ++ + + DF + + + D + + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 214 EYGREGRVSANGDVYSFGIMLME-TFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
E ++G + + D++SFG++L E T ++P + N E LK V+D
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF------------VMDG 248
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L Q D C V +L C +P R EIV L
Sbjct: 249 GYLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS 105
IG+G F VY+A L DG+ VA+K +F+L +A E +++K + H N+IK +
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 106 SCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
S + +VLE G L K+ ++ + + SALE++H S
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRR 156
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS 222
++H D+KP+NV + V L D + + ++ T YM+PE E +
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 223 ANGDVYSFGIMLMETFTGKKP 243
D++S G +L E + P
Sbjct: 215 FKSDIWSLGCLLYEMAALQSP 235
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEM 182
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 183 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L + D + + ++A+AL Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 180
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 181 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L + D + + ++A+AL Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 177
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 48 NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALK---SFNVECEMMKSIRHRNLIKV 103
+ +G G FG V + G +VAVK+ N Q R+L E + +K RH ++IK+
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
S +V+EY+ G L Y+ N LD + + + S ++Y H +
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA 223
+H DLKP NVLLD +M A ++DF ++ ++ D + + + Y APE GR+ A
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRX-SCGSPNYAAPEVI-SGRLYA 193
Query: 224 NG--DVYSFGIMLMETFTGKKPTDE 246
D++S G++L G P D+
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDD 218
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 41 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 101 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 160 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 217 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 182
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 183 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+++ MP G L Y+ + LN + +A + YL
Sbjct: 80 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF AKLL E++ I +MA E
Sbjct: 139 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L + D + + ++A+AL Y
Sbjct: 63 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 121
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 122 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 174
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 175 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 202
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G+VY A + G EVA++ NLQ + E +M+ ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+EY+ GSL + + C +D Q + + ALE+LH S +IH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K N+LL + L+DF + E QS T T +MAPE D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 229 SFGIMLMETFTGKKP 243
S GIM +E G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G+VY A + G EVA++ NLQ + E +M+ ++ N++ + S
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+EY+ GSL + + C +D Q + + ALE+LH S +IH D+
Sbjct: 89 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K N+LL + L+DF + E ++ T +MAPE D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 229 SFGIMLMETFTGKKP 243
S GIM +E G+ P
Sbjct: 202 SLGIMAIEMIEGEPP 216
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G+VY A + G EVA++ NLQ + E +M+ ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+EY+ GSL + + C +D Q + + ALE+LH S +IH D+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K N+LL + L+DF + E ++ T +MAPE D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 229 SFGIMLMETFTGKKP 243
S GIM +E G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+++ MP G L Y+ + LN + +A + YL
Sbjct: 78 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF AKLL E++ I +MA E
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 72.8 bits (177), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+++ MP G L Y+ + LN + +A + YL
Sbjct: 78 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF AKLL E++ I +MA E
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 14/215 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDG-MEVAVKV-FNLQCGR--ALKSFNVECEMMKSIRH 97
D+F +GKG FG+VY AR VA+KV F Q + E E+ + H
Sbjct: 23 DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N++++ + + L+LEY P G L K L S C D + IM ++A AL Y H
Sbjct: 83 PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS-CTFDEQRTATIMEELADALMYCH- 140
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
+IH D+KP N+LL ++DF + S+ + T+ Y+ PE
Sbjct: 141 --GKKVIHRDIKPENLLLGLKGELKIADFGWSV----HAPSLRRKTMCGTLDYLPPEMI- 193
Query: 218 EGRV-SANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
EGR+ + D++ G++ E G P + + E
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNE 228
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 40/285 (14%)
Query: 50 IGKGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+G+G FG VY+ D ++ VAVK N R F E +MK ++++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS---------SNCILDIFQRLNIMIDVASALE 153
++ S + +V+E M HG L+ YL S + + + + ++A +
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL+ + +H DL N ++ + + DF + + + D + + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 214 EYGREGRVSANGDVYSFGIMLME-TFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
E ++G + + D++SFG++L E T ++P + N E LK V+D
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF------------VMDG 248
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L Q D C V +L C +P+ R EIV L
Sbjct: 249 GYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 129
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEX 182
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR D++S G++ E GK P
Sbjct: 183 I-EGRXHDEKVDLWSLGVLCYEFLVGKPP 210
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IGKG F V AR + G EVAVK+ + +L+ E +MK + H N++K+
Sbjct: 15 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ LV+EY G + YL + + + R + SA++Y H + I+H
Sbjct: 75 IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 130
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSA-N 224
DLK N+LLD +M ++DF + E + TF + Y APE + +
Sbjct: 131 DLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 225 GDVYSFGIMLMETFTGKKPTD 245
DV+S G++L +G P D
Sbjct: 187 VDVWSLGVILYTLVSGSLPFD 207
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 83 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 141
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S +T T+ Y+ PE
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 194
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 195 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 222
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + + A+KV F Q +A E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 66 RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S + T+ Y+ PE
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPPEM 177
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR-LGDGME-----VAVKVFNLQCGRALK-SFNVECE 90
EF NNL +G G FG V +A G G E VAVK+ K + E +
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
+M + +H N++ ++ +C++ ++ EY +G L +L + +L+ I
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 150 SALEYLHFG----------YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSM 199
S + LHF S IH D+ NVLL + VA + DF +A+ ++ + +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 200 TQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+ + +MAPE + + DV+S+GI+L E F+
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 38/232 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCGRALK-SFNVECE 90
EF NL +G G FG V A + G ++VAVK+ + + + + E +
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-------------YSSNCIL 136
MM + H N++ ++ +C+ L+ EY +G L YL Y + L
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 137 DIFQRLNIMI---------DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187
+ + LN++ VA +E+L F +H DL NVL+ V + DF
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+A+ ++ + + + + +MAPE EG + DV+S+GI+L E F+
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSIRH 97
++F +GKG FG+VY AR + A+KV F Q +A E E+ +RH
Sbjct: 12 EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N++++ + L+LEY P G++ + L + D + + ++A+AL Y H
Sbjct: 72 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH- 129
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +IH D+KP N+LL N ++DF + S +T T+ Y+ PE
Sbjct: 130 --SKRVIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMI- 182
Query: 218 EGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E G P
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPP 209
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 40/285 (14%)
Query: 50 IGKGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+G+G FG VY+ D ++ VAVK N R F E +MK ++++
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS---------SNCILDIFQRLNIMIDVASALE 153
++ S + +V+E M HG L+ YL S + + + + ++A +
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL+ + +H DL N ++ + + DF + + + D + + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 214 EYGREGRVSANGDVYSFGIMLME-TFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
E ++G + + D++SFG++L E T ++P + N E LK V+D
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF------------VMDG 247
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L Q D C V +L C +P+ R EIV L
Sbjct: 248 GYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++ G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 23 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+++ MP G L Y+ + LN + +A + YL
Sbjct: 83 NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 36/275 (13%)
Query: 56 GSVYKARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE--E 111
G ++K R G ++ VKV ++ R + FN EC ++ H N++ V+ +C +
Sbjct: 24 GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 112 FKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKP 170
L+ +MP+GSL L+ +N ++D Q + +D+A + +LH I L
Sbjct: 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNS 141
Query: 171 SNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN---GDV 227
+V++D++M A +S + S ++APE ++ N D+
Sbjct: 142 RSVMIDEDMTARIS-------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADM 194
Query: 228 YSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQ 287
+SF ++L E T + P ++ N E+ +K ++ E +
Sbjct: 195 WSFAVLLWELVTREVPFADLSNMEIGMK-------------------VALEGLRPTIPPG 235
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
V L C E P +R IV L K++D
Sbjct: 236 ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF AKLL E++ I +MA E
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IGKG F V AR + G EVAVK+ + +L+ E +MK + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ LV+EY G + YL + + + R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSA-N 224
DLK N+LLD +M ++DF + E + TF + Y APE + +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 225 GDVYSFGIMLMETFTGKKPTD 245
DV+S G++L +G P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 17 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 77 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 246
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C +F L C +P+ R + EI+ + + +
Sbjct: 247 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294
Query: 324 LLRNV 328
R V
Sbjct: 295 GFREV 299
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 23 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 83 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF AKLL E++ I +MA E
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 71.6 bits (174), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IGKG F V AR + G EVAVK+ + +L+ E +MK + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ LV+EY G + YL + + + R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSA-N 224
DLK N+LLD +M ++DF + E + TF + Y APE + +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 225 GDVYSFGIMLMETFTGKKPTD 245
DV+S G++L +G P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++G G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 78 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF AKLL E++ I +MA E
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL +++F + S +T T+ Y+ PE
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLPPEM 180
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 181 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L + D + + ++A+AL Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S + T+ Y+ PE
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPPEM 180
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 181 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L + D + + ++A+AL Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S + T+ Y+ PE
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPPEM 177
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + V S T T+ Y+ PE
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLC-GTLDYLPPEM 178
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 179 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 206
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 124
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S + T+ Y+ PE
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPPEM 177
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 178 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 205
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 14/232 (6%)
Query: 17 PSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-F 74
P N+ L + + + A ++F +GKG FG+VY AR + A+KV F
Sbjct: 9 PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF 68
Query: 75 NLQCGRA--LKSFNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 132
Q +A E E+ +RH N++++ + L+LEY P G++ + L
Sbjct: 69 KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QK 127
Query: 133 NCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
D + + ++A+AL Y H S +IH D+KP N+LL ++DF +
Sbjct: 128 LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-- 182
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANG-DVYSFGIMLMETFTGKKP 243
S + T+ Y+ PE EGR+ D++S G++ E GK P
Sbjct: 183 --HAPSSRRDDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPP 231
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 126
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S + T+ Y+ PE
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPPEM 179
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 180 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 207
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L + D + + ++A+AL Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S + T+ Y+ PE
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLPPEM 180
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 71.2 bits (173), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNL-QCGRALKSFNV----E 88
L++ + + + +G+G F +VYKAR + + VA+K L A N E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 89 CEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
++++ + H N+I ++ + ++ +LV ++M LE + ++ +L M+
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
LEYLH + I+H DLKP+N+LLD+N V L+DF +AK +++ T
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTR 176
Query: 209 GYMAPEYGREGRVSANG-DVYSFGIMLME 236
Y APE R+ G D+++ G +L E
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAE 205
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 126
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL +++F + S +T T+ Y+ PE
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLPPEM 179
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 180 I-EGRMHDEKVDLWSLGVLCYEFLVGKPP 207
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++ G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 16 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSI 95
A ++F +GKG FG+VY AR + A+KV F Q +A E E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
RH N++++ + L+LEY P G++ + L D + + ++A+AL Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 127
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY 215
H S +IH D+KP N+LL ++DF + S + T+ Y+ PE
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPPEM 180
Query: 216 GREGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E GK P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 10 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 70 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 239
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C +F L C +P+ R + EI+ + + +
Sbjct: 240 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287
Query: 324 LLRNV 328
R V
Sbjct: 288 GFREV 292
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 11/218 (5%)
Query: 43 EFSENNLIGKGGFGSVYKARL---GDGMEVAVKVFNLQ---CGRALKSFNVECEMMKSIR 96
EF + ++ G FG+VYK G+ +++ V + L+ +A K E +M S+
Sbjct: 23 EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ ++ +++ C + L+ + MP G L Y+ + LN + +A + YL
Sbjct: 83 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +AKLL E++ I +MA E
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ DV+S+G+ + E T G KP D I E++
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 13 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 73 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 190 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 242
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C +F L C +P+ R + EI+ + + +
Sbjct: 243 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 290
Query: 324 LLRNV 328
R V
Sbjct: 291 GFREV 295
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G+VY A + G EVA++ NLQ + E +M+ ++ N++ + S
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+EY+ GSL + + C +D Q + + ALE+LH S +IH ++
Sbjct: 89 VGDELWVVMEYLAGGSLTDVV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K N+LL + L+DF + E QS T T +MAPE D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 201
Query: 229 SFGIMLMETFTGKKP 243
S GIM +E G+ P
Sbjct: 202 SLGIMAIEMIEGEPP 216
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 17 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 77 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 246
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C +F L C +P+ R + EI+ + + +
Sbjct: 247 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294
Query: 324 LLRNV 328
R V
Sbjct: 295 GFREV 299
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 14 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 74 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 134 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 191 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 243
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C +F L C +P+ R + EI+ + + +
Sbjct: 244 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 291
Query: 324 LLRNV 328
R V
Sbjct: 292 GFREV 296
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 16 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 76 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 245
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C +F L C +P+ R + EI+ + + +
Sbjct: 246 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293
Query: 324 LLRNV 328
R V
Sbjct: 294 GFREV 298
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 45 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 165 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 221
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 222 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 274
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C +F L C +P+ R + EI+ + + +
Sbjct: 275 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 322
Query: 324 LLRNV 328
R V
Sbjct: 323 GFREV 327
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IGKG F V AR + G EVAV++ + +L+ E +MK + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ LV+EY G + YL + + + R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSA-N 224
DLK N+LLD +M ++DF + E + TF + Y APE + +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 225 GDVYSFGIMLMETFTGKKPTD 245
DV+S G++L +G P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 16 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 76 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 245
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C +F L C +P+ R + EI+ + + +
Sbjct: 246 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293
Query: 324 LLRNV 328
R V
Sbjct: 294 GFREV 298
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 252
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C +F L C +P+ R + EI+ + + +
Sbjct: 253 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 324 LLRNV 328
R V
Sbjct: 301 GFREV 305
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 67/305 (21%), Positives = 132/305 (43%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 252
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C +F L C +P+ R + EI+ + + +
Sbjct: 253 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 324 LLRNV 328
R V
Sbjct: 301 GFREV 305
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 41 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 96
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 97 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 155
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 156 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 208
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 209 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 252
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+++ +IG G FG VY+A+L D E+ LQ R N E ++M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 78
Query: 104 ------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+E + LVL+Y+P + Y + + I+ +L M + +L Y
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 155 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
PE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAELLLGQP----IFPGDSGVDQLV 233
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV-FNLQCGRA--LKSFNVECEMMKSIRH 97
++F +GKG FG+VY AR + A+KV F Q +A E E+ +RH
Sbjct: 12 EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N++++ + L+LEY P G++ + L D + + ++A+AL Y H
Sbjct: 72 PNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYITELANALSYCH- 129
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +IH D+KP N+LL N ++DF + V S T T+ Y+ PE
Sbjct: 130 --SKRVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRDTLC-GTLDYLPPEMI- 182
Query: 218 EGRVSANG-DVYSFGIMLMETFTGKKP 243
EGR+ D++S G++ E G P
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPP 209
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 30 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 85
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 86 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 144
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 145 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 197
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 198 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 241
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 40/285 (14%)
Query: 50 IGKGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+G+G FG VY+ D ++ VAVK N R F E +MK ++++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS---------SNCILDIFQRLNIMIDVASALE 153
++ S + +V+E M HG L+ YL S + + + + ++A +
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL+ + +H +L N ++ + + DF + + + D + + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 214 EYGREGRVSANGDVYSFGIMLME-TFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
E ++G + + D++SFG++L E T ++P + N E LK V+D
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF------------VMDG 248
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L Q D C V +L C +P R EIV L
Sbjct: 249 GYLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 70.1 bits (170), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 89
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 90 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 201
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 202 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 245
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 111
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 223
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 224 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 267
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 40/285 (14%)
Query: 50 IGKGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+G+G FG VY+ D ++ VAVK N R F E +MK ++++
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS---------SNCILDIFQRLNIMIDVASALE 153
++ S + +V+E M HG L+ YL S + + + + ++A +
Sbjct: 86 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL+ + +H +L N ++ + + DF + + + D + + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 214 EYGREGRVSANGDVYSFGIMLME-TFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
E ++G + + D++SFG++L E T ++P + N E LK V+D
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF------------VMDG 249
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L Q D C V +L C +P R EIV L
Sbjct: 250 GYLDQPD-------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 89
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 90 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 148
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 149 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYR 201
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 202 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 245
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 41 TDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRH 97
TDE+ +GKG F V + ++ G E A K+ N + R + E + + ++H
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 148
N++++ S S E F LV + + G L + YS S+CI I + +N
Sbjct: 63 PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----- 117
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+ H I+H DLKP N+LL L+DF +A + G+ Q+ F
Sbjct: 118 -----HCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF---GF 166
Query: 206 A-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
A T GY++PE R+ D+++ G++L G P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+++ +IG G FG VY+A+L D E+ LQ R N E ++M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 78
Query: 104 ------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+E + LVL+Y+P + Y + + I+ +L M + +L Y
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 155 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
PE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+++ +IG G FG VY+A+L D E+ LQ R N E ++M+ + H N++++
Sbjct: 23 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 79
Query: 104 ------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+E + LVL+Y+P + Y + + I+ +L M + +L Y
Sbjct: 80 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 138
Query: 155 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y A
Sbjct: 139 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 191
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
PE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 192 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 234
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 111
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 170
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 171 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 223
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 224 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 267
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 41 TDEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRH 97
TDE+ IGKG F V + +L G E A K+ N + R + E + + ++H
Sbjct: 3 TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N++++ S S E F LV + + G L+ + + + + LE +
Sbjct: 63 SNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 158 GYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAP 213
+ ++H DLKP N+LL L+DF +A + G+ Q+ FA T GY++P
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWF---GFAGTPGYLSP 175
Query: 214 EYGREGRVSANGDVYSFGIMLMETFTGKKP 243
E R+ D+++ G++L G P
Sbjct: 176 EVLRKEAYGKPVDIWACGVILYILLVGYPP 205
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+++ +IG G FG VY+A+L D E+ LQ R N E ++M+ + H N++++
Sbjct: 26 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 82
Query: 104 ------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+E + LVL+Y+P + Y + + I+ +L M + +L Y
Sbjct: 83 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 141
Query: 155 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y A
Sbjct: 142 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 194
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
PE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 195 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 237
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 75/315 (23%), Positives = 130/315 (41%), Gaps = 61/315 (19%)
Query: 43 EFSENNLI-----GKGGFGSVYKA-------RLGDGMEVAVKVFNLQCGRA-LKSFNVEC 89
EF NL+ G+G FG V KA R G VAVK+ + L+ E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY-TTVAVKMLKENASPSELRDLLSEF 77
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-------------- 135
++K + H ++IK+ +CS + L++EY +GSL +L S +
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 136 ---------LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186
L + ++ ++ ++YL ++H DL N+L+ + +SDF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTD 245
+++ + ED + ++Q + +MA E + + DV+SFG++L E T G P
Sbjct: 195 GLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 246 EIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPE 305
I P L NLL + + C ++ L + C + P+
Sbjct: 255 GI---------------PPERL----FNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPD 294
Query: 306 QRINAKEIVKKLLKI 320
+R +I K L K+
Sbjct: 295 KRPVFADISKDLEKM 309
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 35 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 90
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 91 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 149
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 150 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 202
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 203 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 246
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IGKG F V AR + G EVA+K+ + +L+ E +MK + H N++K+
Sbjct: 20 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ L++EY G + YL + + + R + SA++Y H I+H
Sbjct: 80 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 167 DLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSA- 223
DLK N+LLD +M ++DF + + VG + TF + Y APE + +
Sbjct: 136 DLKAENLLLDADMNIKIADFGFSNEFTVG-----GKLDTFCGSPPYAAPELFQGKKYDGP 190
Query: 224 NGDVYSFGIMLMETFTGKKPTD 245
DV+S G++L +G P D
Sbjct: 191 EVDVWSLGVILYTLVSGSLPFD 212
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 41 TDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRH 97
TDE+ +GKG F V + ++ G E A K+ N + R + E + + ++H
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 148
N++++ S S E F LV + + G L + YS S+CI I + +N
Sbjct: 63 PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVN----- 117
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+ H I+H DLKP N+LL L+DF +A + G+ Q+ F
Sbjct: 118 -----HCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF---GF 166
Query: 206 A-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
A T GY++PE R+ D+++ G++L G P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 50 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 105
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 164
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 165 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 217
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 218 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 261
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 43 EFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGR--------ALKSFNVECEMMK 93
++ ++IG+G V + G E AVK+ + R ++ E +++
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 94 SIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+ H ++I +I S + F LV + M G L YL + L + +IM + A+
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAV 213
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTFATIGYM 211
+LH + I+H DLKP N+LLDDNM LSDF + L GE + T GY+
Sbjct: 214 SFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYL 266
Query: 212 APE------------YGREGRVSANGDVYSFGIMLMETFTGKKP 243
APE YG+E D+++ G++L G P
Sbjct: 267 APEILKCSMDETHPGYGKE------VDLWACGVILFTLLAGSPP 304
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 75/315 (23%), Positives = 130/315 (41%), Gaps = 61/315 (19%)
Query: 43 EFSENNLI-----GKGGFGSVYKA-------RLGDGMEVAVKVFNLQCGRA-LKSFNVEC 89
EF NL+ G+G FG V KA R G VAVK+ + L+ E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY-TTVAVKMLKENASPSELRDLLSEF 77
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-------------- 135
++K + H ++IK+ +CS + L++EY +GSL +L S +
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 136 ---------LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186
L + ++ ++ ++YL ++H DL N+L+ + +SDF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDF 194
Query: 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTD 245
+++ + ED + ++Q + +MA E + + DV+SFG++L E T G P
Sbjct: 195 GLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 246 EIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPE 305
I P L NLL + + C ++ L + C + P+
Sbjct: 255 GI---------------PPERL----FNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPD 294
Query: 306 QRINAKEIVKKLLKI 320
+R +I K L K+
Sbjct: 295 KRPVFADISKDLEKM 309
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+++ +IG G FG VY+A+L D E+ LQ R N E ++M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 78
Query: 104 ------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
+E + LVL+Y+P + Y + + I+ +L M + +L Y
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 155 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
PE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSF---NVECEMMKSIRHRNLIKVIS 105
+G G FG V+ R +G A+KV + LK N E M+ + H +I++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+ + + ++++Y+ G L L S + + +V ALEYLH S II+
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DLKP N+LLD N ++DF AK + + T Y+APE + +
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYNKSI 184
Query: 226 DVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKHWVND 260
D +SFGI++ E G P ++I N E+ + N+
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 228
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 27 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 82
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 83 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 141
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 142 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 194
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 195 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 238
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 74/232 (31%), Positives = 104/232 (44%), Gaps = 41/232 (17%)
Query: 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKS--IRHRNLIKVISS 106
LIG+G +G+VYK L D VAVKVF+ ++F E + + + H N+ + I
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFI-- 73
Query: 107 CSNEEFKA-------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF-- 157
+E A LV+EY P+GSL KYL S D + V L YLH
Sbjct: 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 158 ----GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE------DQSMTQTQTFAT 207
Y I H DL NVL+ ++ +SDF ++ L G ++ T
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 208 IGYMAPEYGREGRVSANG--------DVYSFGIMLMETFTGKKPTDEIFNGE 251
I YMAPE EG V+ D+Y+ G++ E F + TD +F GE
Sbjct: 192 IRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFM--RCTD-LFPGE 239
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 58 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 113
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 172
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 173 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 225
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 226 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 269
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 60 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 115
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 174
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 175 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 227
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 228 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 271
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG VYKA+ + G A KV + L+ + VE E++ + H ++K++ +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
++ +++E+ P G+++ + + L Q I + LE L+F +S IIH DL
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 169 KPSNVLLDDNMVAHLSDFSI-AKLLVGEDQSMTQTQTF-ATIGYMAPEY-----GREGRV 221
K NVL+ L+DF + AK L +++ + +F T +MAPE ++
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNL----KTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
D++S GI L+E + P E+ + LK
Sbjct: 200 DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 233
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 70/223 (31%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 49 LIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEM------MKSIRHRNLIK 102
+IGKG FG V AR EV V LQ LK + M +K+++H L+
Sbjct: 45 VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ S + VL+Y+ G L +L C L+ R ++ASAL YLH S
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLN 159
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRV 221
I++ DLKP N+LLD L+DF + K + + + T TF T Y+APE +
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPY 216
Query: 222 SANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLK 255
D + G +L E G P D I N + LK
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 259
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHRNLIKVISSC 107
+G+G +G VYKA+ G VA+K L + S + E ++K + H N++ +I
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+E LV E+M L+K L + L Q I I + L + + I+H D
Sbjct: 89 HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY--GREGRVSANG 225
LKP N+L++ + L+DF +A+ +S T T+ Y AP+ G + + S +
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSK-KYSTSV 201
Query: 226 DVYSFGIMLMETFTGK 241
D++S G + E TGK
Sbjct: 202 DIWSIGCIFAEMITGK 217
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHRNLIKVISSC 107
+G+G +G VYKA+ G VA+K L + S + E ++K + H N++ +I
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
+E LV E+M L+K L + L Q I I + L + + I+H D
Sbjct: 89 HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY--GREGRVSANG 225
LKP N+L++ + L+DF +A+ +S T T+ Y AP+ G + + S +
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSK-KYSTSV 201
Query: 226 DVYSFGIMLMETFTGK 241
D++S G + E TGK
Sbjct: 202 DIWSIGCIFAEMITGK 217
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG VYKA+ + G A KV + L+ + VE E++ + H ++K++ +
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
++ +++E+ P G+++ + + L Q I + LE L+F +S IIH DL
Sbjct: 79 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 169 KPSNVLLDDNMVAHLSDFSI-AKLLVGEDQSMTQTQTF-ATIGYMAPEY-----GREGRV 221
K NVL+ L+DF + AK L +++ + +F T +MAPE ++
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNL----KTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 191
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
D++S GI L+E + P E+ + LK
Sbjct: 192 DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 225
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 46 ENNLIGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
E+ +G G FG+V Y+ + + N ALK E +M+ + + +
Sbjct: 15 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + D + ++ V+ ++YL
Sbjct: 75 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 129
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L E+ QT + + APE
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 66/305 (21%), Positives = 131/305 (42%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 8 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 68 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N ++ ++ + DF + + + D +
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 185 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 237
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C + L C +P+ R + EI+ + + +
Sbjct: 238 -----VMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 285
Query: 324 LLRNV 328
R V
Sbjct: 286 GFREV 290
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 72/229 (31%), Positives = 113/229 (49%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
+++ +IG G FG VY+A+L D E VA+K LQ R N E ++M+ + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 156
Query: 103 V------ISSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
+ +E + LVL+Y+P + Y + + I+ +L M + +L
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 215
Query: 154 YLH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
Y+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y
Sbjct: 216 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYR 268
Query: 212 APE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 269 APELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 312
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 40/285 (14%)
Query: 50 IGKGGFGSVYKARLGDGME------VAVKVFNLQCG-RALKSFNVECEMMKSIRHRNLIK 102
+G+G FG VY+ D ++ VAVK N R F E +MK ++++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYS---------SNCILDIFQRLNIMIDVASALE 153
++ S + +V+E M HG L+ YL S + + + + ++A +
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
YL+ + +H DL N ++ + + DF + + + + + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 214 EYGREGRVSANGDVYSFGIMLME-TFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
E ++G + + D++SFG++L E T ++P + N E LK V+D
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKF------------VMDG 248
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L Q D C V +L C +P+ R EIV L
Sbjct: 249 GYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 70/228 (30%), Positives = 112/228 (49%), Gaps = 29/228 (12%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+++ +IG G FG VY+A+L D E+ LQ R N E ++M+ + H N++++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRL 78
Query: 104 ----ISSCSNEE--FKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
SS ++ + LVL+Y+P + Y + + I+ +L M + +L Y
Sbjct: 79 RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 155 LH-FGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+H FG I H D+KP N+LLD D V L DF AK LV + +++ + Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
PE +G S+ DV+S G +L E G+ IF G+ + V
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAELLLGQ----PIFPGDSGVDQLV 233
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 75/315 (23%), Positives = 130/315 (41%), Gaps = 61/315 (19%)
Query: 43 EFSENNLI-----GKGGFGSVYKA-------RLGDGMEVAVKVFNLQCGRA-LKSFNVEC 89
EF NL+ G+G FG V KA R G VAVK+ + L+ E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY-TTVAVKMLKENASPSELRDLLSEF 77
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-------------- 135
++K + H ++IK+ +CS + L++EY +GSL +L S +
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 136 ---------LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF 186
L + ++ ++ ++YL ++H DL N+L+ + +SDF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTD 245
+++ + ED + ++Q + +MA E + + DV+SFG++L E T G P
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254
Query: 246 EIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPE 305
I P L NLL + + C ++ L + C + P+
Sbjct: 255 GI---------------PPERL----FNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPD 294
Query: 306 QRINAKEIVKKLLKI 320
+R +I K L K+
Sbjct: 295 KRPVFADISKDLEKM 309
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 39/213 (18%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107
+GKG +G V++ G VAVK+F+ R KS+ E E+ ++ RH N++ I+S
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH---FGYS 160
+ L+ Y GSL YL + LD L I++ +AS L +LH FG
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 161 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-----FATIGYMAP 213
I H DLK N+L+ N ++D +A V QS Q T YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 214 E----------YGREGRVSANGDVYSFGIMLME 236
E + RV D+++FG++L E
Sbjct: 187 EVLDETIQVDCFDSYKRV----DIWAFGLVLWE 215
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 46 ENNLIGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
E+ +G G FG+V Y+ + + N ALK E +M+ + + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + D + ++ V+ ++YL
Sbjct: 81 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 135
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L E+ QT + + APE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 46 ENNLIGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
E+ +G G FG+V Y+ + + N ALK E +M+ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + D + ++ V+ ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 125
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L E+ QT + + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 39/213 (18%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107
+GKG +G V++ G VAVK+F+ R KS+ E E+ ++ RH N++ I+S
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH---FGYS 160
+ L+ Y GSL YL + LD L I++ +AS L +LH FG
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 161 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-----FATIGYMAP 213
I H DLK N+L+ N ++D +A V QS Q T YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 214 E----------YGREGRVSANGDVYSFGIMLME 236
E + RV D+++FG++L E
Sbjct: 187 EVLDETIQVDCFDSYKRV----DIWAFGLVLWE 215
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 46 ENNLIGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
E+ +G G FG+V Y+ + + N ALK E +M+ + + +
Sbjct: 15 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + D + ++ V+ ++YL
Sbjct: 75 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 129
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L E+ QT + + APE
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 46 ENNLIGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
E+ +G G FG+V Y+ + + N ALK E +M+ + + +
Sbjct: 9 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + D + ++ V+ ++YL
Sbjct: 69 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 123
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L E+ QT + + APE
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 218
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 46 ENNLIGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
E+ +G G FG+V Y+ + + N ALK E +M+ + + +
Sbjct: 31 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + D + ++ V+ ++YL
Sbjct: 91 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 145
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L E+ QT + + APE
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 46 ENNLIGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
E+ +G G FG+V Y+ + + N ALK E +M+ + + +
Sbjct: 31 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + D + ++ V+ ++YL
Sbjct: 91 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 145
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L E+ QT + + APE
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 46 ENNLIGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
E+ +G G FG+V Y+ + + N ALK E +M+ + + +
Sbjct: 29 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + D + ++ V+ ++YL
Sbjct: 89 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 143
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L E+ QT + + APE
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 238
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 39/213 (18%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107
+GKG +G V++ G VAVK+F+ R KS+ E E+ ++ RH N++ I+S
Sbjct: 45 VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH---FGYS 160
+ L+ Y GSL YL + LD L I++ +AS L +LH FG
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 161 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-----FATIGYMAP 213
I H DLK N+L+ N ++D +A V QS Q T YMAP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 214 E----------YGREGRVSANGDVYSFGIMLME 236
E + RV D+++FG++L E
Sbjct: 216 EVLDETIQVDCFDSYKRV----DIWAFGLVLWE 244
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 68.9 bits (167), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IGKG F V AR + G EVAVK+ + +L+ E +MK + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ LV+EY G + YL + + + R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSA-N 224
DLK N+LLD +M ++DF + E + F Y APE + +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 225 GDVYSFGIMLMETFTGKKPTD 245
DV+S G++L +G P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 29/292 (9%)
Query: 34 YLELCQATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSF-NVECEM 91
Y + + F++ IGKG FG V+K +V A+K+ +L+ E +
Sbjct: 19 YFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 78
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
+ + K S + +++EY+ GS L LD Q I+ ++
Sbjct: 79 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 136
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L+YLH S IH D+K +NVLL ++ L+DF +A L D + + T +M
Sbjct: 137 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 191
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVD 271
APE ++ + D++S GI +E G+ P E+ P+ L ++
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------------PMKVLFLIP 237
Query: 272 ANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
N + + + FV AC + P R AKE++K +R++
Sbjct: 238 KN--NPPTLEGNYSKPLKEFV----EACLNKEPSFRPTAKELLKHKFILRNA 283
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ + H+N+++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 156 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 159 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 258
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 259 VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 68.6 bits (166), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ + H+N+++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 156 --HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 173 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 272
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 273 VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSF-NVECEMMKSIRHRNLI 101
F++ IGKG FG V+K +V A+K+ +L+ E ++ +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
K S + +++EY+ GS L LD Q I+ ++ L+YLH S
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
IH D+K +NVLL ++ L+DF +A L D + + T +MAPE ++
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281
+ D++S GI +E G+ P E+ P+ L ++ N + +
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELH--------------PMKVLFLIPKN--NPPTLE 225
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
+ FV AC + P R AKE++K +R++
Sbjct: 226 GNYSKPLKEFV----EACLNKEPSFRPTAKELLKHKFILRNA 263
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IGKG F V AR + G EVAV++ + +L+ E +MK + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ LV+EY G + YL + + + R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSANG 225
DLK N+LLD +M ++DF + E + F + Y APE + +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 226 -DVYSFGIMLMETFTGKKPTD 245
DV+S G++L +G P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 68.6 bits (166), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSF-NVECEMMKSIRHRNLI 101
F++ IGKG FG V+K +V A+K+ +L+ E ++ +
Sbjct: 9 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
K S + +++EY+ GS L LD Q I+ ++ L+YLH S
Sbjct: 69 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
IH D+K +NVLL ++ L+DF +A L D + + T +MAPE ++
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281
+ D++S GI +E G+ P E+ P+ L ++ N + +
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELH--------------PMKVLFLIPKN--NPPTLE 225
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
+ FV AC + P R AKE++K +R++
Sbjct: 226 GNYSKPLKEFV----EACLNKEPSFRPTAKELLKHKFILRNA 263
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 156 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 165 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 219 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 264
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 265 VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 70/288 (24%), Positives = 117/288 (40%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 90 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 156 --HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 150 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 204 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 249
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + D + C V+ + C PE R N I++++
Sbjct: 250 VTSG--GRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSF-NVECEMMKSIRHRNLI 101
F++ IGKG FG V+K +V A+K+ +L+ E ++ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
K S + +++EY+ GS L LD Q I+ ++ L+YLH S
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 138
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
IH D+K +NVLL ++ L+DF +A L D + + T +MAPE ++
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281
+ D++S GI +E G+ P E+ P+ L ++ N + +
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELH--------------PMKVLFLIPKN--NPPTLE 240
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
+ FV AC + P R AKE++K +R++
Sbjct: 241 GNYSKPLKEFV----EACLNKEPSFRPTAKELLKHKFILRNA 278
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 156 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 159 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 258
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 259 VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 98 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 156 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 257
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 258 VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 156 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 175 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 229 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 274
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 275 VTSG------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 67/285 (23%), Positives = 114/285 (40%), Gaps = 40/285 (14%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYLH 156
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 157 FGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
+ IH D+ N LL VA + DF +A+ + + +M P
Sbjct: 185 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 214 EYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
E EG ++ D +SFG++L E F+ G P N E+ LE V +
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEFVTS 287
Query: 273 NLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
+ C V+ + C PE R N I++++
Sbjct: 288 G------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 75/287 (26%), Positives = 129/287 (44%), Gaps = 27/287 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQ-CGRALKSFNVECEMMKSIRHRN 99
D++ +IG G V A E VA+K NL+ C ++ E + M H N
Sbjct: 10 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 100 LIKVISSCSNEEFKALVLEYMPHGS---LEKYLYSS----NCILDIFQRLNIMIDVASAL 152
++ +S ++ LV++ + GS + K++ + + +LD I+ +V L
Sbjct: 70 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQT-QTF-ATIG 209
EYLH IH D+K N+LL ++ ++DF ++ L G D + + +TF T
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 210 YMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268
+MAPE + R D++SFGI +E TG P + ++ + ND + T
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET-G 245
Query: 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
V D +L + F + +S C + PE+R A E+++
Sbjct: 246 VQDKEMLKKYGKSF---RKMISL-------CLQKDPEKRPTAAELLR 282
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 46 ENNLIGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
E+ +G G FG+V Y+ + + N ALK E +M+ + + +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + D + ++ V+ ++YL
Sbjct: 433 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 487
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L E+ QT + + APE
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVF-NLQCGRALKSFNV-ECEMMKSIRHRNLIKVISS 106
IG+G +G V+K R D G VA+K F + +K + E M+K ++H NL+ ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS----ALEYLHFGYSAP 162
+ LV EY H L + LD +QR V S L+ ++F +
Sbjct: 71 FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE-------Y 215
IH D+KP N+L+ + V L DF A+LL G S AT Y +PE Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELLVGDTQY 180
Query: 216 GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTL 254
G V A G V++ + + + GK D+++ TL
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 67/230 (29%), Positives = 112/230 (48%), Gaps = 34/230 (14%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
++ +IG G FG V++A+L + EVA+K LQ R N E ++M+ ++H N++ +
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFK---NRELQIMRIVKHPNVVDL 97
Query: 104 IS------SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI------MIDVASA 151
+ +E F LVLEY+P E +S + Q + + M + +
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
L Y+H S I H D+KP N+LLD + V L DF AK+L+ + +++ + Y
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICSRYY 207
Query: 211 MAPE--YGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWV 258
APE +G + N D++S G ++ E G+ +F GE + V
Sbjct: 208 RAPELIFGATN-YTTNIDIWSTGCVMAELMQGQP----LFPGESGIDQLV 252
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 11/217 (5%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDG----MEVAVKVFNLQCG-RALKSFNVECEMMKSIR 96
E + ++G G FG+VYK + DG + VA+KV +A K E +M +
Sbjct: 18 ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
+ +++ C + LV + MP+G L ++ + L LN + +A + YL
Sbjct: 78 SPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE 136
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
++H DL NVL+ ++DF +A+LL ++ I +MA E
Sbjct: 137 ---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 193
Query: 217 REGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
R + DV+S+G+ + E T G KP D I E+
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 230
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 51 GKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS---C 107
+G FG V+KA+L + VAVK+F LQ ++ +S E ++H NL++ I++
Sbjct: 24 ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 108 SNEEFK-ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF--------G 158
SN E + L+ + GSL YL + I+ + ++ ++ L YLH G
Sbjct: 82 SNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTFATIGYMAPEYGR 217
+ I H D K NVLL ++ A L+DF +A + G+ T Q T YMAPE
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV-GTRRYMAPEV-L 197
Query: 218 EGRVSANG------DVYSFGIMLMETFTGKKPTD 245
EG ++ D+Y+ G++L E + K D
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 12/215 (5%)
Query: 46 ENNLIGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRALKS-FNVECEMMKSIRHRNL 100
E+ +G G FG+V Y+ + + N ALK E +M+ + + +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+++I C E + LV+E G L KYL + + D + ++ V+ ++YL
Sbjct: 434 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---E 488
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +H DL NVLL A +SDF ++K L E+ QT + + APE
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 220 RVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMT 253
+ S+ DV+SFG+++ E F+ G+KP + E+T
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 583
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 156 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 159 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 213 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 258
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 259 VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 66/305 (21%), Positives = 130/305 (42%), Gaps = 38/305 (12%)
Query: 40 ATDEFSENNLIGKGGFGSVY----KARLGDGME--VAVKVFNLQCG-RALKSFNVECEMM 92
A ++ + + +G+G FG VY K + D E VA+K N R F E +M
Sbjct: 10 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS------SNCIL---DIFQRLN 143
K ++++++ S + +++E M G L+ YL S +N +L + + +
Sbjct: 70 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
+ ++A + YL+ + +H DL N + ++ + DF + + + D +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 204 TFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLP 263
+ +M+PE ++G + DV+SFG++L E T + + + E L+
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 239
Query: 264 ISTLEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
V++ LL + D C + L C +P+ R + EI+ + + +
Sbjct: 240 -----VMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287
Query: 324 LLRNV 328
R V
Sbjct: 288 GFREV 292
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 156 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 176 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 275
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 276 VTSG------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 156 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 298
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 299 VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 75/287 (26%), Positives = 129/287 (44%), Gaps = 27/287 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQ-CGRALKSFNVECEMMKSIRHRN 99
D++ +IG G V A E VA+K NL+ C ++ E + M H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 100 LIKVISSCSNEEFKALVLEYMPHGS---LEKYLYSS----NCILDIFQRLNIMIDVASAL 152
++ +S ++ LV++ + GS + K++ + + +LD I+ +V L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQT-QTF-ATIG 209
EYLH IH D+K N+LL ++ ++DF ++ L G D + + +TF T
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 210 YMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLE 268
+MAPE + R D++SFGI +E TG P + ++ + ND + T
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET-G 250
Query: 269 VVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
V D +L + F + +S C + PE+R A E+++
Sbjct: 251 VQDKEMLKKYGKSF---RKMISL-------CLQKDPEKRPTAAELLR 287
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 9/206 (4%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSF-NVECEMMKSIRHRNLI 101
F++ IGKG FG V+K +V A+K+ +L+ E ++ +
Sbjct: 25 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
K S +++EY+ GS L + D FQ ++ ++ L+YLH S
Sbjct: 85 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH---SE 139
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
IH D+K +NVLL + L+DF +A L D + + T +MAPE ++
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEI 247
+ D++S GI +E G+ P ++
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNSDM 223
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRA-LKSFNVECEMMKSIRHRNLIKVI 104
+G G FGSV Y+ R ++VA+KV +A + E ++M + + ++++I
Sbjct: 18 LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
C E LV+E G L K+L + + ++ V+ ++YL +
Sbjct: 77 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT-QTQTFATIGYMAPEYGREGRVSA 223
H DL NVLL + A +SDF ++K L +D T ++ + + APE + S+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
DV+S+G+ + E + G+KP ++ E+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKSFNVECEM--- 91
LC+A ++ IG+G +G V+KAR G VA+K +Q G + E+
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 92 --MKSIRHRNLIKVISSCS----NEEFK-ALVLEYMPHGSLEKYL-------YSSNCILD 137
+++ H N++++ C+ + E K LV E++ L YL + I D
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
+ M + L++LH S ++H DLKP N+L+ + L+DF +A++ +
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
M T T+ Y APE + + D++S G + E F +KP +F G
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRG 221
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKSFNVECEM--- 91
LC+A ++ IG+G +G V+KAR G VA+K +Q G + E+
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 92 --MKSIRHRNLIKVISSCS----NEEFK-ALVLEYMPHGSLEKYL-------YSSNCILD 137
+++ H N++++ C+ + E K LV E++ L YL + I D
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
+ M + L++LH S ++H DLKP N+L+ + L+DF +A++ +
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
M T T+ Y APE + + D++S G + E F +KP +F G
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRG 221
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQC--GRALKSFNVECEMMKSIRHRNLIKVISS 106
IGKG F V AR + G EVA+K+ + +L+ E +MK + H N++K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ L++EY G + YL + + + R + SA++Y H I+H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 167 DLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSA- 223
DLK N+LLD +M ++DF + + VG + F Y APE + +
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTVG-----GKLDAFCGAPPYAAPELFQGKKYDGP 193
Query: 224 NGDVYSFGIMLMETFTGKKPTD 245
DV+S G++L +G P D
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFD 215
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + +++E M G L+ +L S L + L++ D+A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 156 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 257
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 258 VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 33/229 (14%)
Query: 32 FSYLELC-QATDEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKSFNV 87
F + C + TD++ +GKG F V + + E A K+ N + R +
Sbjct: 20 FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 88 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDI 138
E + + ++H N++++ S S E F LV + + G L + YS S+CI I
Sbjct: 80 EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQI 139
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLVGE 195
+ +N + + I+H DLKP N+LL L+DF +A + GE
Sbjct: 140 LESVNHI-------------HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 186
Query: 196 DQSMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
Q+ FA T GY++PE R+ D+++ G++L G P
Sbjct: 187 QQAWF---GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK C + F +E ++ H+N+++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + +++E M G L+ +L S L + L++ D+A +YL
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 156 --HFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 173 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 272
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 273 VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKAR--LGDGMEVAVKVFNLQCGRALKSFNVECEM--- 91
LC+A ++ IG+G +G V+KAR G VA+K +Q G + E+
Sbjct: 6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 92 --MKSIRHRNLIKVISSCS----NEEFK-ALVLEYMPHGSLEKYL-------YSSNCILD 137
+++ H N++++ C+ + E K LV E++ L YL + I D
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
+ M + L++LH S ++H DLKP N+L+ + L+DF +A++ +
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
M T T+ Y APE + + D++S G + E F +KP +F G
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRG 221
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVF---NLQCGRALKSFNVECEMMKSIRH 97
D+F +GKG FG+VY AR + A+KV L+ E E+ +RH
Sbjct: 15 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N++++ + + + L+LE+ P G L K L + D + M ++A AL Y H
Sbjct: 75 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH- 132
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
+IH D+KP N+L+ ++DF + S+ + T+ Y+ PE
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTD 245
D++ G++ E G P D
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 214
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVF---NLQCGRALKSFNVECEMMKSIRH 97
D+F +GKG FG+VY AR + A+KV L+ E E+ +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N++++ + + + L+LE+ P G L K L + D + M ++A AL Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH- 131
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
+IH D+KP N+L+ ++DF + S+ + T+ Y+ PE
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTD 245
D++ G++ E G P D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 13/205 (6%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG VYKA+ + + A KV + + L+ + VE +++ S H N++K++ +
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E +++E+ G+++ + L Q + AL YLH IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEY-----GREGRVS 222
K N+L + L+DF ++ +++ + +F T +MAPE ++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 223 ANGDVYSFGIMLMETFTGKKPTDEI 247
DV+S GI L+E + P E+
Sbjct: 219 YKADVWSLGITLIEMAEIEPPHHEL 243
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 49 LIGKGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
++GKGG+G V++ R G M+V K ++ + E +++ ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ +I + L+LEY+ G L L ++ + +++ AL +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH---Q 139
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE-YGRE 218
II+ DLKP N++L+ L+DF + K + T T TF TI YMAPE R
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI---HDGTVTHTFCGTIEYMAPEILMRS 196
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
G A D +S G ++ + TG P F GE
Sbjct: 197 GHNRAV-DWWSLGALMYDMLTGAPP----FTGE 224
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR-LGDGME-----VAVKVFNLQCGRALK-SFNVECE 90
EF NNL +G G FG V +A G G E VAVK+ K + E +
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------SSNCILDIFQ 140
+M + +H N++ ++ +C++ ++ EY +G L +L L++
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 141 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200
L+ VA + +L S IH D+ NVLL + VA + DF +A+ ++ + +
Sbjct: 162 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 218
Query: 201 QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+ + +MAPE + + DV+S+GI+L E F+
Sbjct: 219 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR-LGDGME-----VAVKVFNLQCGRALK-SFNVECE 90
EF NNL +G G FG V +A G G E VAVK+ K + E +
Sbjct: 34 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------SSNCILDIFQ 140
+M + +H N++ ++ +C++ ++ EY +G L +L L++
Sbjct: 94 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 141 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT 200
L+ VA + +L S IH D+ NVLL + VA + DF +A+ ++ + +
Sbjct: 154 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 210
Query: 201 QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+ + +MAPE + + DV+S+GI+L E F+
Sbjct: 211 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 33/273 (12%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGR-ALKSFNVECEMMKSIRHRNLIKVISSC 107
+G G FG V+ G+E +K N + ++ E E++KS+ H N+IK+
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNC---ILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ +V+E G L + + S+ L +M + +AL Y H S ++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146
Query: 165 HCDLKPSNVLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
H DLKP N+L D + + DF +A+L ++ S T T YMAPE + V
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFKRD-V 202
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281
+ D++S G+++ TG P F G ++LE V +E +
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLP----FTG--------------TSLEEVQQKATYKEPNY 244
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
V +L + PE+R +A +++
Sbjct: 245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 43 EFSENNLIGKGGFGSVYKARLGDGMEV----AVKVF---NLQCGRALKSFNVECEMMKSI 95
+F ++G+G FG V+ + G + A+KV L+ +++ +E +++ +
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 83
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H ++K+ + E L+L+++ G L L S + + ++A AL++L
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHL 142
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE 214
H S II+ DLKP N+LLD+ L+DF ++K + ++ + +F T+ YMAPE
Sbjct: 143 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPE 196
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ + D +SFG+++ E TG P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 43 EFSENNLIGKGGFGSVYKARLGDGMEV----AVKVF---NLQCGRALKSFNVECEMMKSI 95
+F ++G+G FG V+ + G + A+KV L+ +++ +E +++ +
Sbjct: 26 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 84
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H ++K+ + E L+L+++ G L L S + + ++A AL++L
Sbjct: 85 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHL 143
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE 214
H S II+ DLKP N+LLD+ L+DF ++K + ++ + +F T+ YMAPE
Sbjct: 144 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPE 197
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ + D +SFG+++ E TG P
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 226
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG VYKA+ + + A KV + + L+ + VE +++ S H N++K++ +
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E +++E+ G+++ + L Q + AL YLH IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEY-----GREGRVS 222
K N+L + L+DF ++ + + + +F T +MAPE ++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS---AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 223 ANGDVYSFGIMLMETFTGKKPTDEI 247
DV+S GI L+E + P E+
Sbjct: 219 YKADVWSLGITLIEMAEIEPPHHEL 243
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 43 EFSENNLIGKGGFGSVYKARLGDGMEV----AVKVF---NLQCGRALKSFNVECEMMKSI 95
+F ++G+G FG V+ + G + A+KV L+ +++ +E +++ +
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEV 83
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H ++K+ + E L+L+++ G L L S + + ++A AL++L
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHL 142
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE 214
H S II+ DLKP N+LLD+ L+DF ++K + ++ + +F T+ YMAPE
Sbjct: 143 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPE 196
Query: 215 YGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ + D +SFG+++ E TG P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 19/229 (8%)
Query: 40 ATDEFSEN----NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMM 92
+ EF EN IG+G +G VYKAR G VA+K L + S + E ++
Sbjct: 4 GSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 63
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
K + H N++K++ E LV E++ H L+K++ ++ + I L I + L
Sbjct: 64 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLL 120
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+ L F +S ++H DLKP N+L++ L+DF +A+ + T T T+ Y A
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRA 178
Query: 213 PEYGREGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
PE + + D++S G + E F G D++F TL
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 47 NNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGR--ALKSFNVECEMMKSIRHRNLIKVI 104
LIGKG FG VY R EVA+++ +++ LK+F E + RH N++ +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+C + A++ +L + + +LD+ + I ++ + YLH + I+
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 165 HCDLKPSNVLLDDNMVAHLSD---FSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGREGR 220
H DLK NV D+ V ++D FSI+ +L G + + Q + ++APE R+
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQN-GWLCHLAPEIIRQLS 210
Query: 221 ---------VSANGDVYSFGIMLMETFTGKKP 243
S + DV++ G + E + P
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 48 NLIGKGGFGSVY----KARLGDGMEVAVKVF---NLQCGRALKSFNVECEMMKSIRHRNL 100
++G+G FG V+ R G A+KV L+ +++ +E +++ + H +
Sbjct: 34 KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFV 92
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+K+ + E L+L+++ G L L S + + ++A L++LH S
Sbjct: 93 VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLDHLH---S 148
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE-YGRE 218
II+ DLKP N+LLD+ L+DF ++K + ++ + +F T+ YMAPE R+
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEK---KAYSFCGTVEYMAPEVVNRQ 205
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
G S + D +S+G+++ E TG P
Sbjct: 206 GH-SHSADWWSYGVLMFEMLTGSLP 229
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVF---NLQCGRALKSFNVECEMMKSIRH 97
D+F +GKG FG+VY AR + A+KV L+ E E+ +RH
Sbjct: 14 DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N++++ + + + L+LE+ P G L K L + D + M ++A AL Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCH- 131
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
+IH D+KP N+L+ ++DF + S+ + T+ Y+ PE
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKPTD 245
D++ G++ E G P D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 177
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 48 NLIGKGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN 99
++G G +G V+ R G M+V K +Q + + E ++++ IR
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 100 LIKVISSCSNEEFK-ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI-DVASALEYLHF 157
+ + E K L+L+Y+ G L +L + + I + ++ ALE+LH
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALEHLH- 176
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
II+ D+K N+LLD N L+DF ++K V D++ TI YMAP+ R
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDIVR 233
Query: 218 EGRVSANG--DVYSFGIMLMETFTGKKP 243
G + D +S G+++ E TG P
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASP 261
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 50 IGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG VYKA+ + + A KV + + L+ + VE +++ S H N++K++ +
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E +++E+ G+++ + L Q + AL YLH IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEY-----GREGRVS 222
K N+L + L+DF ++ + + + F T +MAPE ++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS---AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 223 ANGDVYSFGIMLMETFTGKKPTDEI 247
DV+S GI L+E + P E+
Sbjct: 219 YKADVWSLGITLIEMAEIEPPHHEL 243
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 65.5 bits (158), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 19/229 (8%)
Query: 40 ATDEFSEN----NLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMM 92
+ EF EN IG+G +G VYKAR G VA+K L + S + E ++
Sbjct: 4 GSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 63
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
K + H N++K++ E LV E++ H L+K++ ++ + I L I + L
Sbjct: 64 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLL 120
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+ L F +S ++H DLKP N+L++ L+DF +A+ + T T T+ Y A
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRA 178
Query: 213 PEYGREGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
PE + + D++S G + E F G D++F TL
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLSFC 119
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 177
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 41 TDEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRH 97
+D + +GKG F V + G+E A K+ N + R + E + + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 148
N++++ S E F LV + + G L + YS S+CI I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI---------- 114
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLVGEDQSMTQTQTF 205
LE + + +S I+H +LKP N+LL L+DF +A + V + ++ F
Sbjct: 115 ---LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAW---HGF 167
Query: 206 A-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
A T GY++PE ++ S D+++ G++L G P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 177
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 41 TDEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRH 97
+D + +GKG F V + G+E A K+ N + R + E + + ++H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
N++++ S E F LV + + G L+ + + + + LE + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 158 GYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAP 213
+S I+H +LKP N+LL L+DF +A + V + ++ FA T GY++P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAW---HGFAGTPGYLSP 176
Query: 214 EYGREGRVSANGDVYSFGIMLMETFTGKKP 243
E ++ S D+++ G++L G P
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVGYPP 206
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 41 TDEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRH 97
+D + +GKG F V + G+E A K+ N + R + E + + ++H
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 148
N++++ S E F LV + + G L + YS S+CI I
Sbjct: 64 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI---------- 113
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLVGEDQSMTQTQTF 205
LE + + +S I+H +LKP N+LL L+DF +A + V + ++ F
Sbjct: 114 ---LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAW---HGF 166
Query: 206 A-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
A T GY++PE ++ S D+++ G++L G P
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 37/227 (16%)
Query: 37 LCQATDEFSEN----NLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKSFNVEC 89
+ A+ +FS+N +GKG F V + G+E A K+ N + R + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQ 140
+ + ++H N++++ S E F LV + + G L + YS S+CI I
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI-- 137
Query: 141 RLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLVGEDQ 197
LE + + +S I+H +LKP N+LL L+DF +A + V + +
Sbjct: 138 -----------LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSE 185
Query: 198 SMTQTQTFA-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ FA T GY++PE ++ S D+++ G++L G P
Sbjct: 186 AW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 25/222 (11%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR-LGDGME-----VAVKVFNLQCGRALK-SFNVECE 90
EF NNL +G G FG V +A G G E VAVK+ K + E +
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YSSNCILDIFQ 140
+M + +H N++ ++ +C++ ++ EY +G L +L YS N + +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 141 RL---NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
+L +++ + + + F S IH D+ NVLL + VA + DF +A+ ++ +
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+ + + +MAPE + + DV+S+GI+L E F+
Sbjct: 222 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
D F + ++G+GGFG V+ ++ G A K N + + K + VE +++ +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEY 154
R ++ + + + LV+ M G + ++Y+ + FQ + + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTFA-TIGYMA 212
LH II+ DLKP NVLLDD+ +SD +A +L G+ T+T+ +A T G+MA
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTPGFMA 357
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKP 243
PE G E S D ++ G+ L E + P
Sbjct: 358 PELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 44 FSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRALKSFNVECEMMKSIRHRN 99
FS+ IG G FG+VY AR + + VA+K + Q + E ++ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS----ALEYL 155
I+ E LV+EY L S++ +L++ ++ +++A+ AL+ L
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY-MAPE 214
+ +S +IH D+K N+LL + + L DF A + M F Y MAPE
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-------MAPANXFVGTPYWMAPE 181
Query: 215 Y---GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 249
EG+ DV+S GI +E K P +FN
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 216
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 177
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 51 GKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS---- 106
+G FG V+KA+L + VAVK+F +Q ++ ++ E + ++H N+++ I +
Sbjct: 33 ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF-------GY 159
S + L+ + GSL +L ++ ++ + +I +A L YLH G+
Sbjct: 91 TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
I H D+K NVLL +N+ A ++DF +A K G+ T Q T YMAPE E
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV-GTRRYMAPEV-LE 206
Query: 219 GRVSANG------DVYSFGIMLMETFT----GKKPTDE 246
G ++ D+Y+ G++L E + P DE
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
D F + ++G+GGFG V+ ++ G A K N + + K + VE +++ +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEY 154
R ++ + + + LV+ M G + ++Y+ + FQ + + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTFA-TIGYMA 212
LH II+ DLKP NVLLDD+ +SD +A +L G+ T+T+ +A T G+MA
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTPGFMA 357
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKP 243
PE G E S D ++ G+ L E + P
Sbjct: 358 PELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 120
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 178
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 221
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
D F + ++G+GGFG V+ ++ G A K N + + K + VE +++ +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEY 154
R ++ + + + LV+ M G + ++Y+ + FQ + + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTFA-TIGYMA 212
LH II+ DLKP NVLLDD+ +SD +A +L G+ T+T+ +A T G+MA
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTPGFMA 357
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKP 243
PE G E S D ++ G+ L E + P
Sbjct: 358 PELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 7 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 67 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 123
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 181
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 224
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRALKSFNVECEM--MKSIRHRNLIKVIS 105
+G+G FG V A +VA+K + Q ++ VE E+ +K +RH ++IK+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+ +V+EY G L Y+ + + R + A+EY H I+H
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHKIVH 131
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DLKP N+LLDDN+ ++DF ++ ++ D + +T + + Y APE G++ A
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-INGKLYAGP 187
Query: 226 --DVYSFGIMLMETFTGKKPTDEIF 248
DV+S GI+L G+ P D+ F
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEF 212
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
D F + ++G+GGFG V+ ++ G A K N + + K + VE +++ +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEY 154
R ++ + + + LV+ M G + ++Y+ + FQ + + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA-KLLVGEDQSMTQTQTFA-TIGYMA 212
LH II+ DLKP NVLLDD+ +SD +A +L G+ T+T+ +A T G+MA
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTPGFMA 357
Query: 213 PE--YGREGRVSANGDVYSFGIMLMETFTGKKP 243
PE G E S D ++ G+ L E + P
Sbjct: 358 PELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMMK 93
L++ ++F + ++GKG FG V+ A + A+K L+ L +VEC M++
Sbjct: 11 LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 68
Query: 94 ------SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 147
+ H L + + +E V+EY+ G L ++ S + D+ + +
Sbjct: 69 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAE 127
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LVGEDQSMTQTQTF- 205
+ L++LH S I++ DLK N+LLD + ++DF + K ++G+ +T F
Sbjct: 128 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----AKTNEFC 180
Query: 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
T Y+APE + + + D +SFG++L E G+ P
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
++FS + +IG+GGFG VY R D K++ ++C + + E + ++ R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 243
Query: 102 KVISS-------CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
++S+ C + F + +L+ M G L +L + R ++
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEII 302
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ-TFATI 208
LE++H + +++ DLKP+N+LLD++ +SD +A D S + + T
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTH 354
Query: 209 GYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKP 243
GYMAPE ++G ++ D +S G ML + G P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
++FS + +IG+GGFG VY R D K++ ++C + + E + ++ R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 243
Query: 102 KVISS-------CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
++S+ C + F + +L+ M G L +L + R ++
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEII 302
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ-TFATI 208
LE++H + +++ DLKP+N+LLD++ +SD +A D S + + T
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTH 354
Query: 209 GYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKP 243
GYMAPE ++G ++ D +S G ML + G P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
++FS + +IG+GGFG VY R D K++ ++C + + E + ++ R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 243
Query: 102 KVISS-------CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
++S+ C + F + +L+ M G L +L + R ++
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEII 302
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ-TFATI 208
LE++H + +++ DLKP+N+LLD++ +SD +A D S + + T
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTH 354
Query: 209 GYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKP 243
GYMAPE ++G ++ D +S G ML + G P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 44 FSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNL---QCGRALKSFNVECEMMKSIRHRN 99
FS+ IG G FG+VY AR + + VA+K + Q + E ++ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS----ALEYL 155
I+ E LV+EY L S++ +L++ ++ +++A+ AL+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY-MAPE 214
+ +S +IH D+K N+LL + + L DF A + M F Y MAPE
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-------MAPANXFVGTPYWMAPE 220
Query: 215 Y---GREGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 249
EG+ DV+S GI +E K P +FN
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN 255
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 70/274 (25%), Positives = 113/274 (41%), Gaps = 29/274 (10%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSF-NVECEMMKSIRHRNLI 101
F++ + IGKG FG VYK EV A+K+ +L+ E ++ +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ S +++EY+ GS L L+ I+ ++ L+YLH S
Sbjct: 81 RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---SE 135
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
IH D+K +NVLL + L+DF +A L D + + T +MAPE ++
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281
D++S GI +E G+ P +D P+ L ++ N S +
Sbjct: 194 DFKADIWSLGITAIELAKGEPPN--------------SDLHPMRVLFLIPKN--SPPTLE 237
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
+ FV AC + P R AKE++K
Sbjct: 238 GQHSKPFKEFV----EACLNKDPRFRPTAKELLK 267
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 28/216 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
++FS + +IG+GGFG VY R D K++ ++C + + E + ++ R ++
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKAD----TGKMYAMKCLDKKRIKMKQGETL-ALNERIML 242
Query: 102 KVISS-------CSNEEFK-----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
++S+ C + F + +L+ M G L +L + R ++
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEII 301
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQ-TFATI 208
LE++H + +++ DLKP+N+LLD++ +SD +A D S + + T
Sbjct: 302 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTH 353
Query: 209 GYMAPEYGREG-RVSANGDVYSFGIMLMETFTGKKP 243
GYMAPE ++G ++ D +S G ML + G P
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 69/286 (24%), Positives = 136/286 (47%), Gaps = 31/286 (10%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + + +G G G V+K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 9 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 69 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 126
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ E + T YM+PE +
Sbjct: 127 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQG 180
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
S D++S G+ L+E G+ P + E+ L + VN+ P + + + S E
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFEL-LDYIVNEPPP-----KLPSAVFSLE 234
Query: 279 DIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEI-VKKLLKIRDS 323
FV K C +++P +R + K++ V +K D+
Sbjct: 235 FQDFVNK-------------CLIKNPAERADLKQLMVHAFIKRSDA 267
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 9/202 (4%)
Query: 45 SENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
S+ ++G G FG V+K G+++A K+ + + + E +M + H NLI++
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
+ ++ LV+EY+ G L + + L + M + + ++H Y I
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---I 208
Query: 164 IHCDLKPSNVLL--DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
+H DLKP N+L D + DF +A+ ++ F T ++APE V
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFV 265
Query: 222 SANGDVYSFGIMLMETFTGKKP 243
S D++S G++ +G P
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSP 287
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 64/274 (23%), Positives = 111/274 (40%), Gaps = 34/274 (12%)
Query: 56 GSVYKARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISSCSNE--E 111
G ++K R G ++ VKV ++ R + FN EC ++ H N++ V+ +C +
Sbjct: 24 GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 112 FKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMIDVASALEYLHFGYSAPII--HCDL 168
L+ + P+GSL L+ +N ++D Q + +D A +LH P+I H L
Sbjct: 83 HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHA-L 139
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
+V +D++ A +S + QS + A + A + E + D +
Sbjct: 140 NSRSVXIDEDXTARISXADVKFSF----QSPGRXYAPAWVAPEALQKKPEDTNRRSADXW 195
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHFVAKEQC 288
SF ++L E T + P ++ N E+ K ++ E +
Sbjct: 196 SFAVLLWELVTREVPFADLSNXEIGXK-------------------VALEGLRPTIPPGI 236
Query: 289 VSFVFNLAMACAVESPEQRINAKEIVKKLLKIRD 322
V L C E P +R IV L K +D
Sbjct: 237 SPHVSKLXKICXNEDPAKRPKFDXIVPILEKXQD 270
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 84/308 (27%), Positives = 129/308 (41%), Gaps = 54/308 (17%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107
+GKG +G V++ L G VAVK+F+ R +S+ E E+ ++ RH N++ I+S
Sbjct: 16 VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH---FGYS 160
+ L+ Y HGSL +L L+ L + + A L +LH FG
Sbjct: 72 MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 161 A--PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLV-GEDQ-SMTQTQTFATIGYMAPEYG 216
I H D K NVL+ N+ ++D +A + G D + T YMAPE
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 217 REGRVSAN-------GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
E ++ + D+++FG++L E I NG V D+ P
Sbjct: 190 DE-QIRTDCFESYKWTDIWAFGLVLWEI-----ARRTIVNGI------VEDYRP--PFYD 235
Query: 270 VDANLLSQEDIHFV--------------AKEQCVSFVFNLAMACAVESPEQRINAKEIVK 315
V N S ED+ V A + +S + + C +P R+ A I K
Sbjct: 236 VVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKK 295
Query: 316 KLLKIRDS 323
L KI +S
Sbjct: 296 TLQKISNS 303
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107
IGKG FG V++ + G EVAVK+F+ R +S+ E E+ +++ RH N++ I++
Sbjct: 12 IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------ 157
+ + LV +Y HGSL YL ++ + + + AS L +LH
Sbjct: 68 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 125
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMA 212
G A I H DLK N+L+ N ++D +A V D + + T YMA
Sbjct: 126 GKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 213 PEY------GREGRVSANGDVYSFGIMLME 236
PE + D+Y+ G++ E
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWE 211
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 64.3 bits (155), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 46/288 (15%)
Query: 50 IGKGGFGSVYKARLG------DGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIK 102
+G G FG VY+ ++ ++VAVK + + F +E ++ H+N+++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYL- 155
I + ++LE M G L+ +L S L + L++ D+A +YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 156 --HFGYSAPIIHCDLKPSNVLLD---DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
HF IH D+ N LL VA + DF +A+ + + +
Sbjct: 173 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
M PE EG ++ D +SFG++L E F+ G P N E+ LE
Sbjct: 227 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------LEF 272
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
V + + C V+ + C PE R N I++++
Sbjct: 273 VTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 64.3 bits (155), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH---- 97
+F E ++G+G FG V KAR D A+K L + E ++ S+ H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 98 ---------RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
RN +K +++ + + +EY +G+L ++S N + + +
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK-------LLVGEDQSMTQ 201
AL Y+H S IIH DLKP N+ +D++ + DF +AK +L + Q++
Sbjct: 126 LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 202 -----TQTFATIGYMAPE-YGREGRVSANGDVYSFGIMLME 236
T T Y+A E G + D+YS GI+ E
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 40 ATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRH 97
++ +F + +G G + +VYK G+ VA+K L S + E +MK ++H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC----------ILDIFQRLNIMID 147
N++++ E LV E+M L+KY+ S ++ FQ
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ------- 114
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
L+ L F + I+H DLKP N+L++ L DF +A+ T + T
Sbjct: 115 -WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVT 171
Query: 208 IGYMAPEYGREGRV-SANGDVYSFGIMLMETFTGK 241
+ Y AP+ R S + D++S G +L E TGK
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107
IGKG FG V++ + G EVAVK+F+ R +S+ E E+ +++ RH N++ I++
Sbjct: 37 IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------ 157
+ + LV +Y HGSL YL ++ + + + AS L +LH
Sbjct: 93 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 150
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMA 212
G A I H DLK N+L+ N ++D +A V D + + T YMA
Sbjct: 151 GKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 213 PEY------GREGRVSANGDVYSFGIMLME 236
PE + D+Y+ G++ E
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWE 236
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 49 LIGKGGFGSVYKARLGDG--------MEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
++GKGG+G V++ R G M+V K ++ + E +++ ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ +I + L+LEY+ G L L ++ + +++ AL +LH
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH---Q 139
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPE-YGRE 218
II+ DLKP N++L+ L+DF + K + T T F TI YMAPE R
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI---HDGTVTHXFCGTIEYMAPEILMRS 196
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
G A D +S G ++ + TG P F GE
Sbjct: 197 GHNRAV-DWWSLGALMYDMLTGAPP----FTGE 224
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107
IGKG FG V++ + G EVAVK+F+ R +S+ E E+ +++ RH N++ I++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------ 157
+ + LV +Y HGSL YL ++ + + + AS L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 124
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMA 212
G A I H DLK N+L+ N ++D +A V D + + T YMA
Sbjct: 125 GKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 213 PEY------GREGRVSANGDVYSFGIMLME 236
PE + D+Y+ G++ E
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWE 210
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107
IGKG FG V++ + G EVAVK+F+ R +S+ E E+ +++ RH N++ I++
Sbjct: 14 IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------ 157
+ + LV +Y HGSL YL ++ + + + AS L +LH
Sbjct: 70 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 127
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMA 212
G A I H DLK N+L+ N ++D +A V D + + T YMA
Sbjct: 128 GKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 213 PEY------GREGRVSANGDVYSFGIMLME 236
PE + D+Y+ G++ E
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWE 213
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVFNLQCGRA-LKSFNVECEMMKSIRHRNLIKVI 104
+G G FGSV Y+ R ++VA+KV +A + E ++M + + ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
C E LV+E G L K+L + + ++ V+ ++YL +
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT-QTQTFATIGYMAPEYGREGRVSA 223
H +L NVLL + A +SDF ++K L +D T ++ + + APE + S+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEM 252
DV+S+G+ + E + G+KP ++ E+
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107
IGKG FG V++ + G EVAVK+F+ R +S+ E E+ +++ RH N++ I++
Sbjct: 17 IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------ 157
+ + LV +Y HGSL YL ++ + + + AS L +LH
Sbjct: 73 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 130
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMA 212
G A I H DLK N+L+ N ++D +A V D + + T YMA
Sbjct: 131 GKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 213 PEY------GREGRVSANGDVYSFGIMLME 236
PE + D+Y+ G++ E
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWE 216
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISSC 107
IGKG FG V++ + G EVAVK+F+ R +S+ E E+ +++ RH N++ I++
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 108 SNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------ 157
+ + LV +Y HGSL YL ++ + + + AS L +LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTASGLAHLHMEIVGTQ 163
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS-----MTQTQTFATIGYMA 212
G A I H DLK N+L+ N ++D +A V D + + T YMA
Sbjct: 164 GKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 213 PEY------GREGRVSANGDVYSFGIMLME 236
PE + D+Y+ G++ E
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWE 249
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 44 FSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-----GRALKSFNVECEMMKSIRH 97
F + ++GKGGFG V ++ G A K + G A+ + N E ++++ +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-ALN-EKQILEKVNS 243
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH 156
R ++ + + ++ LVL M G L+ ++Y + + ++ LE LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
I++ DLKP N+LLDD+ +SD +A + V E Q++ T+GYMAPE
Sbjct: 304 ---RERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGR--VGTVGYMAPEVV 357
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ R + + D ++ G +L E G+ P
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSP 384
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
+F E LIG GGFG V+KA+ DG +K +A + E + + + H N++
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 102 KV------------ISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNC-ILDIFQRLNI 144
SS ++ K + +E+ G+LE+++ LD L +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
+ ++Y+H S +I+ DLKPSN+ L D + DF + L + + + ++
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRS 181
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLME 236
T+ YM+PE D+Y+ G++L E
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNLQCGRALKSFNVECEMMK 93
L++ ++F + ++GKG FG V+ A + A+K L+ L +VEC M++
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 67
Query: 94 ------SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 147
+ H L + + +E V+EY+ G L ++ S + D+ + +
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAE 126
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL-LVGEDQSMTQTQTF- 205
+ L++LH S I++ DLK N+LLD + ++DF + K ++G+ +T F
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----AKTNXFC 179
Query: 206 ATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
T Y+APE + + + D +SFG++L E G+ P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 44 FSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQC-----GRALKSFNVECEMMKSIRH 97
F + ++GKGGFG V ++ G A K + G A+ + N E ++++ +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-ALN-EKQILEKVNS 243
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLH 156
R ++ + + ++ LVL M G L+ ++Y + + ++ LE LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
I++ DLKP N+LLDD+ +SD +A + V E Q++ T+GYMAPE
Sbjct: 304 ---RERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGR--VGTVGYMAPEVV 357
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ R + + D ++ G +L E G+ P
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSP 384
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F IG G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EYMP G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----YLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F IG G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EYMP G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----YLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 66/278 (23%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + M VA+K N + F E M+ H +++K+I
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 78 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ N L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 235
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 236 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLI 101
+F E LIG GGFG V+KA+ DG ++ +A + E + + + H N++
Sbjct: 13 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIV 68
Query: 102 KVI-----------------------------SSCSNEEFKALVLEYMPHGSLEKYLYSS 132
SS S + + +E+ G+LE+++
Sbjct: 69 HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 133 NC-ILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191
LD L + + ++Y+H S +IH DLKPSN+ L D + DF +
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLME 236
L + + +T++ T+ YM+PE D+Y+ G++L E
Sbjct: 186 LKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLG 176
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+ L + S + E ++K + H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 177
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+ L + S + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 117
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 175
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 117
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 175
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 117
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 175
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 118
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 176
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 221
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLG 176
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 119
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 177
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 120
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 119
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 177
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 119
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 120 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 177
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 117
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 175
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 5 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 65 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 121
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 179
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 224
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 4 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+K++ ++ + I L I + L+ L F
Sbjct: 64 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 120
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLG 178
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 221
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 118
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 176
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 221
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+K++ ++ + I L I + L+ L
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 120
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223
>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2-
Yl)amino]benzamide
Length = 320
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 39/280 (13%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRN--LIKVIS 105
IG GG V++ A+K NL+ + L S+ E + ++ + +I++
Sbjct: 16 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+E + L +L I D ++R + + LE +H + I+H
Sbjct: 76 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 130
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS-AN 224
DLKP+N L+ D M+ L DF IA + + S+ + T+ YM PE ++ S N
Sbjct: 131 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 189
Query: 225 G----------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
G DV+S G +L GK P +I N +++ H + D P +E D
Sbjct: 190 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 243
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
+ ++D+ V K C P+QRI+ E++
Sbjct: 244 IPEKDLQDVLK------------CCLKRDPKQRISIPELL 271
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISS 106
IGKG F V AR + G EVAVK+ + +L+ E + K + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ LV EY G + YL + + R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYGREGRVSANG 225
DLK N+LLD + ++DF + E + F Y APE + +
Sbjct: 138 DLKAENLLLDADXNIKIADFGFS----NEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 226 -DVYSFGIMLMETFTGKKPTD 245
DV+S G++L +G P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 67/237 (28%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMK----- 93
D F ++GKG FG V AR+ + G AVKV L+ L+ +VEC M +
Sbjct: 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILS 78
Query: 94 -SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+ H L ++ + V+E++ G L ++ S + R ++ SAL
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISAL 137
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
+LH II+ DLK NVLLD L+DF + K G +T T Y+A
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIA 192
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKP-----TDEIF----NGEMTLKHWVND 260
PE +E D ++ G++L E G P D++F N E+ W+++
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 66/278 (23%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + M VA+K N + F E M+ H +++K+I
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 78 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ N L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 235
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 236 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 68/280 (24%), Positives = 133/280 (47%), Gaps = 34/280 (12%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + + +G G G V+K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 25 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 85 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 142
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YM+PE +
Sbjct: 143 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 196
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMT----LKHWVNDWLPISTLEVVDANL 274
S D++S G+ L+E G+ P +G M L + VN+ P + + +
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGS-GSGSMAIFELLDYIVNEPPP-----KLPSGV 250
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
S E FV K C +++P +R + K+++
Sbjct: 251 FSLEFQDFVNK-------------CLIKNPAERADLKQLM 277
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 27 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 87 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G ++ T Y+APE
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEYLAPEIIL 197
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPP 223
>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(ttk)
pdb|3GFW|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrolo-Pyridin Ligand
Length = 313
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 39/280 (13%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRN--LIKVIS 105
IG GG V++ A+K NL+ + L S+ E + ++ + +I++
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+E + L +L I D ++R + + LE +H + I+H
Sbjct: 96 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 150
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS-AN 224
DLKP+N L+ D M+ L DF IA + + S+ + T+ YM PE ++ S N
Sbjct: 151 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 225 G----------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
G DV+S G +L GK P +I N +++ H + D P +E D
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 263
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
+ ++D+ V K C P+QRI+ E++
Sbjct: 264 IPEKDLQDVLK------------CCLKRDPKQRISIPELL 291
>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715
Length = 317
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 39/280 (13%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRN--LIKVIS 105
IG GG V++ A+K NL+ + L S+ E + ++ + +I++
Sbjct: 20 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+E + L +L I D ++R + + LE +H + I+H
Sbjct: 80 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 134
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS-AN 224
DLKP+N L+ D M+ L DF IA + + S+ + T+ YM PE ++ S N
Sbjct: 135 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 193
Query: 225 G----------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
G DV+S G +L GK P +I N +++ H + D P +E D
Sbjct: 194 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 247
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
+ ++D+ V K C P+QRI+ E++
Sbjct: 248 IPEKDLQDVLK------------CCLKRDPKQRISIPELL 275
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 49 LIGK-GGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
+IG+ G FG VYKA+ + + A KV + + L+ + VE +++ S H N++K++ +
Sbjct: 16 IIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 75
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E +++E+ G+++ + L Q + AL YLH IIH
Sbjct: 76 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 132
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT--FATIGYMAPEY-----GREG 219
DLK N+L + L+DF ++ ++ Q + T +MAPE ++
Sbjct: 133 DLKAGNILFTLDGDIKLADFGVS---AKNTRTXIQRRDSFIGTPYWMAPEVVMCETSKDR 189
Query: 220 RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
DV+S GI L+E + P E+ + LK
Sbjct: 190 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 225
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G ++ T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+ ++ ++ + I L I + L+ L F
Sbjct: 62 NIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T T+ Y APE
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 69/294 (23%), Positives = 138/294 (46%), Gaps = 37/294 (12%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + + +G G G V+K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YM+PE +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 177
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQE 278
S D++S G+ L+E G+ P E + P++ E++D
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-------DSRPPMAIFELLD------- 223
Query: 279 DIHFVAKE---QCVSFVFNLAM-----ACAVESPEQRINAKEI-VKKLLKIRDS 323
++ E + S VF+L C +++P +R + K++ V +K D+
Sbjct: 224 ---YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 274
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 66/278 (23%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + M VA+K N + F E M+ H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ N L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 615
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 616 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain
Length = 343
Score = 61.6 bits (148), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 39/280 (13%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRN--LIKVIS 105
IG GG V++ A+K NL+ + L S+ E + ++ + +I++
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+E + L +L I D ++R + + LE +H + I+H
Sbjct: 77 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 131
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS-AN 224
DLKP+N L+ D M+ L DF IA + + S+ + T+ YM PE ++ S N
Sbjct: 132 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 225 G----------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
G DV+S G +L GK P +I N +++ H + D P +E D
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 244
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
+ ++D+ V K C P+QRI+ E++
Sbjct: 245 IPEKDLQDVLK------------CCLKRDPKQRISIPELL 272
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 34 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 94 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPP 230
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F IG G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPE-----YLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 38/232 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKAR-LGDGME-----VAVKVFNLQCGRALK-SFNVECE 90
EF NNL +G G FG V +A G G E VAVK+ K + E +
Sbjct: 27 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 91 MMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY------------------- 130
+M + +H N++ ++ +C++ ++ EY +G L +L
Sbjct: 87 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 131 ---SSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFS 187
L++ L+ VA + +L S IH D+ NVLL + VA + DF
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 188 IAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT 239
+A+ ++ + + + + +MAPE + + DV+S+GI+L E F+
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEM-----MK 93
AT + IG G +G+VYKAR G VA+K + G + E+ ++
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 94 SIRHRNLIKVISSC----SNEEFK-ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMID 147
+ H N+++++ C ++ E K LV E++ L YL + L ++M
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
L++LH I+H DLKP N+L+ L+DF +A++ M T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVVVT 174
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKK 242
+ Y APE + + D++S G + E F K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH---- 97
+F E ++G+G FG V KAR D A+K L + E ++ S+ H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65
Query: 98 ---------RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
RN +K +++ + + +EY + +L ++S N + + +
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK-------LLVGEDQSMTQ 201
AL Y+H S IIH DLKP N+ +D++ + DF +AK +L + Q++
Sbjct: 126 LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 202 -----TQTFATIGYMAPE-YGREGRVSANGDVYSFGIMLME 236
T T Y+A E G + D+YS GI+ E
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With Atp
pdb|3HMO|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With The Inhibitor Staurosporine
pdb|3HMP|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With A Quinazolin Ligand Compound 4
Length = 342
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 39/280 (13%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRN--LIKVIS 105
IG GG V++ A+K NL+ + L S+ E + ++ + +I++
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+E + L +L I D ++R + + LE +H + I+H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 178
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS-AN 224
DLKP+N L+ D M+ L DF IA + + S+ + T+ YM PE ++ S N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 237
Query: 225 G----------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
G DV+S G +L GK P +I N +++ H + D P +E D
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 291
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
+ ++D+ V K C P+QRI+ E++
Sbjct: 292 IPEKDLQDVLK------------CCLKRDPKQRISIPELL 319
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + + VA+K N + F E M+ H +++K+I
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 75 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ N L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 232
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 233 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + + VA+K N + F E M+ H +++K+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 83 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ N L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 240
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 241 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + + VA+K N + F E M+ H +++K+I
Sbjct: 18 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 78 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ N L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 235
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 236 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + + VA+K N + F E M+ H +++K+I
Sbjct: 21 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 81 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ N L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 195 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 238
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 239 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 272
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + + VA+K N + F E M+ H +++K+I
Sbjct: 20 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 80 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ N L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 194 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 237
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 238 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 271
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 50 IGKGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRHRNLIKVISS 106
+GKG F V + ++ G E A K+ N + R + E + + ++H N++++ S
Sbjct: 30 LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
S E L+ + + G L + + + + + LE + + ++H
Sbjct: 90 ISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 167 DLKPSNVLLDDNM---VAHLSDFSIAKLLVGEDQSMTQTQTFA-TIGYMAPEYGREGRVS 222
DLKP N+LL + L+DF +A + GE Q+ FA T GY++PE R+
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSPEVLRKDPYG 202
Query: 223 ANGDVYSFGIMLMETFTGKKP 243
D+++ G++L G P
Sbjct: 203 KPVDLWACGVILYILLVGYPP 223
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + + VA+K N + F E M+ H +++K+I
Sbjct: 46 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 106 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ N L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 219
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 220 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 263
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 264 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDS 235
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEM-----MK 93
AT + IG G +G+VYKAR G VA+K + G + E+ ++
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 94 SIRHRNLIKVISSC----SNEEFK-ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMID 147
+ H N+++++ C ++ E K LV E++ L YL + L ++M
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
L++LH I+H DLKP N+L+ L+DF +A++ M T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVT 174
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKK 242
+ Y APE + + D++S G + E F K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + + +G G G V+K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 150
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YM+PE +
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 204
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G+ L+E G+ P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 34 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 94 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 204
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPP 230
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + + +G G G V+K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YM+PE +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 177
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G+ L+E G+ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + + +G G G V+K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YM+PE +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 177
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G+ L+E G+ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + + +G G G V+K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 68 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 185
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YM+PE +
Sbjct: 186 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 239
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G+ L+E G+ P
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYP 264
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 70
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + + +G G G V+K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YM+PE +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 177
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G+ L+E G+ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 71/280 (25%), Positives = 125/280 (44%), Gaps = 39/280 (13%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRN--LIKVIS 105
IG GG V++ A+K NL+ + L S+ E + ++ + +I++
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+E + L +L I D ++R + ++ LE +H + I+H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYWKNM---LEAVHTIHQHGIVH 178
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS-AN 224
DLKP+N L+ D M+ L DF IA + + S+ + T+ YM PE ++ S N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 237
Query: 225 G----------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
G DV+S G +L GK P +I N +++ H + D P +E D
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 291
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
+ ++D+ V K C P+QRI+ E++
Sbjct: 292 IPEKDLQDVLK------------CCLKRDPKQRISIPELL 319
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVF--NLQCGRALKSFNVECEMMKSI---- 95
E+ L+GKGGFG+V+ RL D ++VA+KV N G + S +V C + ++
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 96 ----RHRNLIKVISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
H +I+++ +E LVLE +P L Y+ + + R V +
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC-FFGQVVA 150
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG 209
A+++ H S ++H D+K N+L+D A L DF LL D+ T T
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD--GTRV 203
Query: 210 YMAPEY-GREGRVSANGDVYSFGIMLMETFTGKKPTD---EIFNGEM 252
Y PE+ R + V+S GI+L + G P + EI E+
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + + +G G G V+K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 123
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YM+PE +
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQG 177
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G+ L+E G+ P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 65/239 (27%), Positives = 98/239 (41%), Gaps = 45/239 (18%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKS----FNVECEMMKSIRHRNLIKVI- 104
IG+G F +VYK L V V LQ + KS F E E +K ++H N+++
Sbjct: 34 IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 105 ---SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI------DVASALEYL 155
S+ ++ LV E G+L+ YL F+ I + + L++L
Sbjct: 93 SWESTVKGKKCIVLVTELXTSGTLKTYLKR-------FKVXKIKVLRSWCRQILKGLQFL 145
Query: 156 HFGYSAPIIHCDLKPSNVLLD---------DNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
H + PIIH DLK N+ + D +A L S AK ++G
Sbjct: 146 H-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG------------ 192
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 265
T + APE E + + DVY+FG +E T + P E N + + P S
Sbjct: 193 TPEFXAPEXYEE-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPAS 250
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 1 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ H L+ ++ ++ + I L I + L+ L
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPL-IKSYLFQLLQGLA 117
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 175
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 220
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G G E A K + + G + + E +++
Sbjct: 12 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
IRH N+I + N+ L+LE + G L +L + + + + + + Y
Sbjct: 72 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 130
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFSIA-KLLVGEDQSMTQTQTFATIG 209
LH S I H DLKP N++L D V + L DF IA K+ G + F T
Sbjct: 131 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGTPE 183
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
++APE + D++S G++ +G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 62 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+P G + +L + R + EYLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE-----YLAPEIIL 232
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP 258
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 20/214 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G G E A K + + G + + E +++
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
IRH N+I + N+ L+LE + G L +L + + + + + + Y
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 123
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFSIA-KLLVGEDQSMTQTQTFATIG 209
LH S I H DLKP N++L D V + L DF IA K+ G + F T
Sbjct: 124 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGTPE 176
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
++APE + D++S G++ +G P
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrimido-Diazepin Ligand
Length = 313
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 123/280 (43%), Gaps = 39/280 (13%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRN--LIKVIS 105
IG GG V++ A+K NL+ + L S+ E + ++ + +I++
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+E + L +L I D ++R + + LE +H + I+H
Sbjct: 96 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 150
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS-AN 224
DLKP+N L+ D M+ L DF IA + + + + T+ YM PE ++ S N
Sbjct: 151 SDLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 225 G----------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
G DV+S G +L GK P +I N +++ H + D P +E D
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 263
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
+ ++D+ V K C P+QRI+ E++
Sbjct: 264 IPEKDLQDVLK------------CCLKRDPKQRISIPELL 291
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 20/214 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARL-GDGMEVAVK------VFNLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G G E A K + + + G + + E +++
Sbjct: 26 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
IRH N+I + N+ L+LE + G L +L + + + + + + Y
Sbjct: 86 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHY 144
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAH----LSDFSIA-KLLVGEDQSMTQTQTFATIG 209
LH S I H DLKP N++L D V + L DF IA K+ G + F T
Sbjct: 145 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGTPE 197
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
++APE + D++S G++ +G P
Sbjct: 198 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEM-----MK 93
AT + IG G +G+VYKAR G VA+K + G + E+ ++
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 94 SIRHRNLIKVISSC----SNEEFK-ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMID 147
+ H N+++++ C ++ E K LV E++ L YL + L ++M
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
L++LH I+H DLKP N+L+ L+DF +A++ M T
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVT 174
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKK 242
+ Y APE + + D++S G + E F K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 78/289 (26%), Positives = 124/289 (42%), Gaps = 42/289 (14%)
Query: 50 IGKGGFGSVYKARLGD---GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
+G+G FG V+ R+ D G + AVK L+ RA + + C + S R ++ + +
Sbjct: 82 LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEEL--MACAGLTSPR---IVPLYGA 134
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + +E + GSL + + C+ + + L + LEYLH S I+H
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALEGLEYLH---SRRILHG 190
Query: 167 DLKPSNVLLD-DNMVAHLSDFSIAKLL----VGEDQSMTQTQTFATIGYMAPEYGREGRV 221
D+K NVLL D A L DF A L +G+D +T T +MAPE
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDL-LTGDYIPGTETHMAPEVVLGRSC 249
Query: 222 SANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIH 281
A DV+S M++ G P + F G + LK ++ P+ + A L +Q
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK-IASEPPPVREIPPSCAPLTAQAIQE 308
Query: 282 FVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGG 330
+ KE P R++A E+ K+ + L+ VGG
Sbjct: 309 GLRKE-----------------PIHRVSAAELGGKV----NRALQQVGG 336
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 36/299 (12%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--RHRNLIKVISS- 106
IGKG +G V+ + G +VAVKVF S+ E E+ +++ RH N++ I++
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 107 ---CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF------ 157
+ L+ +Y +GSL YL S+ LD L + S L +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE--DQSMTQTQTFATIGYMAPEY 215
G A I H DLK N+L+ N ++D +A + + + + T YM PE
Sbjct: 159 GKPA-IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 216 GREG------RVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIST--- 266
E + D+YSFG++L E ++ E L + +D +P
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWE--VARRCVSGGIVEEYQLPY--HDLVPSDPSYE 273
Query: 267 --LEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDS 323
E+V L + + ++C+ + L C +P R+ A + K L K+ +S
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 15/223 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHR 98
+ F + IG+G +G VYKAR G VA+K L + S + E ++K + H
Sbjct: 6 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
N++K++ E LV E++ H L+ ++ ++ + I L I + L+ L F
Sbjct: 66 NIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPL-IKSYLFQLLQGLAFC 122
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEILLG 180
Query: 219 GRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 37/232 (15%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNV 87
EF + L +G+G FG V +A + VAVK+ RAL S
Sbjct: 25 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS--- 81
Query: 88 ECEMMKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYL---------YSSNCIL 136
E +++ I H N++ ++ +C+ +V+ E+ G+L YL Y +
Sbjct: 82 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLY 141
Query: 137 DIFQRLNIMI----DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL 192
F L +I VA +E+L S IH DL N+LL + V + DF +A+ +
Sbjct: 142 KDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 193 VGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+++D ++DF +AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNV--ECEMMKSIRHRN 99
+F +G+GGFG V++A+ D A+K L R L V E + + + H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPG 64
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------------SSNCILDIFQR--- 141
+++ N + E + S + YLY + C ++ +R
Sbjct: 65 IVRYF----NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 142 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMT- 200
L+I + +A A+E+LH S ++H DLKPSN+ + V + DF + + +++ T
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 201 ---------QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLME 236
T T YM+PE S D++S G++L E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+++D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 57/188 (30%), Positives = 92/188 (48%), Gaps = 24/188 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVK----VFNL--QCGRALKSFNVECEMMKS 94
DE+ IG G +G V AR G +VA+K F++ R L+ E +++K
Sbjct: 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR----ELKILKH 109
Query: 95 IRHRNLIKVI----SSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
+H N+I + + EFK++ VL+ M L + ++SS L + + +
Sbjct: 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP-LTLEHVRYFLYQL 167
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE--DQSMTQTQTFA 206
L+Y+H SA +IH DLKPSN+L+++N + DF +A+ L + T+ A
Sbjct: 168 LRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 207 TIGYMAPE 214
T Y APE
Sbjct: 225 TRWYRAPE 232
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 40 ATDEFSENNLIGKGGFGSVYKAR-LGDGMEVA---VKVFNLQCGRALKSFNVECEM---- 91
AT + IG G +G+VYKAR G VA V+V N G + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 92 -MKSIRHRNLIKVISSC----SNEEFK-ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNI 144
+++ H N+++++ C ++ E K LV E++ L YL + L ++
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT 204
M L++LH I+H DLKP N+L+ L+DF +A++ M T
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPV 179
Query: 205 FATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKK 242
T+ Y APE + + D++S G + E F K
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 65/278 (23%), Positives = 113/278 (40%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + M VA+K N + F E M+ H +++K+I
Sbjct: 18 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 78 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 235
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 236 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 269
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRN 99
D+F + +G G G V K + G+ +A K+ +L+ A+++ + E +++
Sbjct: 16 DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFG 158
++ + ++ ++ +E+M GSL++ L + I + I +++I V L YL
Sbjct: 76 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 133
Query: 159 YSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ I+H D+KPSN+L++ L DF ++ L+ SM + T YMAPE +
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMAPERLQG 187
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
S D++S G+ L+E G+ P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V AR G +VAVK+ +L+ + + E +M+ +H N++++ S
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
E +++E++ G+L + S L+ Q + V AL YLH + +IH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K ++LL + LSDF + + + T +MAPE + D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 229 SFGIMLMETFTGKKP 243
S GIM++E G+ P
Sbjct: 226 SLGIMVIEMVDGEPP 240
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+++D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 71/227 (31%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGR-ALKSFNVECEM--M 92
DE+ + +G G G V A +VA+K+ F + R A + NVE E+ +
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIFQRLNIMI 146
K + H +IK+ + E++ +VLE M G L K L + C L +Q L
Sbjct: 70 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 124
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
A++YLH IIH DLKP NVLL +++ + ++DF +K+L GE M
Sbjct: 125 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM--RT 175
Query: 204 TFATIGYMAPE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE G G A D +S G++L +G P E
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSE 221
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 57/188 (30%), Positives = 92/188 (48%), Gaps = 24/188 (12%)
Query: 42 DEFSENNLIGKGGFGSVYKARLG-DGMEVAVK----VFNL--QCGRALKSFNVECEMMKS 94
DE+ IG G +G V AR G +VA+K F++ R L+ E +++K
Sbjct: 55 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR----ELKILKH 110
Query: 95 IRHRNLIKVI----SSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
+H N+I + + EFK++ VL+ M L + ++SS L + + +
Sbjct: 111 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP-LTLEHVRYFLYQL 168
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE--DQSMTQTQTFA 206
L+Y+H SA +IH DLKPSN+L+++N + DF +A+ L + T+ A
Sbjct: 169 LRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 207 TIGYMAPE 214
T Y APE
Sbjct: 226 TRWYRAPE 233
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+++D ++DF +AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E + +++
Sbjct: 42 DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +VLEY P G + +L + R + EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 30/226 (13%)
Query: 42 DEFSENNLIGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNVECEM 91
D + +G+G FG V +A + VAVK+ RAL S E ++
Sbjct: 27 DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS---ELKI 83
Query: 92 MKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSSNC-----------ILDI 138
+ I H N++ ++ +C+ +V+ E+ G+L YL S L +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTL 143
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
+ VA +E+L S IH DL N+LL + V + DF +A+ + +
Sbjct: 144 EHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 201 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 71/227 (31%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGR-ALKSFNVECEM--M 92
DE+ + +G G G V A +VA+K+ F + R A + NVE E+ +
Sbjct: 9 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIFQRLNIMI 146
K + H +IK+ + E++ +VLE M G L K L + C L +Q L
Sbjct: 69 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 123
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
A++YLH IIH DLKP NVLL +++ + ++DF +K+L GE M
Sbjct: 124 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM--RT 174
Query: 204 TFATIGYMAPE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE G G A D +S G++L +G P E
Sbjct: 175 LCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSE 220
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 71/227 (31%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGR-ALKSFNVECEM--M 92
DE+ + +G G G V A +VA+K+ F + R A + NVE E+ +
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIFQRLNIMI 146
K + H +IK+ + E++ +VLE M G L K L + C L +Q L
Sbjct: 70 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 124
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
A++YLH IIH DLKP NVLL +++ + ++DF +K+L GE M
Sbjct: 125 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM--RT 175
Query: 204 TFATIGYMAPE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE G G A D +S G++L +G P E
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSE 221
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 64/252 (25%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRALKSFNVECEM--MKSIRHRNLIKVIS 105
+G+G FG V A G +VA+K+ N + ++ +E E+ ++ +RH ++IK+
Sbjct: 22 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+EY + L Y+ + + + R + SA+EY H I+H
Sbjct: 82 VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 136
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DLKP N+LLD+++ ++DF ++ ++ D + +T + + Y APE G++ A
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 192
Query: 226 --DVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVNDWLPISTLEVVDANL 274
DV+S G++L + P D+ I NG TL +++ ++ N
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 252
Query: 275 LSQEDIHFVAKE 286
L++ IH + ++
Sbjct: 253 LNRISIHEIMQD 264
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 71/227 (31%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGR-ALKSFNVECEM--M 92
DE+ + +G G G V A +VA+K+ F + R A + NVE E+ +
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIFQRLNIMI 146
K + H +IK+ + E++ +VLE M G L K L + C L +Q L
Sbjct: 70 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 124
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
A++YLH IIH DLKP NVLL +++ + ++DF +K+L GE M
Sbjct: 125 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM--RT 175
Query: 204 TFATIGYMAPE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE G G A D +S G++L +G P E
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSE 221
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 64/252 (25%), Positives = 124/252 (49%), Gaps = 24/252 (9%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRALKSFNVECEM--MKSIRHRNLIKVIS 105
+G+G FG V A G +VA+K+ N + ++ +E E+ ++ +RH ++IK+
Sbjct: 21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+EY + L Y+ + + + R + SA+EY H I+H
Sbjct: 81 VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 135
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DLKP N+LLD+++ ++DF ++ ++ D + +T + + Y APE G++ A
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 191
Query: 226 --DVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVNDWLPISTLEVVDANL 274
DV+S G++L + P D+ I NG TL +++ ++ N
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 251
Query: 275 LSQEDIHFVAKE 286
L++ IH + ++
Sbjct: 252 LNRISIHEIMQD 263
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 24/225 (10%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRALKSFNVECEM--MKSIRHRNLIKVIS 105
+G+G FG V A G +VA+K+ N + ++ +E E+ ++ +RH ++IK+
Sbjct: 12 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+EY L Y+ + + + R + SA+EY H I+H
Sbjct: 72 VIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 126
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DLKP N+LLD+++ ++DF ++ ++ D + +T + + Y APE G++ A
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 182
Query: 226 --DVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVN 259
DV+S G++L + P D+ I NG TL +++
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 227
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 113/225 (50%), Gaps = 24/225 (10%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQC-GRALKSFNVECEM--MKSIRHRNLIKVIS 105
+G+G FG V A G +VA+K+ N + ++ +E E+ ++ +RH ++IK+
Sbjct: 16 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+EY + L Y+ + + + R + SA+EY H I+H
Sbjct: 76 VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 130
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG 225
DLKP N+LLD+++ ++DF ++ ++ D + +T + + Y APE G++ A
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 186
Query: 226 --DVYSFGIMLMETFTGKKPTDE---------IFNGEMTLKHWVN 259
DV+S G++L + P D+ I NG TL +++
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLS 231
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 71/227 (31%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGR-ALKSFNVECEM--M 92
DE+ + +G G G V A +VA+K+ F + R A + NVE E+ +
Sbjct: 16 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIFQRLNIMI 146
K + H +IK+ + E++ +VLE M G L K L + C L +Q L
Sbjct: 76 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 130
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
A++YLH IIH DLKP NVLL +++ + ++DF +K+L GE M
Sbjct: 131 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLM--RT 181
Query: 204 TFATIGYMAPE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE G G A D +S G++L +G P E
Sbjct: 182 LCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSE 227
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 65/278 (23%), Positives = 113/278 (40%), Gaps = 33/278 (11%)
Query: 50 IGKGGFGSV----YKARLGDGMEVAVKVF-NLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
IG+G FG V Y + M VA+K N + F E M+ H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ E +++E G L +L LD+ + +++AL YL S +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+ NVL+ L DF +++ + ED + + ++ I +MAPE R ++
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 224 NGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
DV+ FG+ + E G KP + N ++ + + LP+
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP---------------- 615
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKI 320
C +++L C P +R E+ +L I
Sbjct: 616 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY P G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+++D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 13 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 68
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 69 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 115
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 41 TDEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSIRH 97
T+E+ +GKG F V + ++ G E A + N + R + E + + ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDV 148
N++++ S S E L+ + + G L + YS S+CI I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI---------- 119
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNM---VAHLSDFSIAKLLVGEDQSMTQTQTF 205
LE + + ++H +LKP N+LL + L+DF +A + GE Q+ F
Sbjct: 120 ---LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GF 173
Query: 206 A-TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
A T GY++PE R+ D+++ G++L G P
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a
Mutant In Complex With Sp600125 Inhibitor
Length = 390
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 70/280 (25%), Positives = 124/280 (44%), Gaps = 39/280 (13%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCG--RALKSFNVECEMMKSIRHRN--LIKVIS 105
IG GG V++ A+K NL+ + L S+ E + ++ + +I++
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ +V+E + L +L I D ++R + ++ LE +H + I+H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYWKNM---LEAVHTIHQHGIVH 178
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS-AN 224
DLKP+N L+ D M+ L DF IA + + S+ + + YM PE ++ S N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 225 G----------DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANL 274
G DV+S G +L GK P +I N +++ H + D P +E D
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID--PNHEIEFPD--- 291
Query: 275 LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIV 314
+ ++D+ V K C P+QRI+ E++
Sbjct: 292 IPEKDLQDVLK------------CCLKRDPKQRISIPELL 319
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 76/288 (26%), Positives = 121/288 (42%), Gaps = 40/288 (13%)
Query: 50 IGKGGFGSVYKARLGD---GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
+G+G FG V+ R+ D G + AVK L+ RA + + C + S R ++ + +
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAEEL--MACAGLTSPR---IVPLYGA 153
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
+ + +E + GSL + + C+ + + L + LEYLH S I+H
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALEGLEYLH---SRRILHG 209
Query: 167 DLKPSNVLLD-DNMVAHLSDFSIAKLLVGEDQS---MTQTQTFATIGYMAPEYGREGRVS 222
D+K NVLL D A L DF A L + +T T +MAPE
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD 269
Query: 223 ANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQEDIHF 282
A DV+S M++ G P + F G + LK ++ P+ + A L +Q
Sbjct: 270 AKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK-IASEPPPVREIPPSCAPLTAQAIQEG 328
Query: 283 VAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKLLKIRDSLLRNVGG 330
+ KE P R++A E+ K+ + L+ VGG
Sbjct: 329 LRKE-----------------PIHRVSAAELGGKV----NRALQQVGG 355
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 30/226 (13%)
Query: 42 DEFSENNLIGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNVECEM 91
D + +G+G FG V +A + VAVK+ RAL S E ++
Sbjct: 27 DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS---ELKI 83
Query: 92 MKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSSNC-------ILDIFQRL 142
+ I H N++ ++ +C+ +V+ E+ G+L YL S + F L
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTL 143
Query: 143 NIMI----DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
+I VA +E+L S IH DL N+LL + V + DF +A+ + +
Sbjct: 144 EHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 201 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 67/230 (29%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL IG G +GSV A G+ VAVK + Q K
Sbjct: 12 TFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 71
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 72 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 131
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 132 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDE 183
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 184 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 46/237 (19%)
Query: 22 SMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVY--KARLGDGMEVAVKVFNLQCG 79
SM + +TF ++E+ +G G F V+ K RL K+F L+C
Sbjct: 1 SMQTTNIRKTFIFMEV------------LGSGAFSEVFLVKQRLTG------KLFALKCI 42
Query: 80 RALKSF-----NVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYL 129
+ +F E ++K I+H N++ + + LV++ + G L E+ +
Sbjct: 43 KKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV 102
Query: 130 YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDF 186
Y+ + Q+ V SA++YLH I+H DLKP N+L ++N ++DF
Sbjct: 103 YTEKDASLVIQQ------VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDF 153
Query: 187 SIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
++K+ +Q+ + T GY+APE + S D +S G++ G P
Sbjct: 154 GLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 31/221 (14%)
Query: 43 EFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNVECEMMKSIRH---- 97
+F E ++G+G FG V KAR D A+K L + E ++ S+ H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVV 65
Query: 98 ---------RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
RN +K ++ + + EY + +L ++S N + + +
Sbjct: 66 RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK-------LLVGEDQSMTQ 201
AL Y+H S IIH +LKP N+ +D++ + DF +AK +L + Q++
Sbjct: 126 LEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 202 -----TQTFATIGYMAPE-YGREGRVSANGDVYSFGIMLME 236
T T Y+A E G + D YS GI+ E
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 68/280 (24%), Positives = 124/280 (44%), Gaps = 29/280 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHRNLIKVISSC 107
IG+G +G VYKA+ G A+K L+ + S + E ++K ++H N++K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
++ LV E++ L+K L L+ + ++ + + + Y H ++H D
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY--GREGRVSANG 225
LKP N+L++ ++DF +A+ + T T+ Y AP+ G + + S
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSK-KYSTTI 182
Query: 226 DVYSFGIMLMET------FTGKKPTDEIFN-----GEMTLKHWVNDWLPISTLEVVDANL 274
D++S G + E F G D++ G K+W N ++ L D N
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN----VTELPKYDPNF 238
Query: 275 LSQEDIHFVA--KEQCVSFVFNLAMACAVESPEQRINAKE 312
E + + + K S + L+ ++ P QRI AK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLD-PNQRITAKQ 277
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 58.5 bits (140), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY P G + +L + R + EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+++D ++DF AK + G + T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 37/227 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGR-ALKSFNVECEM--M 92
DE+ + +G G G V A +VA+++ F + R A + NVE E+ +
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIFQRLNIMI 146
K + H +IK+ + E++ +VLE M G L K L + C L +Q L
Sbjct: 209 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 263
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
A++YLH IIH DLKP NVLL +++ + ++DF +K+L GE S+ +T
Sbjct: 264 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GE-TSLMRTL 315
Query: 204 TFATIGYMAPE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE G G A D +S G++L +G P E
Sbjct: 316 C-GTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSE 360
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 28/267 (10%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V A G +VAVK +L+ + + E +M+ H N++ + SS
Sbjct: 53 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+E++ G+L + ++ ++ Q + + V AL YLH + +IH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K ++LL + LSDF + E + T +MAPE D++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ-EDIHFVAKEQ 287
S GIM++E G+ P FN P+ + + +L + +D+H V+
Sbjct: 226 SLGIMVIEMIDGEPP---YFNEP-----------PLQAMRRIRDSLPPRVKDLHKVS--- 268
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIV 314
S + V P QR A+E++
Sbjct: 269 --SVLRGFLDLMLVREPSQRATAQELL 293
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 68/280 (24%), Positives = 124/280 (44%), Gaps = 29/280 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHRNLIKVISSC 107
IG+G +G VYKA+ G A+K L+ + S + E ++K ++H N++K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
++ LV E++ L+K L L+ + ++ + + + Y H ++H D
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY--GREGRVSANG 225
LKP N+L++ ++DF +A+ + T T+ Y AP+ G + + S
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSK-KYSTTI 182
Query: 226 DVYSFGIMLMET------FTGKKPTDEIFN-----GEMTLKHWVNDWLPISTLEVVDANL 274
D++S G + E F G D++ G K+W N ++ L D N
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN----VTELPKYDPNF 238
Query: 275 LSQEDIHFVA--KEQCVSFVFNLAMACAVESPEQRINAKE 312
E + + + K S + L+ ++ P QRI AK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLD-PNQRITAKQ 277
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 39/200 (19%)
Query: 68 EVAVKVFNLQCGRALKSFNV---------ECEMMKSIR-HRNLIKVISSCSNEEFKALVL 117
E AVK+ ++ G + + V E ++++ + H N+I++ + F LV
Sbjct: 31 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 90
Query: 118 EYMPHGSLEKYLYSSNCILDIFQR--LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 175
+ M G L YL + + R + +++V AL L+ I+H DLKP N+LL
Sbjct: 91 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILL 144
Query: 176 DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE------------YGREGRVSA 223
DD+M L+DF + L D + T Y+APE YG+E
Sbjct: 145 DDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE----- 196
Query: 224 NGDVYSFGIMLMETFTGKKP 243
D++S G+++ G P
Sbjct: 197 -VDMWSTGVIMYTLLAGSPP 215
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 68/280 (24%), Positives = 124/280 (44%), Gaps = 29/280 (10%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIRHRNLIKVISSC 107
IG+G +G VYKA+ G A+K L+ + S + E ++K ++H N++K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 108 SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCD 167
++ LV E++ L+K L L+ + ++ + + + Y H ++H D
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 168 LKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY--GREGRVSANG 225
LKP N+L++ ++DF +A+ + T T+ Y AP+ G + + S
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSK-KYSTTI 182
Query: 226 DVYSFGIMLMET------FTGKKPTDEIFN-----GEMTLKHWVNDWLPISTLEVVDANL 274
D++S G + E F G D++ G K+W N ++ L D N
Sbjct: 183 DIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPN----VTELPKYDPNF 238
Query: 275 LSQEDIHFVA--KEQCVSFVFNLAMACAVESPEQRINAKE 312
E + + + K S + L+ ++ P QRI AK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLD-PNQRITAKQ 277
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 2 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ L+K++ ++ + I L I + L+ L
Sbjct: 62 HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 118
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 176
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 221
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L K+ S + +V+EY P G + +L + R + EYLH
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+++D ++DF AK + G + T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ L+K++ ++ + I L I + L+ L
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFM-DASALTGIPLPL-IKSYLFQLLQGLA 120
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 121 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 58.5 bits (140), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 39/200 (19%)
Query: 68 EVAVKVFNLQCGRALKSFNV---------ECEMMKSIR-HRNLIKVISSCSNEEFKALVL 117
E AVK+ ++ G + + V E ++++ + H N+I++ + F LV
Sbjct: 44 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103
Query: 118 EYMPHGSLEKYLYSSNCILDIFQR--LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 175
+ M G L YL + + R + +++V AL L+ I+H DLKP N+LL
Sbjct: 104 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILL 157
Query: 176 DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE------------YGREGRVSA 223
DD+M L+DF + L D + T Y+APE YG+E
Sbjct: 158 DDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE----- 209
Query: 224 NGDVYSFGIMLMETFTGKKP 243
D++S G+++ G P
Sbjct: 210 -VDMWSTGVIMYTLLAGSPP 228
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 12 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 71
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 72 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 131
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 132 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDE 183
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 184 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 50 IGKGGFGSVYK-ARLGDGMEVAVK-----VFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
IG+G +GSV K G +AVK V + + L +V +M+S +++
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQF 86
Query: 104 ISSCSNEEFKALVLEYMPHG--SLEKYLYSSNCILD--IFQRLNIMIDVASALEYLHFGY 159
+ E + +E M KY+YS +LD I + + I +A+ H
Sbjct: 87 YGALFREGDCWICMELMSTSFDKFYKYVYS---VLDDVIPEEILGKITLATVKALNHLKE 143
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEY---- 215
+ IIH D+KPSN+LLD + L DF I+ LV S+ +T+ YMAPE
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPS 200
Query: 216 -GREGRVSANGDVYSFGIMLMETFTGKKP 243
R+G DV+S GI L E TG+ P
Sbjct: 201 ASRQG-YDVRSDVWSLGITLYELATGRFP 228
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 71/227 (31%), Positives = 108/227 (47%), Gaps = 37/227 (16%)
Query: 42 DEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGR-ALKSFNVECEM--M 92
DE+ + +G G G V A +VA+++ F + R A + NVE E+ +
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 93 KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIFQRLNIMI 146
K + H +IK+ + E++ +VLE M G L K L + C L +Q L
Sbjct: 195 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---- 249
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQ 203
A++YLH IIH DLKP NVLL +++ + ++DF +K+L GE S+ +T
Sbjct: 250 ---LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GE-TSLMRTL 301
Query: 204 TFATIGYMAPE----YGREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE G G A D +S G++L +G P E
Sbjct: 302 C-GTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSE 346
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 58.2 bits (139), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+G G +GSV Y ARL +VAVK + Q + E ++K ++H N+I ++
Sbjct: 36 VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 105 ----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ S E+F + L G+ + S + D + ++ + L+Y+H S
Sbjct: 94 DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH---S 149
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSNV ++++ + DF +A+ D+ MT GY+A + R
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRWYRAPE 198
Query: 221 VSANG-------DVYSFGIMLMETFTGK 241
+ N D++S G ++ E GK
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
++F L+GKG FG V R G A+K+ + A E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + + + V+EY G L +L + R ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
S +++ D+K N++LD + ++DF + K + + +M +TF T Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVL 177
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 28 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+ G + +L + R + EYLH
Sbjct: 88 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D+ ++DF AK + G + T Y+APE
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 198
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPP 224
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ L+K++ +S + I L I + L+ L
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDAS-ALTGIPLPL-IKSYLFQLLQGLA 120
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
++F L+GKG FG V R G A+K+ + A E ++++ RH
Sbjct: 8 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + + + V+EY G L +L + R ++ SALEYLH
Sbjct: 68 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 125
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
S +++ D+K N++LD + ++DF + K + + +M +TF T Y+APE
Sbjct: 126 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVL 180
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGRLP 207
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 18 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 77
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 78 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 137
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 138 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDE 189
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 190 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
++F L+GKG FG V R G A+K+ + A E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + + + V+EY G L +L + R ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
S +++ D+K N++LD + ++DF + K + + +M +TF T Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVL 177
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 3 TFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 62
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + + D
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDH 122
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 123 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 174
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 175 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 17 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 74
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 75 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 134
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 135 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 190
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 191 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L K+ S + +V+EY P G + +L + R + EYLH
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+++D ++DF AK + G + T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + S D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF + + D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 14/216 (6%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKSFNVECEM 91
+L +++ +IG+G FG V R +V A+K+ F + F E ++
Sbjct: 68 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
M ++++ + ++ + +V+EYMP G L L S+ + + + R +V A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLA 185
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L+ +H S IH D+KP N+LLD + L+DF + E T T Y+
Sbjct: 186 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYI 241
Query: 212 APEY----GREGRVSANGDVYSFGIMLMETFTGKKP 243
+PE G +G D +S G+ L E G P
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L K+ S + +V+EY P G + +L + R + EYLH
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+++D ++DF AK + G + T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 212
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 4 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 63
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 64 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 123
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 124 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 175
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 176 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 123 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 174
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 175 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFA 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+ G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 41 TDEFSENNLIGKGGFGSVY--KARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSI 95
+D + ++GKG FG V K ++ G E AVKV + ++ +S E +++K +
Sbjct: 31 SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H N++K+ ++ + LV E G L + S ++ I+ V S + Y+
Sbjct: 90 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 148
Query: 156 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
H I+H DLKP N+LL+ + + DF ++ + S T Y+A
Sbjct: 149 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIA 202
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
PE G DV+S G++L +G P FNG
Sbjct: 203 PEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNG 235
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 14/216 (6%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKSFNVECEM 91
+L +++ +IG+G FG V R +V A+K+ F + F E ++
Sbjct: 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
M ++++ + ++ + +V+EYMP G L L S+ + + + R +V A
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLA 180
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L+ +H S IH D+KP N+LLD + L+DF + E T T Y+
Sbjct: 181 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYI 236
Query: 212 APE----YGREGRVSANGDVYSFGIMLMETFTGKKP 243
+PE G +G D +S G+ L E G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLA-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 9 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 68
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 69 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 128
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 129 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDE 180
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 181 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 4 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 63
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 64 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 123
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 124 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 175
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 176 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 12 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 71
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 72 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 131
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 132 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 183
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 184 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 5 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 64
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 65 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 124
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 125 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 176
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 177 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 13 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 72
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 73 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 132
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 133 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDE 184
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 185 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 12 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 71
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 72 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 131
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 132 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 183
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 184 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 6 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 65
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 66 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 125
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 126 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 177
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 178 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 33/229 (14%)
Query: 42 DEFSENNLIGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNVECEM 91
D + +G+G FG V +A + VAVK+ RAL S E ++
Sbjct: 28 DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKI 84
Query: 92 MKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSS-------NCILDIFQRL 142
+ I H N++ ++ +C+ +V+ E+ G+L YL S D+++
Sbjct: 85 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF 144
Query: 143 NIM-------IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195
+ VA +E+L S IH DL N+LL + V + DF +A+ + +
Sbjct: 145 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 196 DQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 133
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 134 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 185
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 186 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 14/216 (6%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKSFNVECEM 91
+L +++ +IG+G FG V R +V A+K+ F + F E ++
Sbjct: 68 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 92 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 151
M ++++ + ++ + +V+EYMP G L L S+ + + + R +V A
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLA 185
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
L+ +H S IH D+KP N+LLD + L+DF + E T T Y+
Sbjct: 186 LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYI 241
Query: 212 APE----YGREGRVSANGDVYSFGIMLMETFTGKKP 243
+PE G +G D +S G+ L E G P
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 23/224 (10%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 133
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ E
Sbjct: 134 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--- 185
Query: 199 MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK 241
T AT Y APE + D++S G ++ E TG+
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLX-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 23/224 (10%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 133
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ E
Sbjct: 134 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--- 185
Query: 199 MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK 241
T AT Y APE + D++S G ++ E TG+
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/236 (23%), Positives = 105/236 (44%), Gaps = 19/236 (8%)
Query: 39 QATDEFSENNLIGKGGFG-SVYKARLGDGMEVAVKVFNLQ--CGRALKSFNVECEMMKSI 95
Q+ +++ IG+G FG ++ DG + +K N+ + + E ++ ++
Sbjct: 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR---LNIMIDVASAL 152
+H N+++ S +V++Y G L K + + +L FQ L+ + + AL
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLAL 138
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG--- 209
+++H I+H D+K N+ L + L DF IA++L + T A IG
Sbjct: 139 KHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-----NSTVELARACIGTPY 190
Query: 210 YMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPIS 265
Y++PE + D+++ G +L E T K + + LK + P+S
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS 246
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK 241
M T AT Y APE + D++S G ++ E TG+
Sbjct: 179 M--TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 18 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 77
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 78 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 137
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 138 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 189
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 190 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKV---FNLQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+IG+G FG V R +V A+K+ F + F E ++M ++++
Sbjct: 82 VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 141
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ ++++ +V+EYMP G L L S+ + + + + +V AL+ +H S +I
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH---SMGLI 196
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQT-FATIGYMAPEY----GREG 219
H D+KP N+LLD + L+DF + ++ M T T Y++PE G +G
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVHCDTAVGTPDYISPEVLKSQGGDG 254
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
D +S G+ L E G P
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTP 278
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 23/224 (10%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 133
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ E
Sbjct: 134 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--- 185
Query: 199 MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK 241
T AT Y APE + D++S G ++ E TG+
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 27 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 86
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 87 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 146
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 147 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 198
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 199 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 35/237 (14%)
Query: 24 PLVAMWRTFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--L 76
P+ TF EL + E E NL +G G +GSV A G+ VAVK +
Sbjct: 2 PMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 61
Query: 77 QCGRALKSFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYS 131
Q K E ++K ++H N+I ++ + S EEF + L ++ L +
Sbjct: 62 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 121
Query: 132 SNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL 191
D Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+
Sbjct: 122 QKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR- 175
Query: 192 LVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
D MT GY+A + R + N D++S G ++ E TG+
Sbjct: 176 --HTDDEMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 39/200 (19%)
Query: 68 EVAVKVFNLQCGRALKSFNV---------ECEMMKSIR-HRNLIKVISSCSNEEFKALVL 117
E AVK+ ++ G + + V E ++++ + H N+I++ + F LV
Sbjct: 44 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103
Query: 118 EYMPHGSLEKYLYSSNCILDIFQR--LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLL 175
+ M G L YL + + R + +++V AL L+ I+H DLKP N+LL
Sbjct: 104 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILL 157
Query: 176 DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE------------YGREGRVSA 223
DD+M L+DF + L D T Y+APE YG+E
Sbjct: 158 DDDMNIKLTDFGFSCQL---DPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKE----- 209
Query: 224 NGDVYSFGIMLMETFTGKKP 243
D++S G+++ G P
Sbjct: 210 -VDMWSTGVIMYTLLAGSPP 228
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 13 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 72
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 73 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 132
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 133 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 184
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 185 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 9 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 68
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 69 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 128
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 129 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 180
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 181 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNV 87
EF + L +G+G FG V +A + VAVK+ RAL S
Sbjct: 14 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--- 70
Query: 88 ECEMMKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSSN--------CILD 137
E +++ I H N++ ++ +C+ +V+ E+ G+L YL S D
Sbjct: 71 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 138 IFQRLNIM-------IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+++ + VA +E+L S IH DL N+LL + V + DF +A+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 188 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 9 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 68
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 69 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 128
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 129 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 180
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 181 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+ G + +L + R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 211
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 62 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+ G + +L + R + EYLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G + T Y+APE
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIL 232
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP 258
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 19 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAK 78
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 79 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 138
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 139 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 190
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 191 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 30 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 89
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 90 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 149
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 150 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 201
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 202 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 13 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 72
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 73 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 132
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 133 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 184
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 185 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNV 87
EF + L +G+G FG V +A + VAVK+ RAL S
Sbjct: 14 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--- 70
Query: 88 ECEMMKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSSN--------CILD 137
E +++ I H N++ ++ +C+ +V+ E+ G+L YL S D
Sbjct: 71 ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 138 IFQRLNIM-------IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+++ + VA +E+L S IH DL N+LL + V + DF +A+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 188 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 26 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 85
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 86 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 145
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 146 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 197
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 198 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNV 87
EF + L +G+G FG V +A + VAVK+ RAL S
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--- 79
Query: 88 ECEMMKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSSN--------CILD 137
E +++ I H N++ ++ +C+ +V+ E+ G+L YL S D
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 138 IFQRLNIM-------IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+++ + VA +E+L S IH DL N+LL + V + DF +A+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCGRALKSFNV---ECEMMKSIRH 97
D+F +G G FG V + + G A+K+ + Q LK E +++++
Sbjct: 62 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L+K+ S + +V+EY+ G + +L + R + EYLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S +I+ DLKP N+L+D ++DF AK + G ++ T Y+APE
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC-----GTPEYLAPEIIL 232
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP 243
+ D ++ G+++ E G P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPP 258
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 19 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 78
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 79 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 138
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 139 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 190
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 191 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 19 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 78
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 79 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 138
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 139 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 190
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 191 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 23 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 80
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 81 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 140
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 141 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 196
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 197 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 41 TDEFSENNLIGKGGFGSVY--KARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSI 95
+D + ++GKG FG V K ++ G E AVKV + ++ +S E +++K +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H N++K+ ++ + LV E G L + S ++ I+ V S + Y+
Sbjct: 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 142
Query: 156 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
H I+H DLKP N+LL+ + + DF ++ + S T Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIA 196
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
PE G DV+S G++L +G P FNG
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNG 229
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 4 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ S++ + L I + L+ L
Sbjct: 64 HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 223
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G G V A R+ + VAVK+ +++ C +K E + K + H N++K
Sbjct: 14 LGEGAAGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 116
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 49 LIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI-RHRNL------ 100
L+G G +G VYK R + G A+KV ++ G + E M+K HRN+
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 101 -IKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHF 157
IK +++ LV+E+ GS+ + ++ N + + + I ++ L +LH
Sbjct: 90 FIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH- 146
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEY- 215
+IH D+K NVLL +N L DF ++ L D+++ + TF T +MAPE
Sbjct: 147 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVI 201
Query: 216 ----GREGRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S GI +E G P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNV 87
EF + L +G+G FG V +A + VAVK+ RAL S
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--- 79
Query: 88 ECEMMKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSSN--------CILD 137
E +++ I H N++ ++ +C+ +V+ E+ G+L YL S D
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 138 IFQRLNIM-------IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+++ + VA +E+L S IH DL N+LL + V + DF +A+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 197 DIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 39/239 (16%)
Query: 50 IGKGGFGSVYKA--RLGDGMEVAVKVFNLQ----CGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V A R+ + VAVK+ +++ C +K E + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINAMLNHENVVKF 70
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL--NIMIDVASALEYLH----- 156
+ L LEY G L F R+ +I + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL-------------FDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 157 --FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE 214
+ + I H D+KP N+LLD+ +SDF +A + ++ + T+ Y+APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 215 YGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW------VNDWLPIST 266
+ A DV+S GI+L G+ P D+ + W +N W I +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 15/225 (6%)
Query: 40 ATDEFSENNLIGKGGFGSVYKARLG-DGMEVAVKVFNLQC-GRALKSFNV-ECEMMKSIR 96
+ + F + IG+G +G VYKAR G VA+K L + S + E ++K +
Sbjct: 3 SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K++ E LV E++ S++ + L I + L+ L
Sbjct: 63 HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 157 FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYG 216
F +S ++H DLKP N+L++ L+DF +A+ + T T+ Y APE
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 177
Query: 217 REGRVSANG-DVYSFGIMLMET------FTGKKPTDEIFNGEMTL 254
+ + D++S G + E F G D++F TL
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 222
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 68/236 (28%), Positives = 103/236 (43%), Gaps = 25/236 (10%)
Query: 44 FSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
++ N IG+G +G V A + G + A K + F E E+MKS+ H N+I+
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 103 VISSCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
+ + + LV+E G L E+ ++ + IM DV SA+ Y H
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---KL 125
Query: 162 PIIHCDLKPSNVL-LDDNMVAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+ H DLKP N L L D+ + L DF +A + M +T+ T Y++P+ E
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKV-GTPYYVSPQV-LE 181
Query: 219 GRVSANGDVYSFGIMLMETFTG----KKPTD-----EIFNGEMTLKHWVNDWLPIS 265
G D +S G+M+ G PTD +I G T DWL +S
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE--KDWLNVS 235
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 41 TDEFSENNLIGKGGFGSVY--KARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSI 95
+D + ++GKG FG V K ++ G E AVKV + ++ +S E +++K +
Sbjct: 48 SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H N++K+ ++ + LV E G L + S ++ I+ V S + Y+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 165
Query: 156 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
H I+H DLKP N+LL+ + + DF ++ + S T Y+A
Sbjct: 166 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIA 219
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
PE G DV+S G++L +G P FNG
Sbjct: 220 PEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNG 252
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNV 87
EF + L +G+G FG V +A + VAVK+ RAL S
Sbjct: 14 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--- 70
Query: 88 ECEMMKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSSN--------CILD 137
E +++ I H N++ ++ +C+ +V+ E+ G+L YL S D
Sbjct: 71 ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 138 IFQRLNIM-------IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+++ + VA +E+L S IH DL N+LL + V + DF +A+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 188 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 14/201 (6%)
Query: 49 LIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNV--ECEMMKSIRHRNLIKVIS 105
++GKG FG V K + E AVKV N + + + E E++K + H N++K+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+ +V E G L + + I+ V S + Y+H I+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 166 CDLKPSNVLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS 222
DLKP N+LL+ + + DF ++ Q+ T Y+APE R G
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 223 ANGDVYSFGIMLMETFTGKKP 243
DV+S G++L +G P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNV 87
EF + L +G+G FG V +A + VAVK+ RAL S
Sbjct: 14 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--- 70
Query: 88 ECEMMKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSSN--------CILD 137
E +++ I H N++ ++ +C+ +V+ E+ G+L YL S D
Sbjct: 71 ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 138 IFQRLNIM-------IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+++ + VA +E+L S IH DL N+LL + V + DF +A+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 188 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V++ + G + AVK L+ R + V C + S R ++ + +
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 120
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ + +E + GSL + + C+ + + L + LEYLH + I+H D+
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRRILHGDV 176
Query: 169 KPSNVLLD-DNMVAHLSDFSIAKLLVGEDQS---MTQTQTFATIGYMAPEYGREGRVSAN 224
K NVLL D A L DF A L + +T T +MAPE A
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
D++S M++ G P + F G + LK
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 14/201 (6%)
Query: 49 LIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNV--ECEMMKSIRHRNLIKVIS 105
++GKG FG V K + E AVKV N + + + E E++K + H N++K+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+ +V E G L + + I+ V S + Y+H I+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 166 CDLKPSNVLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS 222
DLKP N+LL+ + + DF ++ Q+ T Y+APE R G
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 223 ANGDVYSFGIMLMETFTGKKP 243
DV+S G++L +G P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 67/235 (28%), Positives = 101/235 (42%), Gaps = 23/235 (9%)
Query: 44 FSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIK 102
++ N IG+G +G V A + G + A K + F E E+MKS+ H N+I+
Sbjct: 28 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ + + LV+E G L + + + IM DV SA+ Y H
Sbjct: 88 LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-DAARIMKDVLSAVAYCH---KLN 143
Query: 163 IIHCDLKPSNVL-LDDNMVAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
+ H DLKP N L L D+ + L DF +A + M +T+ T Y++P+ EG
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKV-GTPYYVSPQV-LEG 199
Query: 220 RVSANGDVYSFGIMLMETFTG----KKPTD-----EIFNGEMTLKHWVNDWLPIS 265
D +S G+M+ G PTD +I G T DWL +S
Sbjct: 200 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE--KDWLNVS 252
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSEN----NLIGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E + +G G +GSV + + G+++AVK + Q K
Sbjct: 36 TFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAK 95
Query: 84 SFNVECEMMKSIRHRNLIKVI----SSCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 96 RTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 155
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 156 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 207
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 208 MT--------GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 41 TDEFSENNLIGKGGFGSVY--KARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSI 95
+D + ++GKG FG V K ++ G E AVKV + ++ +S E +++K +
Sbjct: 49 SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H N++K+ ++ + LV E G L + S ++ I+ V S + Y+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 166
Query: 156 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
H I+H DLKP N+LL+ + + DF ++ + S T Y+A
Sbjct: 167 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIA 220
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
PE G DV+S G++L +G P FNG
Sbjct: 221 PEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNG 253
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNV 87
EF + L +G+G FG V +A + VAVK+ RAL S
Sbjct: 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--- 116
Query: 88 ECEMMKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSSN--------CILD 137
E +++ I H N++ ++ +C+ +V+ E+ G+L YL S D
Sbjct: 117 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 176
Query: 138 IFQRLNIM-------IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+++ + VA +E+L S IH DL N+LL + V + DF +A+
Sbjct: 177 LYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR 233
Query: 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 234 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V++ + G + AVK L+ R + V C + S R ++ + +
Sbjct: 82 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 136
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ + +E + GSL + + C+ + + L + LEYLH + I+H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRRILHGDV 192
Query: 169 KPSNVLLD-DNMVAHLSDFSIAKLLVGEDQS---MTQTQTFATIGYMAPEYGREGRVSAN 224
K NVLL D A L DF A L + +T T +MAPE A
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
D++S M++ G P + F G + LK
Sbjct: 253 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNV 87
EF + L +G+G FG V +A + VAVK+ RAL S
Sbjct: 25 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--- 81
Query: 88 ECEMMKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSS--------NCILD 137
E +++ I H N++ ++ +C+ +V+ E+ G+L YL S D
Sbjct: 82 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPED 141
Query: 138 IFQRLNIM-------IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+++ + VA +E+L S IH DL N+LL + V + DF +A+
Sbjct: 142 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198
Query: 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 199 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 39/238 (16%)
Query: 38 CQATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFN--------------------- 75
C ++++ + IGKG +G V A D A+KV +
Sbjct: 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 76 -----LQCGRALKSFNVECEMMKSIRHRNLIKVISSC--SNEEFKALVLEYMPHGSLEKY 128
+Q ++ E ++K + H N++K++ NE+ +V E + G + +
Sbjct: 69 APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 129 LYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSI 188
D Q D+ +EYLH+ IIH D+KPSN+L+ ++ ++DF +
Sbjct: 129 PTLKPLSED--QARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 189 AKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANG---DVYSFGIMLMETFTGKKP 243
+ G D + + T T +MAPE E R +G DV++ G+ L G+ P
Sbjct: 184 SNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 39/234 (16%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVFNLQCG----RALKSFNV 87
EF + L +G+G FG V +A + VAVK+ RAL S
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--- 79
Query: 88 ECEMMKSIRHR-NLIKVISSCSNEEFKALVL-EYMPHGSLEKYLYSSN--------CILD 137
E +++ I H N++ ++ +C+ +V+ E+ G+L YL S D
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 138 IFQRLNIM-------IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAK 190
+++ + VA +E+L S IH DL N+LL + V + DF +A+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 191 LLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ + + + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 31/229 (13%)
Query: 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRH 97
+++ IG+G +G V A VA+K F Q C R L+ E +++ RH
Sbjct: 45 YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR----EIQILLRFRH 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN-----IMIDVASAL 152
N+I + +A+ Y+ +E LY +L Q N + + L
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK---LLKSQQLSNDHICYFLYQILRGL 157
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE-DQSMTQTQTFATIGYM 211
+Y+H SA ++H DLKPSN+L++ + DF +A++ E D + T+ AT Y
Sbjct: 158 KYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 212 APEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
APE + + + D++S G +L E + + IF G KH+++
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 255
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 14/201 (6%)
Query: 49 LIGKGGFGSVYKARLG-DGMEVAVKVFNLQCGRALKSFNV--ECEMMKSIRHRNLIKVIS 105
++GKG FG V K + E AVKV N + + + E E++K + H N++K+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+ +V E G L + + I+ V S + Y+H I+H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 166 CDLKPSNVLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVS 222
DLKP N+LL+ + + DF ++ Q+ T Y+APE R G
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 223 ANGDVYSFGIMLMETFTGKKP 243
DV+S G++L +G P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + D+ +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+G FG V++ + G + AVK L+ R + V C + S R ++ + +
Sbjct: 80 LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 134
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ + +E + GSL + + C+ + + L + LEYLH + I+H D+
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALEGLEYLH---TRRILHGDV 190
Query: 169 KPSNVLLD-DNMVAHLSDFSIAKLLVGEDQS---MTQTQTFATIGYMAPEYGREGRVSAN 224
K NVLL D A L DF A L + +T T +MAPE A
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLK 255
D++S M++ G P + F G + LK
Sbjct: 251 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 62
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 123 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 174
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 175 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 17 TFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 76
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 77 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 136
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 137 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 188
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 189 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 50 IGKGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKSFNV-ECEMMKSIRHRNLIKVISS 106
+G+G + +VYK ++L D + VA+K L+ + E ++K ++H N++ +
Sbjct: 10 LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 107 CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E+ LV EY+ L++YL I+++ + + L Y H ++H
Sbjct: 69 IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124
Query: 167 DLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE--YGREGRVSAN 224
DLKP N+L+++ L+DF +A+ + T T+ Y P+ G S
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDILLGSTD-YSTQ 181
Query: 225 GDVYSFGIMLMETFTGK 241
D++ G + E TG+
Sbjct: 182 IDMWGVGCIFYEMATGR 198
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 12/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
++F L+GKG FG V R G A+K+ + A E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + + + V+EY G L +L + R ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
S +++ D+K N++LD + ++DF + K + + +M + F T Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFCGTPEYLAPEVL 177
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 27/173 (15%)
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA +E+L S IH DL N+LL +N V + DF +A+ + + + T
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIFNGEMTLKHWVNDWLPIST 266
+ +MAPE + S DV+S+G++L E F+ G P +
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGV------------------- 305
Query: 267 LEVVDANLLS--QEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
+D + S +E + A E ++ + + C P++R E+V+KL
Sbjct: 306 --QMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356
Score = 29.3 bits (64), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 26/99 (26%), Positives = 47/99 (47%), Gaps = 12/99 (12%)
Query: 50 IGKGGFGSVYKA------RLGDGMEVAVKVFNL-QCGRALKSFNVECEMMKSIRHR-NLI 101
+G+G FG V +A + VAVK+ K+ E +++ I H N++
Sbjct: 35 LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 102 KVISSCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDIF 139
++ +C+ + +V+ EY +G+L YL S D+F
Sbjct: 95 NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKR---DLF 130
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------SFNVECEMMKSIRHRNLIK 102
+G G F V K R G+E A K + RA + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ N L+LE + G L +L + + + + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 163 IIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
I H DLKP N+ LLD N+ + H+ DF +A + + + F T ++APE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S G++ +G P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V A + G VAVK +L+ + + E +M+ +H N++++ +S
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+E++ G+L + ++ ++ Q + + V AL LH + +IH D+
Sbjct: 92 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K ++LL + LSDF + E + T +MAPE D++
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ-EDIHFVAKEQ 287
S GIM++E G+ P FN P+ ++++ NL + +++H V+
Sbjct: 205 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSP-S 249
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ L V P QR A E++K
Sbjct: 250 LKGFLDRL----LVRDPAQRATAAELLK 273
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 12/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
++F L+GKG FG V R G A+K+ + A E ++++ RH
Sbjct: 10 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + + + V+EY G L +L + R ++ SALEYLH
Sbjct: 70 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 127
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
S +++ D+K N++LD + ++DF + K + + +M + F T Y+APE
Sbjct: 128 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFCGTPEYLAPEVL 182
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLP 209
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------SFNVECEMMKSIRHRNLIK 102
+G G F V K R G+E A K + RA + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ N L+LE + G L +L + + + + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 163 IIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
I H DLKP N+ LLD N+ + H+ DF +A + + + F T ++APE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S G++ +G P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 27 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 86
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 87 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 146
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 147 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 198
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 199 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 69/264 (26%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 87 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 141
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
+ + + D++S G +L E + + IF G KH+++ I L ++ + SQ
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP--SQ 249
Query: 278 EDIHFVAKEQCVSFVFNLAMACAV 301
ED++ + + +++ +L V
Sbjct: 250 EDLNXIINLKARNYLLSLPHKNKV 273
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 43/235 (18%)
Query: 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRH 97
++ + IG+G +G V A + + VA+K F Q C R L+ E +++ RH
Sbjct: 45 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 100
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN-----------IMI 146
N+I + N+ +A +E M L +L + D+++ L +
Sbjct: 101 ENIIGI-----NDIIRAPTIEQMKDVYLVTHLMGA----DLYKLLKTQHLSNDHICYFLY 151
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTF 205
+ L+Y+H SA ++H DLKPSN+LL+ + DF +A++ D + T+
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 206 ATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
AT Y APE + + + D++S G +L E + + IF G KH+++
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 255
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ + G P
Sbjct: 196 WXLC-----GTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 26 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 85
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 86 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 145
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 146 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 197
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 198 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V A + G VAVK +L+ + + E +M+ +H N++++ +S
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+E++ G+L + ++ ++ Q + + V AL LH + +IH D+
Sbjct: 88 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K ++LL + LSDF + E + T +MAPE D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ-EDIHFVAKEQ 287
S GIM++E G+ P FN P+ ++++ NL + +++H V+
Sbjct: 201 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSP-S 245
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ L V P QR A E++K
Sbjct: 246 LKGFLDRL----LVRDPAQRATAAELLK 269
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 13 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 72
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 73 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 132
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 133 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 184
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 185 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------SFNVECEMMKSIRHRNLIK 102
+G G F V K R G+E A K + RA + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ N L+LE + G L +L + + + + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 163 IIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
I H DLKP N+ LLD N+ + H+ DF +A + + + F T ++APE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S G++ +G P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 12/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
++F L+GKG FG V R G A+K+ + A E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + + + V+EY G L +L + R ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
S +++ D+K N++LD + ++DF + K + + +M + F T Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFCGTPEYLAPEVL 177
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+G G +GSV Y ARL +VAVK + Q + E ++K ++H N+I ++
Sbjct: 28 VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 105 ----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ S E+F + L G+ + + D + ++ + L+Y+H S
Sbjct: 86 DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH---S 141
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSNV ++++ + DF +A+ D+ MT GY+A + R
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMT--------GYVATRWYRAPE 190
Query: 221 VSANG-------DVYSFGIMLMETFTGK 241
+ N D++S G ++ E GK
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLQGK 218
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------SFNVECEMMKSIRHRNLIK 102
+G G F V K R G+E A K + RA + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ N L+LE + G L +L + + + + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 163 IIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
I H DLKP N+ LLD N+ + H+ DF +A + + + F T ++APE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S G++ +G P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V A + G VAVK +L+ + + E +M+ +H N++++ +S
Sbjct: 37 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+E++ G+L + ++ ++ Q + + V AL LH + +IH D+
Sbjct: 97 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K ++LL + LSDF + E + T +MAPE D++
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ-EDIHFVAKEQ 287
S GIM++E G+ P FN P+ ++++ NL + +++H V+
Sbjct: 210 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSPS- 254
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ L V P QR A E++K
Sbjct: 255 LKGFLDRL----LVRDPAQRATAAELLK 278
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 12/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
++F L+GKG FG V R G A+K+ + A E ++++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + + + V+EY G L +L + R ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
S +++ D+K N++LD + ++DF + K + + +M + F T Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KXFCGTPEYLAPEVL 177
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+++D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+APE + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 45/178 (25%), Positives = 87/178 (48%), Gaps = 14/178 (7%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMK-SIRHRNLIK 102
F +++G G G++ + D +VAVK +C + E ++++ S H N+I+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ + +F+ + +E + +L++Y+ + + + ++ S L +LH S
Sbjct: 83 YFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 163 IIHCDLKPSNVLLD-----DNMVAHLSDFSIA-KLLVGEDQSMTQTQTFATIGYMAPE 214
I+H DLKP N+L+ + A +SDF + KL VG ++ T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+G G +GSV Y ARL +VAVK + Q + E ++K ++H N+I ++
Sbjct: 36 VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 105 ----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ S E+F + L G+ + + D + ++ + L+Y+H S
Sbjct: 94 DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH---S 149
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSNV ++++ + DF +A+ D+ MT GY+A + R
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMT--------GYVATRWYRAPE 198
Query: 221 VSANG-------DVYSFGIMLMETFTGK 241
+ N D++S G ++ E GK
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V A + G VAVK +L+ + + E +M+ +H N++++ +S
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+E++ G+L + ++ ++ Q + + V AL LH + +IH D+
Sbjct: 99 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K ++LL + LSDF + E + T +MAPE D++
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ-EDIHFVAKEQ 287
S GIM++E G+ P FN P+ ++++ NL + +++H V+
Sbjct: 212 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSP-S 256
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ L V P QR A E++K
Sbjct: 257 LKGFLDRL----LVRDPAQRATAAELLK 280
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ + RH N+I
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 89 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 143
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 237
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 55.8 bits (133), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 69/264 (26%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 87 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 141
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
+ + + D++S G +L E + + IF G KH+++ I L ++ + SQ
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLDQLNHI--LGILGSP--SQ 249
Query: 278 EDIHFVAKEQCVSFVFNLAMACAV 301
ED++ + + +++ +L V
Sbjct: 250 EDLNXIINLKARNYLLSLPHKNKV 273
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------SFNVECEMMKSIRHRNLIK 102
+G G F V K R G+E A K + RA + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ N L+LE + G L +L + + + + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 163 IIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
I H DLKP N+ LLD N+ + H+ DF +A + + + F T ++APE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S G++ +G P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 48/199 (24%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 50 IGKGGFGSVYKARLGDGMEVA----VKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS 105
IG+G +G+V+KA+ + E+ V++ + G + C ++K ++H+N++++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHD 68
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ LV E+ L+KY S N LD + + + L + H S ++H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV-SAN 224
DLKP N+L++ N L+DF +A+ + + T+ Y P+ ++ S +
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 225 GDVYSFGIMLMETFTGKKP 243
D++S G + E +P
Sbjct: 183 IDMWSAGCIFAELANAARP 201
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 88/205 (42%), Gaps = 18/205 (8%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALK------SFNVECEMMKSIRHRNLIK 102
+G G F V K R G+E A K + RA + E +++ + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 103 VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ N L+LE + G L +L + + + + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLH---TKK 135
Query: 163 IIHCDLKPSNV-LLDDNM-VAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
I H DLKP N+ LLD N+ + H+ DF +A + + + F T ++APE
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192
Query: 219 GRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S G++ +G P
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASP 217
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 28/228 (12%)
Query: 40 ATDEFS---------ENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVEC 89
+TD FS + +++G+G V L E AVK+ Q G E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 90 EMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
EM+ + HRN++++I E+ LV E M GS+ +++ ++ + ++ DV
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDV 120
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVA--HLSDFSIAK--LLVGEDQSMTQTQ 203
ASAL++LH + I H DLKP N+L + N V+ + DF + L G+ ++ +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 204 TFATIG---YMAPE----YGREGRV-SANGDVYSFGIMLMETFTGKKP 243
G YMAPE + E + D++S G++L +G P
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 87 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 141
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 235
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V A + G VAVK +L+ + + E +M+ +H N++++ +S
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+E++ G+L + ++ ++ Q + + V AL LH + +IH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K ++LL + LSDF + E + T +MAPE D++
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ-EDIHFVAKEQ 287
S GIM++E G+ P FN P+ ++++ NL + +++H V+
Sbjct: 255 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSP-S 299
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ L V P QR A E++K
Sbjct: 300 LKGFLDRL----LVRDPAQRATAAELLK 323
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ + RH N+I
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFRHENIIGI 88
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 89 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 143
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 144 SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 237
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 28/228 (12%)
Query: 40 ATDEFS---------ENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVEC 89
+TD FS + +++G+G V L E AVK+ Q G E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 90 EMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 148
EM+ + HRN++++I E+ LV E M GS+ +++ ++ + ++ DV
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDV 120
Query: 149 ASALEYLHFGYSAPIIHCDLKPSNVLLD-DNMVA--HLSDFSIAK--LLVGEDQSMTQTQ 203
ASAL++LH + I H DLKP N+L + N V+ + DF + L G+ ++ +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 204 TFATIG---YMAPE----YGREGRV-SANGDVYSFGIMLMETFTGKKP 243
G YMAPE + E + D++S G++L +G P
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 39 QATDEFSENNLIGKGGFG----SVYKARLGDGMEVAVKVFNLQCGRALKSFNVECE-MMK 93
Q TD + IG G + ++KA ME AVK+ + ++ + E E +++
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIID----KSKRDPTEEIEILLR 71
Query: 94 SIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRLNIMIDVASAL 152
+H N+I + + ++ +V E M G L +K L + ++ + +
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTV 129
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
EYLH + ++H DLKPSN+L D + DF AK L E+ + T + T
Sbjct: 130 EYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCY-TA 184
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
++APE A D++S G++L TG P
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNL-QCGRALKSFNV-ECEMMKSIRHRNLIKVISS 106
IG G +G K R DG + K + A K V E +++ ++H N+++
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 107 CSNEEFKAL--VLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSA 161
+ L V+EY G L + LD L +M + AL+ H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 162 --PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
++H DLKP+NV LD L DF +A++L D S +T T YM+PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT-FVGTPYYMSPEQMNRM 191
Query: 220 RVSANGDVYSFGIMLME 236
+ D++S G +L E
Sbjct: 192 SYNEKSDIWSLGCLLYE 208
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 41 TDEFSENNLIGKGGFGSVY--KARLGDGMEVAVKVFN---LQCGRALKSFNVECEMMKSI 95
+D + ++GKG FG V K ++ G E AVKV + ++ +S E +++K +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H N+ K+ ++ + LV E G L + S ++ I+ V S + Y
Sbjct: 84 DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYX 142
Query: 156 HFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
H I+H DLKP N+LL+ + + DF ++ + S T Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYYIA 196
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
PE G DV+S G++L +G P FNG
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVILYILLSGCPP----FNG 229
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 145
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 87 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 141
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 235
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 30 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 89
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 90 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 149
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 150 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 201
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
M GY+A + R + N D++S G ++ E TG+
Sbjct: 202 MX--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 88
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 89 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 143
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 237
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 85 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 139
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 233
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 84
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 85 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 139
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 233
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 92 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 146
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 240
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 37 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 92
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 93 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 147
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 148 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 241
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 28 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 83
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 84 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 138
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 139 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 232
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 145
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 39 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 94
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 95 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 149
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 150 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 243
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 86
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 87 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 141
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 235
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T Y+AP + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 44/254 (17%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGRALKSFNVEC 89
ELC+ +IGKG F V + G + AVK+ F G + + E
Sbjct: 27 ELCE---------VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA 77
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
+ ++H ++++++ + S++ +V E+M L +I +R + +
Sbjct: 78 SICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYS 128
Query: 150 SA---------LEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQ 197
A LE L + + IIH D+KP NVLL +++ L DF +A + +GE
Sbjct: 129 EAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGE-S 186
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP----TDEIFNGEMT 253
+ T +MAPE + DV+ G++L +G P + +F G +
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK 246
Query: 254 LKHWVN--DWLPIS 265
K+ +N W IS
Sbjct: 247 GKYKMNPRQWSHIS 260
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
IG+G G V A + G VAVK +L+ + + E +M+ +H N++++ +S
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
+ +V+E++ G+L + ++ ++ Q + + V AL LH + +IH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 169 KPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVY 228
K ++LL + LSDF + E + T +MAPE D++
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 229 SFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ-EDIHFVAKEQ 287
S GIM++E G+ P FN P+ ++++ NL + +++H V+
Sbjct: 332 SLGIMVIEMVDGEPP---YFNEP-----------PLKAMKMIRDNLPPRLKNLHKVSP-S 376
Query: 288 CVSFVFNLAMACAVESPEQRINAKEIVK 315
F+ L V P QR A E++K
Sbjct: 377 LKGFLDRL----LVRDPAQRATAAELLK 400
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 29/228 (12%)
Query: 44 FSENNLIGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRH 97
++ + IG+G +G V A + + VA+K F Q C R L+ E +++ RH
Sbjct: 45 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRH 100
Query: 98 RNLI---KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 153
N+I +I + + E+ K + +++ + L K L + + D + + L+
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLK 158
Query: 154 YLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMA 212
Y+H SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y A
Sbjct: 159 YIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 213 PEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
PE + + + D++S G +L E + + IF G KH+++
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 255
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G+GGF V L DG A+K + + E +M + H N++++++ C
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 109 NEEFKA----LVLEYMPHGSLE---KYLYSSNCILDIFQRLNIMIDVASALEYLHF-GYS 160
E L+L + G+L + L L Q L +++ + LE +H GY+
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA 156
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDF-SIAKLLV---GEDQSMTQTQTFA----TIGYMA 212
H DLKP+N+LL D L D S+ + + G Q++T Q +A TI Y A
Sbjct: 157 ----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT-LQDWAAQRCTISYRA 211
Query: 213 PE-YGREGR--VSANGDVYSFGIMLMETFTGKKPTDEIFN 249
PE + + + DV+S G +L G+ P D +F
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 11/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
+EF L+GKG FG V + G A+K+ + A E ++++ RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + S + V+EY G L +L + R ++ SAL+YLH
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 268
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
+++ DLK N++LD + ++DF + K + + +M +TF T Y+APE
Sbjct: 269 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVL 324
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGRLP 351
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLIKV 103
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN-----------IMIDVASAL 152
N+ +A +E M + Y+ D+++ L + + L
Sbjct: 91 -----NDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGL 141
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYM 211
+Y+H SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y
Sbjct: 142 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 212 APEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
APE + + + D++S G +L E + + IF G KH+++
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 11/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
+EF L+GKG FG V + G A+K+ + A E ++++ RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + S + V+EY G L +L + R ++ SAL+YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 265
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
+++ DLK N++LD + ++DF + K + + +M +TF T Y+APE
Sbjct: 266 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVL 321
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLP 348
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 54.3 bits (129), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + F +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPAF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + D +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + D +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 61/240 (25%), Positives = 107/240 (44%), Gaps = 32/240 (13%)
Query: 50 IGKGGFGSVYKARLGDGM-EVAVKVF---NLQCGR------ALKSFNVEC----EMMKSI 95
+G G +G V + +G E A+KV GR ++ F+ E ++KS+
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
H N+IK+ ++++ LV E+ G L + + + + D NIM + S + YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYL 162
Query: 156 HFGYSAPIIHCDLKPSNVLLDDN---MVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
H I+H D+KP N+LL++ + + DF ++ + T Y+A
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDRLGTAYYIA 216
Query: 213 PEYGREGRVSANGDVYSFGIML------METFTGKKPTDEIFNGEMTLKHW-VNDWLPIS 265
PE ++ + + DV+S G+++ F G+ D I E ++ NDW IS
Sbjct: 217 PEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS 275
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA++ F Q C R L+ E +++ RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 145
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 30/231 (12%)
Query: 38 CQATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ------CGRALKSFNVECE 90
+ D + +G+G +G VYKA VA+K L+ G A++ E
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVS 85
Query: 91 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 150
++K ++HRN+I++ S + L+ EY L+KY+ + D+ R+ I +
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNP---DVSMRV-IKSFLYQ 140
Query: 151 ALEYLHFGYSAPIIHCDLKPSNVLL-----DDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+ ++F +S +H DLKP N+LL + V + DF +A+ + T
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEI 198
Query: 206 ATIGYMAPEYGREGR-VSANGDVYS----FGIMLMET--FTGKKPTDEIFN 249
T+ Y PE R S + D++S + MLM+T F G D++F
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 41 TDEFSENNLIGKGGFGSVYKARL-GDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRN 99
+D F + +G+G VY+ + G A+KV + K E ++ + H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEY 154
+IK+ +LVLE + G L EK YS D ++ + A+ Y
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVAY 163
Query: 155 LHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
LH I+H DLKP N+L + ++DF ++K++ E Q + +T T GY
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYC 217
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
APE R D++S GI+ G +P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G+ VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + D +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREGRVSANG-------DVYSFGIMLMETFTGK 241
MT GY+A + R + N D++S G ++ E TG+
Sbjct: 179 MT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 15/227 (6%)
Query: 21 ASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQCG 79
A + W T S + D+F +G G FG V + + G A+K+ + Q
Sbjct: 22 AKEDFLKKWETPS--QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 80 RALKSFNV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 136
LK E +++++ L+K+ S + +V+EY+ G + +L
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 137 DIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGED 196
+ R + EYLH S +I+ DLKP N+L+D ++DF AK + G
Sbjct: 140 EPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 197 QSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+ T +APE + D ++ G+++ E G P
Sbjct: 196 WXLC-----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 12/197 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNL-QCGRALKSFNV-ECEMMKSIRHRNLIKVISS 106
IG G +G K R DG + K + A K V E +++ ++H N+++
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 107 CSNEEFKAL--VLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSA 161
+ L V+EY G L + LD L +M + AL+ H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 162 --PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
++H DLKP+NV LD L DF +A++L D+ + + T YM+PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAK-EFVGTPYYMSPEQMNRM 191
Query: 220 RVSANGDVYSFGIMLME 236
+ D++S G +L E
Sbjct: 192 SYNEKSDIWSLGCLLYE 208
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 27 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 86
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 87 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 146
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 147 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 198
Query: 199 MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK 241
M AT Y APE + D++S G ++ E TG+
Sbjct: 199 M--XGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 62
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 123 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 174
Query: 199 MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK 241
M AT Y APE + D++S G ++ E TG+
Sbjct: 175 M--AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 50 IGKGGFGSVYKARLGDGMEVA----VKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS 105
IG+G +G+V+KA+ + E+ V++ + G + C ++K ++H+N++++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHD 68
Query: 106 SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIH 165
+++ LV E+ L+KY S N LD + + + L + H S ++H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 166 CDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV-SAN 224
DLKP N+L++ N L++F +A+ + + T+ Y P+ ++ S +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 225 GDVYSFGIMLMETFTGKKP 243
D++S G + E +P
Sbjct: 183 IDMWSAGCIFAELANAGRP 201
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK 241
M AT Y APE + D++S G ++ E TG+
Sbjct: 179 M--AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 31 TFSYLELCQATDEFSE--NNL--IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALK 83
TF EL + E E NL +G G +GSV A G VAVK + Q K
Sbjct: 7 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 66
Query: 84 SFNVECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDI 138
E ++K ++H N+I ++ + S EEF + L ++ L + D
Sbjct: 67 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 126
Query: 139 FQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS 198
Q L + + L+Y+H SA IIH DLKPSN+ ++++ + DF +A+ D
Sbjct: 127 VQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDE 178
Query: 199 MTQTQTFATIGYMAPEYGREG-RVSANGDVYSFGIMLMETFTGK 241
M AT Y APE + D++S G ++ E TG+
Sbjct: 179 M--AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 128
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 12/197 (6%)
Query: 50 IGKGGFGSVYKARL-GDGMEVAVKVFNL-QCGRALKSFNV-ECEMMKSIRHRNLIKVISS 106
IG G +G K R DG + K + A K V E +++ ++H N+++
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 107 CSNEEFKAL--VLEYMPHGSLEKYLYSSN---CILDIFQRLNIMIDVASALEYLHFGYSA 161
+ L V+EY G L + LD L +M + AL+ H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 162 --PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
++H DLKP+NV LD L DF +A++L D S + T YM+PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKA-FVGTPYYMSPEQMNRM 191
Query: 220 RVSANGDVYSFGIMLME 236
+ D++S G +L E
Sbjct: 192 SYNEKSDIWSLGCLLYE 208
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 145
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + + AT Y APE
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQ--CGRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q C R L+ E +++ RH N+I
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 91
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 92 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 146
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + + AT Y APE
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 240
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 38/232 (16%)
Query: 50 IGKGGFGSVYKA---RLGDGMEVAVKVFNL--QCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKG +G V+K+ R G+ + V K+F+ A ++F + + H N++ ++
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVK-KIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 105 S--SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAP 162
+ N+ LV +YM L + ++ IL+ + ++ + ++YLH S
Sbjct: 76 NVLRADNDRDVYLVFDYM-ETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGG 129
Query: 163 IIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVG-------------------EDQSMTQTQ 203
++H D+KPSN+LL+ ++DF +++ V +D T
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 204 TFATIGYMAPEYGREGRVSANG-DVYSFGIMLMETFTGKKPTDEIFNGEMTL 254
AT Y APE G D++S G +L E GK IF G T+
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP----IFPGSSTM 237
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 69/257 (26%), Positives = 114/257 (44%), Gaps = 37/257 (14%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVK-----VFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V K R + G +AVK V + + R L ++ M+++ +
Sbjct: 59 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 115
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------NIMIDVASALEYLHF 157
+ E + +E M SL+K+ ++D Q + I + + ALE+LH
Sbjct: 116 YGALFREGDVWICMELM-DTSLDKFYKQ---VIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA----- 212
S +IH D+KPSNVL++ + DF I+ LV S+ +T YMA
Sbjct: 172 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKTIDAGCKPYMAPERIN 226
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
PE ++G S D++S GI ++E + P D LK V + P + A
Sbjct: 227 PELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-----QLPA 280
Query: 273 NLLSQEDIHFVAKEQCV 289
+ S E + F + QC+
Sbjct: 281 DKFSAEFVDFTS--QCL 295
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 42/234 (17%)
Query: 41 TDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVK--------VFNLQCGRALKSFNVECEM 91
+ +F +L+G+G +G V A G VA+K +F L+ R +K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-------I 62
Query: 92 MKSIRHRNLIKVISSCSNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 147
+K +H N+I + + + F+ +++ + L + + + D Q +
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQ 120
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL----------VGEDQ 197
A++ LH + +IH DLKPSN+L++ N + DF +A+++ G+
Sbjct: 121 TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 198 SMTQTQTFATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
M T+ AT Y APE + S DV+S G +L E F ++P IF G
Sbjct: 178 GM--TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP---IFPG 225
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 40/150 (26%), Positives = 75/150 (50%), Gaps = 9/150 (6%)
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
H N++K+ ++ LV+E + G L + + + + IM + SA+ ++H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-EASYIMRKLVSAVSHMH 123
Query: 157 FGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAP 213
++H DLKP N+L +DN+ + DF A+L ++Q + +T F T+ Y AP
Sbjct: 124 ---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL-KTPCF-TLHYAAP 178
Query: 214 EYGREGRVSANGDVYSFGIMLMETFTGKKP 243
E + + D++S G++L +G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 58/258 (22%), Positives = 98/258 (37%), Gaps = 37/258 (14%)
Query: 50 IGKGGFGSVYKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCSN 109
+G+G FG V++ + + F G E ++ RHRN++ + S +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 110 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN----------IMIDVASALEYLHFGY 159
E ++ E++ LDIF+R+N I+ V E L F +
Sbjct: 73 MEELVMIFEFISG-------------LDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGR 217
S I H D++P N++ + + +F A+ L D F Y APE +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQ 176
Query: 218 EGRVSANGDVYSFGIMLMETFTGKKP---------TDEIFNGEMTLKHWVNDWLPISTLE 268
VS D++S G ++ +G P + I N E T + I ++
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 269 VVDANLLSQEDIHFVAKE 286
VD L+ + A E
Sbjct: 237 FVDRLLVKERKSRMTASE 254
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+LE + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 42/234 (17%)
Query: 41 TDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVK--------VFNLQCGRALKSFNVECEM 91
+ +F +L+G+G +G V A G VA+K +F L+ R +K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-------I 62
Query: 92 MKSIRHRNLIKVISSCSNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 147
+K +H N+I + + + F+ +++ + L + + + D Q +
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQ 120
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL----------VGEDQ 197
A++ LH + +IH DLKPSN+L++ N + DF +A+++ G+
Sbjct: 121 TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 198 SMTQTQTFATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
M T+ AT Y APE + S DV+S G +L E F ++P IF G
Sbjct: 178 GM--TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP---IFPG 225
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 32/215 (14%)
Query: 43 EFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALK----SFNVECEMMKSIR 96
EF E +G G F V A + K+F ++C +ALK S E +++ I+
Sbjct: 25 EFKET--LGTGAFSEVVLAE----EKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIK 78
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASA 151
H N++ + + LV++ + G L EK Y+ + ++ V A
Sbjct: 79 HENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ------VLDA 132
Query: 152 LEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
+ YLH I+H DLKP N+L D+ +SDF ++K+ E + + T
Sbjct: 133 VYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTP 186
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
GY+APE + S D +S G++ G P
Sbjct: 187 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 88 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRLNIM 145
E ++++ +RH+N+I+++ NEE + + V+EY G E + Q
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 146 IDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF 205
+ LEYLH S I+H D+KP N+LL +S +A+ L T +
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 206 ATIGYMAPEYGREGRVSANG---DVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + PE G + +G D++S G+ L TG P F G+ K + N
Sbjct: 173 GSPAFQPPEIAN-GLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGDNIYKLFEN 224
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFNL--QCGRALKS-FNVECEMMKSIRH 97
++F +IG+G FG V +L + +V A+K+ N RA + F E +++ +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNI--MIDVASALEY 154
+ + + + ++ LV++Y G L L + + + R + M+ ++
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDF-SIAKLLVGEDQSMTQTQTFATIGYMAP 213
LH+ +H D+KP N+L+D N L+DF S KL+ ED ++ + T Y++P
Sbjct: 194 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLM--EDGTVQSSVAVGTPDYISP 245
Query: 214 EY-----GREGRVSANGDVYSFGIMLMETFTGKKP 243
E G +GR D +S G+ + E G+ P
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRN 99
+ +GKGGF Y+ D EV A KV L + + E + KS+ + +
Sbjct: 28 YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++ +++F +VLE SL + + + R M ++YLH
Sbjct: 88 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH--- 143
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +IH DLK N+ L+D+M + DF +A + E + T Y+APE +
Sbjct: 144 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKK 201
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
S D++S G +L GK P
Sbjct: 202 GHSFEVDIWSLGCILYTLLVGKPP 225
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 122/288 (42%), Gaps = 47/288 (16%)
Query: 47 NNLIGKGGFGSVYKA---RLGD-----GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHR 98
N +G+G F ++K +GD EV +KV + +SF MM + H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
+L+ C + LV E++ GSL+ YL + ++I +L + +A+A +HF
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 159 YSAPIIHCDLKPSNVLL---DDNMVAH-----LSDFSIAKLLVGEDQSMTQTQTFATIGY 210
+IH ++ N+LL +D + LSD I+ ++ +D + Q + I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPW 183
Query: 211 MAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
+ PE + ++ D +SFG L E +G G+ P+S L+
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG---------GDK----------PLSALD- 223
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L ED H + + NL C P+ R + + I++ L
Sbjct: 224 SQRKLQFYEDRHQLPAPKAAELA-NLINNCMDYEPDHRPSFRAIIRDL 270
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 10/106 (9%)
Query: 143 NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202
+ + + AL YL + +IH D+KPSN+LLD+ L DF I+ LV +D++ ++
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRS 184
Query: 203 QTFATIGYMAPEY-----GREGRVSANGDVYSFGIMLMETFTGKKP 243
A YMAPE + DV+S GI L+E TG+ P
Sbjct: 185 AGCAA--YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 47 NNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIR-HRNLIKVI 104
+ L+G+G + V A L +G E AVK+ Q G + E E + + ++N++++I
Sbjct: 18 SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
++ LV E + GS+ ++ + + ++ DVA+AL++LH + I
Sbjct: 78 EFFEDDTRFYLVFEKLQGGSILAHIQKQK-HFNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIG----------YMAPE 214
H DLKP N+L + +S I +G + + T T YMAPE
Sbjct: 134 HRDLKPENILCESP--EKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 215 Y-----GREGRVSANGDVYSFGIMLMETFTGKKP 243
+ D++S G++L +G P
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALK-SFNVECEMMKSIRHRN 99
D + +++G G F V A + VA+K + + S E ++ I+H N
Sbjct: 18 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSS-NCILDIFQRLNIMIDVASALE 153
++ + + L+++ + G L EK Y+ + IFQ L+ A++
Sbjct: 78 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVK 130
Query: 154 YLHFGYSAPIIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
YLH I+H DLKP N+L LD++ +SDF ++K+ ED + T GY
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 184
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + S D +S G++ G P
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRN 99
+ +GKGGF Y+ D EV A KV L + + E + KS+ + +
Sbjct: 44 YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++ +++F +VLE SL + + + R M ++YLH
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH--- 159
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +IH DLK N+ L+D+M + DF +A + E + T Y+APE +
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKK 217
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
S D++S G +L GK P
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPP 241
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVK---VFNLQC--GRALKSFNVECEMMKSIRHRNLI-- 101
IG+G +G V A + + VA+K F Q R L+ E +++ RH N+I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR----EIKILLRFRHENIIGI 90
Query: 102 -KVISSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
+I + + E+ K + +++ + L K L + + D + + L+Y+H
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH--- 145
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL-VGEDQSMTQTQTFATIGYMAPEYGRE 218
SA ++H DLKPSN+LL+ + DF +A++ D + T+ AT Y APE
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 219 GR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN 259
+ + + D++S G +L E + + IF G KH+++
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALK-SFNVECEMMKSIRHRN 99
D + +++G G F V A + VA+K + + S E ++ I+H N
Sbjct: 18 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSS-NCILDIFQRLNIMIDVASALE 153
++ + + L+++ + G L EK Y+ + IFQ L+ A++
Sbjct: 78 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVK 130
Query: 154 YLHFGYSAPIIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
YLH I+H DLKP N+L LD++ +SDF ++K+ ED + T GY
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 184
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + S D +S G++ G P
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALK-SFNVECEMMKSIRHRN 99
D + +++G G F V A + VA+K + + S E ++ I+H N
Sbjct: 18 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSS-NCILDIFQRLNIMIDVASALE 153
++ + + L+++ + G L EK Y+ + IFQ L+ A++
Sbjct: 78 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD-------AVK 130
Query: 154 YLHFGYSAPIIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
YLH I+H DLKP N+L LD++ +SDF ++K+ ED + T GY
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 184
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + S D +S G++ G P
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEVAVKVFNLQC--GRALK----SFNVECEMMKSI 95
D + +++G G F V A + K+ ++C +AL+ S E ++ I
Sbjct: 18 DIYDFRDVLGTGAFSEVILAE----DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 73
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSS-NCILDIFQRLNIMIDVA 149
+H N++ + + L+++ + G L EK Y+ + IFQ L+
Sbjct: 74 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD------ 127
Query: 150 SALEYLHFGYSAPIIHCDLKPSNVL---LDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
A++YLH I+H DLKP N+L LD++ +SDF ++K+ ED +
Sbjct: 128 -AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACG 180
Query: 207 TIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
T GY+APE + S D +S G++ G P
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKSFNVECEMM 92
C ++ + IG+G FG V+KAR G +VA+K + N + G + + E +++
Sbjct: 13 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKIL 71
Query: 93 KSIRHRNLIKVISSCSNE-----EFKA---LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 144
+ ++H N++ +I C + KA LV ++ H L L + + + +
Sbjct: 72 QLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 130
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL--LVGEDQSMTQT 202
M + + L Y+H I+H D+K +NVL+ + V L+DF +A+ L Q
Sbjct: 131 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 203 QTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFT 239
T+ Y PE R D++ G ++ E +T
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 50/219 (22%), Positives = 90/219 (41%), Gaps = 17/219 (7%)
Query: 50 IGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISSCS 108
+G G FG V++ G K N + E +M + H LI + +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 109 NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDL 168
++ L+LE++ G L + + + + + +N M L+++H I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175
Query: 169 KPSNVLLDDNMVAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGD 226
KP N++ + + + DF +A L ++ T AT + APE V D
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTD 232
Query: 227 VYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVN----DW 261
+++ G++ +G P F GE L+ N DW
Sbjct: 233 MWAIGVLGYVLLSGLSP----FAGEDDLETLQNVKRCDW 267
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
+EF L+GKG FG V + G A+K+ + A E ++++ RH
Sbjct: 8 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + S + V+EY G L +L + R ++ SAL+YLH
Sbjct: 68 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 125
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
+++ DLK N++LD + ++DF + K + + +M + F T Y+APE
Sbjct: 126 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KXFCGTPEYLAPEVL 181
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLP 208
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRN 99
+ +GKGGF Y+ D EV A KV L + + E + KS+ + +
Sbjct: 44 YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++ +++F +VLE SL + + + R M ++YLH
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH--- 159
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +IH DLK N+ L+D+M + DF +A + E + T Y+APE +
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKTLCGTPNYIAPEVLCKK 217
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
S D++S G +L GK P
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPP 241
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 51.2 bits (121), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
+EF L+GKG FG V + G A+K+ + A E ++++ RH
Sbjct: 9 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + S + V+EY G L +L + R ++ SAL+YLH
Sbjct: 69 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 126
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
+++ DLK N++LD + ++DF + K + + +M + F T Y+APE
Sbjct: 127 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KXFCGTPEYLAPEVL 182
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLP 209
>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
pdb|2H34|B Chain B, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
Length = 309
Score = 51.2 bits (121), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 29/80 (36%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQ-TQTFATIGYMAPEYGREGRVSA 223
H D+KP N+L+ + A+L DF IA D+ +TQ T T+ Y APE E +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYXAPERFSESHATY 214
Query: 224 NGDVYSFGIMLMETFTGKKP 243
D+Y+ +L E TG P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKSFNVECEMM 92
C ++ + IG+G FG V+KAR G +VA+K + N + G + + E +++
Sbjct: 13 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKIL 71
Query: 93 KSIRHRNLIKVISSCSNEEFKA--------LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 144
+ ++H N++ +I C + LV ++ H L L + + + +
Sbjct: 72 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 130
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL--LVGEDQSMTQT 202
M + + L Y+H I+H D+K +NVL+ + V L+DF +A+ L Q
Sbjct: 131 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 203 QTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFT 239
T+ Y PE R D++ G ++ E +T
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 10/204 (4%)
Query: 44 FSENNLIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRN 99
+ +GKGGF Y+ D EV A KV L + + E + KS+ + +
Sbjct: 44 YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 100 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGY 159
++ +++F +VLE SL + + + R M ++YLH
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY-FMRQTIQGVQYLH--- 159
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
+ +IH DLK N+ L+D+M + DF +A + E + T Y+APE +
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPEVLCKK 217
Query: 220 RVSANGDVYSFGIMLMETFTGKKP 243
S D++S G +L GK P
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPP 241
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 55/105 (52%), Gaps = 13/105 (12%)
Query: 142 LNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQS--- 198
L+I I +A A+E+LH S ++H DLKPSN+ + V + DF + + +++
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 199 MTQTQTFAT----IG---YMAPEYGREGRVSANGDVYSFGIMLME 236
+T +AT +G YM+PE S D++S G++L E
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVFNLQCGRALKSFN---VECEMMKSIRH 97
+EF L+GKG FG V + G A+K+ + A E ++++ RH
Sbjct: 10 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 98 RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHF 157
L + S + V+EY G L +L + R ++ SAL+YLH
Sbjct: 70 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH- 127
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTF-ATIGYMAPEYG 216
+++ DLK N++LD + ++DF + K + + +M + F T Y+APE
Sbjct: 128 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KXFCGTPEYLAPEVL 183
Query: 217 REGRVSANGDVYSFGIMLMETFTGKKP 243
+ D + G+++ E G+ P
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGRLP 210
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 41 TDEFSENNLIGKGGFGS----VYKARLGDGMEVAVKVFNLQCGRALKSFNVECE-MMKSI 95
+D + IG G + V+KA ME AVKV + ++ + + E E +++
Sbjct: 26 SDGYVVKETIGVGSYSECKRCVHKA---TNMEYAVKVID----KSKRDPSEEIEILLRYG 78
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
+H N+I + + + LV E M G L + + ++ + +EYL
Sbjct: 79 QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYL 137
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
H S ++H DLKPSN+L D + DF AK L E+ + T + T ++
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN-GLLMTPCY-TANFV 192
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
APE + D++S GI+L G P
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 50 IGKGGFGSVYKARLG-DGMEVAVKVF--NLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
+G G +G+V A G G +VA+K Q K E ++K +RH N+I ++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 107 CSNEEFKA------LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ +E LV+ +M L K + D Q L + + L Y+H +
Sbjct: 93 FTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL--VYQMLKGLRYIH---A 146
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG- 219
A IIH DLKP N+ ++++ + DF +A+ E T+ Y APE
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYRAPEVILNWM 201
Query: 220 RVSANGDVYSFGIMLMETFTGK 241
R + D++S G ++ E TGK
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGK 223
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKSFNVECEMM 92
C ++ + IG+G FG V+KAR G +VA+K + N + G + + E +++
Sbjct: 12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKIL 70
Query: 93 KSIRHRNLIKVISSCSNEEFKA--------LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 144
+ ++H N++ +I C + LV ++ H L L + + + +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL--LVGEDQSMTQT 202
M + + L Y+H I+H D+K +NVL+ + V L+DF +A+ L Q
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 186
Query: 203 QTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFT 239
T+ Y PE R D++ G ++ E +T
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 50.8 bits (120), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 38/232 (16%)
Query: 41 TDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVK--------VFNLQCGRALKSFNVECEM 91
+ +F +L+G+G +G V A G VA+K +F L+ R +K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-------I 62
Query: 92 MKSIRHRNLIKVISSCSNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 147
+K +H N+I + + + F+ +++ + L + + + D Q +
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQ 120
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLL---VGEDQSMTQTQT 204
A++ LH + +IH DLKPSN+L++ N + DF +A+++ ++ T Q+
Sbjct: 121 TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 205 -----FATIGYMAPEYG-REGRVSANGDVYSFGIMLMETFTGKKPTDEIFNG 250
AT Y APE + S DV+S G +L E F ++P IF G
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRP---IFPG 225
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 50.8 bits (120), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V A G+ VAVK + Q K E ++K + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + ++ LD + ++ + +++LH S
Sbjct: 92 FTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ + T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
+AN D++S G ++ E G IF G + W
Sbjct: 202 YAANVDIWSVGCIMGELVKGCV----IFQGTDHIDQW 234
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 71/313 (22%), Positives = 128/313 (40%), Gaps = 63/313 (20%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVF----NLQCGRALKSFNV 87
EF N L +G G FG V +A + M VAVK+ +L AL S
Sbjct: 42 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS--- 98
Query: 88 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----------SSNCIL 136
E +++ + H N++ ++ +C+ ++ EY +G L +L +S I+
Sbjct: 99 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 158
Query: 137 DIFQRL-------NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189
+ + + VA + +L S IH DL N+LL + + DF +A
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248
+ + + + + + +MAPE + DV+S+GI L E F+ G P +
Sbjct: 216 RHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP----Y 271
Query: 249 NGEMTLKHWVNDWLPISTLEVVDANL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ 306
G +P VD+ + +E ++ E + ++++ C P +
Sbjct: 272 PG-----------MP------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 314
Query: 307 RINAKEIVKKLLK 319
R K+IV+ + K
Sbjct: 315 RPTFKQIVQLIEK 327
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 69/288 (23%), Positives = 121/288 (42%), Gaps = 47/288 (16%)
Query: 47 NNLIGKGGFGSVYKA---RLGD-----GMEVAVKVFNLQCGRALKSFNVECEMMKSIRHR 98
N +G+G F ++K +GD EV +KV + +SF MM + H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 99 NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 158
+L+ C + LV E++ GSL+ YL + ++I +L + +A A +HF
Sbjct: 73 HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 159 YSAPIIHCDLKPSNVLL---DDNMVAH-----LSDFSIAKLLVGEDQSMTQTQTFATIGY 210
+IH ++ N+LL +D + LSD I+ ++ +D + Q + I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--ILQER----IPW 183
Query: 211 MAPEYGREGR-VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEV 269
+ PE + ++ D +SFG L E +G G+ P+S L+
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG---------GDK----------PLSALD- 223
Query: 270 VDANLLSQEDIHFVAKEQCVSFVFNLAMACAVESPEQRINAKEIVKKL 317
L ED H + + NL C P+ R + + I++ L
Sbjct: 224 SQRKLQFYEDRHQLPAPKAAELA-NLINNCMDYEPDHRPSFRAIIRDL 270
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 11 RQRGK-RPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKARLGDGME- 68
+Q G+ R + +S P +M R S Q D + +LIG G +G V +A D +E
Sbjct: 24 QQEGQQRKQHHSSKPTASMPRPHSDW---QIPDRYEIRHLIGTGSYGHVCEAY--DKLEK 78
Query: 69 --VAVK----VFN--LQCGRALKSFNVECEMMKSIRHRNLIKVIS---SCSNEEFKALVL 117
VA+K VF + C R L+ E ++ + H +++KV+ E+F L +
Sbjct: 79 RVVAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 118 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDD 177
S K L+ + L ++ ++ ++Y+H SA I+H DLKP+N L++
Sbjct: 135 VLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQ 191
Query: 178 NMVAHLSDFSIAKLL 192
+ + DF +A+ +
Sbjct: 192 DCSVKVCDFGLARTV 206
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 39 QATDEFSENNLIGKGGFG----SVYKARLGDGMEVAVKVFNLQCGRALKSFNVECE-MMK 93
Q TD + IG G + ++KA E AVK+ + ++ + E E +++
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKAT---NXEFAVKIID----KSKRDPTEEIEILLR 71
Query: 94 SIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRLNIMIDVASAL 152
+H N+I + + ++ +V E G L +K L + ++ + +
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK--FFSEREASAVLFTITKTV 129
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIAKLLVGEDQSMTQTQTFATI 208
EYLH + ++H DLKPSN+L D + DF AK L E+ + T + T
Sbjct: 130 EYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLXTPCY-TA 184
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
++APE A D++S G++L TG P
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 41 TDEFSENNLIGKGGFGS----VYKARLGDGMEVAVKVFNLQCGRALKSFNVECE-MMKSI 95
+D + IG G + V+KA ME AVKV + ++ + + E E +++
Sbjct: 26 SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVID----KSKRDPSEEIEILLRYG 78
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 155
+H N+I + + + LV E M G L + + ++ + +EYL
Sbjct: 79 QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYL 137
Query: 156 HFGYSAPIIHCDLKPSNVLLDDNM----VAHLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
H S ++H DLKPSN+L D + DF AK L E+ + T + T ++
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN-GLLMTPCY-TANFV 192
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
APE + D++S GI+L G P
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 37 LCQATDEFSENNLIGKGGFGSVYKAR-LGDGMEVAVK---VFNLQCGRALKSFNVECEMM 92
C ++ + IG+G FG V+KAR G +VA+K + N + G + + E +++
Sbjct: 13 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKIL 71
Query: 93 KSIRHRNLIKVISSCSNEEFKA--------LVLEYMPHGSLEKYLYSSNCILDIFQRLNI 144
+ ++H N++ +I C + LV ++ H L L + + + +
Sbjct: 72 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 130
Query: 145 MIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKL--LVGEDQSMTQT 202
M + + L Y+H I+H D+K +NVL+ + V L+DF +A+ L Q
Sbjct: 131 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYX 187
Query: 203 QTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFT 239
T+ Y PE R D++ G ++ E +T
Sbjct: 188 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 71/313 (22%), Positives = 128/313 (40%), Gaps = 63/313 (20%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVF----NLQCGRALKSFNV 87
EF N L +G G FG V +A + M VAVK+ +L AL S
Sbjct: 35 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS--- 91
Query: 88 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----------SSNCIL 136
E +++ + H N++ ++ +C+ ++ EY +G L +L +S I+
Sbjct: 92 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 151
Query: 137 DIFQRL-------NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189
+ + + VA + +L S IH DL N+LL + + DF +A
Sbjct: 152 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 208
Query: 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248
+ + + + + + +MAPE + DV+S+GI L E F+ G P +
Sbjct: 209 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP----Y 264
Query: 249 NGEMTLKHWVNDWLPISTLEVVDANL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ 306
G +P VD+ + +E ++ E + ++++ C P +
Sbjct: 265 PG-----------MP------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 307
Query: 307 RINAKEIVKKLLK 319
R K+IV+ + K
Sbjct: 308 RPTFKQIVQLIEK 320
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 71/313 (22%), Positives = 128/313 (40%), Gaps = 63/313 (20%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVF----NLQCGRALKSFNV 87
EF N L +G G FG V +A + M VAVK+ +L AL S
Sbjct: 42 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS--- 98
Query: 88 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----------SSNCIL 136
E +++ + H N++ ++ +C+ ++ EY +G L +L +S I+
Sbjct: 99 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 158
Query: 137 DIFQRL-------NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189
+ + + VA + +L S IH DL N+LL + + DF +A
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248
+ + + + + + +MAPE + DV+S+GI L E F+ G P +
Sbjct: 216 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP----Y 271
Query: 249 NGEMTLKHWVNDWLPISTLEVVDANL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ 306
G +P VD+ + +E ++ E + ++++ C P +
Sbjct: 272 PG-----------MP------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 314
Query: 307 RINAKEIVKKLLK 319
R K+IV+ + K
Sbjct: 315 RPTFKQIVQLIEK 327
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 71/313 (22%), Positives = 128/313 (40%), Gaps = 63/313 (20%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVF----NLQCGRALKSFNV 87
EF N L +G G FG V +A + M VAVK+ +L AL S
Sbjct: 37 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS--- 93
Query: 88 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----------SSNCIL 136
E +++ + H N++ ++ +C+ ++ EY +G L +L +S I+
Sbjct: 94 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 153
Query: 137 DIFQRL-------NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189
+ + + VA + +L S IH DL N+LL + + DF +A
Sbjct: 154 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 210
Query: 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248
+ + + + + + +MAPE + DV+S+GI L E F+ G P +
Sbjct: 211 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP----Y 266
Query: 249 NGEMTLKHWVNDWLPISTLEVVDANL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ 306
G +P VD+ + +E ++ E + ++++ C P +
Sbjct: 267 PG-----------MP------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 309
Query: 307 RINAKEIVKKLLK 319
R K+IV+ + K
Sbjct: 310 RPTFKQIVQLIEK 322
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 18/213 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKAR-LGDGMEVAVKVF------NLQCGRALKSFNVECEMMKS 94
D + +G G F V K R G++ A K + + G + + E ++K
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 95 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEY 154
I+H N+I + N+ L+ E + G L +L + + + + + + + Y
Sbjct: 71 IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYY 129
Query: 155 LHFGYSAPIIHCDLKPSNVLLDDNMVA----HLSDFSIAKLLVGEDQSMTQTQTFATIGY 210
LH S I H DLKP N++L D V + DF +A + D F T +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 211 MAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
+APE + D++S G++ +G P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 32/226 (14%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMM- 92
L + +D + IG G FG R E VAVK ++ G + + NV+ E++
Sbjct: 12 LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKY--IERGEKIAA-NVKREIIN 68
Query: 93 -KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----YSSNCILDIFQRLNIMI 146
+S+RH N+++ A+V+EY G L + + +S + FQ+L
Sbjct: 69 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL---- 124
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLVGEDQSMTQTQT 204
S + Y H + + H DLK N LLD + L DF +K V Q + T
Sbjct: 125 --ISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---T 176
Query: 205 FATIGYMAPEY----GREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE +G+V+ DV+S G+ L G P ++
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFED 219
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 32/226 (14%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMM- 92
L + +D + IG G FG R E VAVK ++ G + NV+ E++
Sbjct: 12 LPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKY--IERGEKIDE-NVKREIIN 68
Query: 93 -KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----YSSNCILDIFQRLNIMI 146
+S+RH N+++ A+V+EY G L + + +S + FQ+L +
Sbjct: 69 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 128
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHL--SDFSIAKLLVGEDQSMTQTQT 204
A A++ + H DLK N LLD + L +DF +K V Q + T
Sbjct: 129 SYAHAMQ---------VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGT 179
Query: 205 FATIGYMAPEY----GREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
A Y+APE +G+V+ DV+S G+ L G P ++
Sbjct: 180 PA---YIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFED 219
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 71/313 (22%), Positives = 128/313 (40%), Gaps = 63/313 (20%)
Query: 43 EFSENNL-----IGKGGFGSVYKA------RLGDGMEVAVKVF----NLQCGRALKSFNV 87
EF N L +G G FG V +A + M VAVK+ +L AL S
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS--- 75
Query: 88 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----------SSNCIL 136
E +++ + H N++ ++ +C+ ++ EY +G L +L +S I+
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 137 DIFQRL-------NIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189
+ + + VA + +L S IH DL N+LL + + DF +A
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKPTDEIF 248
+ + + + + + +MAPE + DV+S+GI L E F+ G P +
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP----Y 248
Query: 249 NGEMTLKHWVNDWLPISTLEVVDANL--LSQEDIHFVAKEQCVSFVFNLAMACAVESPEQ 306
G +P VD+ + +E ++ E + ++++ C P +
Sbjct: 249 PG-----------MP------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 307 RINAKEIVKKLLK 319
R K+IV+ + K
Sbjct: 292 RPTFKQIVQLIEK 304
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFN---------LQCGRALKSF--NVEC 89
++F +IG+G FG V ++ + + A+K+ N C R + N +C
Sbjct: 74 EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNI--MI 146
+ + ++ + + +E LV++Y G L L + + + R I M+
Sbjct: 134 QWITALHY--------AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 185
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
++ LH+ +H D+KP NVLLD N L+DF + L + +D ++ +
Sbjct: 186 LAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVG 238
Query: 207 TIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKP 243
T Y++PE + G+ D +S G+ + E G+ P
Sbjct: 239 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMM- 92
+ + +D + IG G FG R E VAVK ++ G A+ NV+ E++
Sbjct: 13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKY--IERGAAIDE-NVQREIIN 69
Query: 93 -KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----YSSNCILDIFQRLNIMI 146
+S+RH N+++ A+++EY G L + + +S + FQ+L
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL---- 125
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLVGEDQSMTQTQT 204
S + Y H S I H DLK N LLD + L DF +K V Q + T
Sbjct: 126 --LSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---T 177
Query: 205 FATIGYMAPEY-GREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE R+ DV+S G+ L G P ++
Sbjct: 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 85 FNVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL---EKYLY----SSNCILD 137
F E +++ I++ + +N + ++ EYM + S+ ++Y + + C +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 138 IFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQ 197
I I+ V ++ Y+H I H D+KPSN+L+D N LSDF ++ +V D+
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DK 205
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANG---DVYSFGIMLMETFTGKKPTD------EIF 248
+ ++ T +M PE+ S NG D++S GI L F P E+F
Sbjct: 206 KIKGSR--GTYEFMPPEFF-SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 249 NG--------EMTLKHWVNDWLPISTLE-VVDANLLSQEDIHFVA 284
N + H++ P++ + N LS EDI F+
Sbjct: 263 NNIRTKNIEYPLDRNHFL---YPLTNKKSTCSNNFLSNEDIDFLK 304
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 10/233 (4%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKGGF ++ D EV A K+ L + ++E + +S+ H++++
Sbjct: 24 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ +F +VLE SL + + + R + + +YLH +I
Sbjct: 84 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 139
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H DLK N+ L++++ + DF +A + E + T Y+APE + S
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
DV+S G ++ GK P + E L+ N++ + V A+L+ +
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--- 95
T EF E IG G FGSV+K RL DG A+K ++ N E+
Sbjct: 6 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 64
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---NIMIDVASAL 152
+H ++++ S+ + ++ + EY GSL + + I+ F+ ++++ V L
Sbjct: 65 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 124
Query: 153 EYLHFGYSAPIIHCDLKPSNVLL 175
Y+H S ++H D+KPSN+ +
Sbjct: 125 RYIH---SMSLVHMDIKPSNIFI 144
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVI 104
+IG+G + V RL + A+KV + + E + + + + +
Sbjct: 27 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 105 SSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
SC E + V+EY+ G L ++ + + R +++ AL YLH I
Sbjct: 87 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 142
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA 223
I+ DLK NVLLD L+D+ + K G T + T Y+APE R
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 200
Query: 224 NGDVYSFGIMLMETFTGKKPTD 245
+ D ++ G+++ E G+ P D
Sbjct: 201 SVDWWALGVLMFEMMAGRSPFD 222
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 55/233 (23%), Positives = 101/233 (43%), Gaps = 10/233 (4%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKGGF ++ D EV A K+ L + ++E + +S+ H++++
Sbjct: 28 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ +F +VLE SL + L+ L + + + +YLH +I
Sbjct: 88 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 143
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H DLK N+ L++++ + DF +A + E + T Y+APE + S
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGHSFE 201
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
DV+S G ++ GK P + E L+ N++ + V A+L+ +
Sbjct: 202 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 254
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 32/226 (14%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMM- 92
L + +D + IG G FG R E VAVK ++ G + NV+ E++
Sbjct: 11 LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKY--IERGEKIDE-NVKREIIN 67
Query: 93 -KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----YSSNCILDIFQRLNIMI 146
+S+RH N+++ A+V+EY G L + + +S + FQ+L
Sbjct: 68 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL---- 123
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLVGEDQSMTQTQT 204
S + Y H + + H DLK N LLD + L DF +K V Q + T
Sbjct: 124 --ISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---T 175
Query: 205 FATIGYMAPEY----GREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE +G+V+ DV+S G+ L G P ++
Sbjct: 176 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFED 218
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 10/233 (4%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKGGF ++ D EV A K+ L + ++E + +S+ H++++
Sbjct: 24 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ +F +VLE SL + + + R + + +YLH +I
Sbjct: 84 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 139
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H DLK N+ L++++ + DF +A + E + T Y+APE + S
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGHSFE 197
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
DV+S G ++ GK P + E L+ N++ + V A+L+ +
Sbjct: 198 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 250
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 49 LIGKGGFGSV-YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI------RHRNLI 101
++GKG FG V R G AVK+ L+ ++ +VEC M++ + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ S + V+EY+ G L ++ + F+ + + A L F S
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
II+ DLK NV+LD ++DF + K + + +T T Y+APE
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 222 SANGDVYSFGIMLMETFTGKKP-----TDEIFNGEM 252
+ D ++FG++L E G+ P DE+F M
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGDGMEV-AVKVFN---------LQCGRALKSF--NVEC 89
++F +IG+G FG V ++ + + A+K+ N C R + N +C
Sbjct: 90 EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNI--MI 146
+ + ++ + + +E LV++Y G L L + + + R I M+
Sbjct: 150 QWITALHY--------AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMV 201
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFA 206
++ LH+ +H D+KP NVLLD N L+DF + L + +D ++ +
Sbjct: 202 LAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVG 254
Query: 207 TIGYMAPEYGRE-----GRVSANGDVYSFGIMLMETFTGKKP 243
T Y++PE + G+ D +S G+ + E G+ P
Sbjct: 255 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--- 95
T EF E IG G FGSV+K RL DG A+K ++ N E+
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---NIMIDVASAL 152
+H ++++ S+ + ++ + EY GSL + + I+ F+ ++++ V L
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 153 EYLHFGYSAPIIHCDLKPSNVLL 175
Y+H S ++H D+KPSN+ +
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFI 148
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--- 95
T EF E IG G FGSV+K RL DG A+K ++ N E+
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 66
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---NIMIDVASAL 152
+H ++++ S+ + ++ + EY GSL + + I+ F+ ++++ V L
Sbjct: 67 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 153 EYLHFGYSAPIIHCDLKPSNVLL 175
Y+H S ++H D+KPSN+ +
Sbjct: 127 RYIH---SMSLVHMDIKPSNIFI 146
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVI 104
+IG+G + V RL + A+KV + + E + + + + +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 105 SSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
SC E + V+EY+ G L ++ + + R +++ AL YLH I
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 131
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA 223
I+ DLK NVLLD L+D+ + K G T + T Y+APE R
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 189
Query: 224 NGDVYSFGIMLMETFTGKKPTD 245
+ D ++ G+++ E G+ P D
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFD 211
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 41 TDEFSENNLIGKGGFGSVYK--ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI--- 95
T EF E IG G FGSV+K RL DG A+K ++ N E+
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 66
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL---NIMIDVASAL 152
+H ++++ S+ + ++ + EY GSL + + I+ F+ ++++ V L
Sbjct: 67 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 153 EYLHFGYSAPIIHCDLKPSNVLL 175
Y+H S ++H D+KPSN+ +
Sbjct: 127 RYIH---SMSLVHMDIKPSNIFI 146
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNL----QCGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 9 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE M P L ++ + + R + V A+
Sbjct: 69 SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 127
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 128 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 180
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 181 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 232
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 11/202 (5%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVI 104
+IG+G + V RL + A+KV + + E + + + + +
Sbjct: 12 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 105 SSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
SC E + V+EY+ G L ++ + + R +++ AL YLH I
Sbjct: 72 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 127
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA 223
I+ DLK NVLLD L+D+ + K G T + T Y+APE R
Sbjct: 128 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 185
Query: 224 NGDVYSFGIMLMETFTGKKPTD 245
+ D ++ G+++ E G+ P D
Sbjct: 186 SVDWWALGVLMFEMMAGRSPFD 207
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 49 LIGKGGFGSV-YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSI------RHRNLI 101
++GKG FG V R G AVK+ L+ ++ +VEC M++ + L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 102 KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSA 161
++ S + V+EY+ G L ++ + F+ + + A L F S
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 162 PIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRV 221
II+ DLK NV+LD ++DF + K + + +T T Y+APE
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 222 SANGDVYSFGIMLMETFTGKKP-----TDEIFNGEM 252
+ D ++FG++L E G+ P DE+F M
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 10/233 (4%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKGGF ++ D EV A K+ L + ++E + +S+ H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ +F +VLE SL + + + R + + +YLH +I
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 137
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H DLK N+ L++++ + DF +A + E + T Y+APE + S
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 195
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
DV+S G ++ GK P + E L+ N++ + V A+L+ +
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V A G+ VAVK + Q K E ++K + H+N+I +++
Sbjct: 30 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + ++ LD + ++ + +++LH S
Sbjct: 90 FTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---S 142
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ + T T Y APE
Sbjct: 143 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVILGMG 199
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E G IF G + W
Sbjct: 200 YKENVDIWSVGCIMGELVKGSV----IFQGTDHIDQW 232
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 62/242 (25%), Positives = 108/242 (44%), Gaps = 27/242 (11%)
Query: 17 PSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFN 75
PS D P + L+ + TD F+ ++GKG FG V A R G A+K+
Sbjct: 2 PSEDRKQPS-------NNLDRVKLTD-FNFLMVLGKGSFGKVMLADRKGTEELYAIKI-- 51
Query: 76 LQCGRALKSFNVECEMMKS-----IRHRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYL 129
L+ ++ +VEC M++ + + + SC + V+EY+ G L ++
Sbjct: 52 LKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI 111
Query: 130 YSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIA 189
+ Q + +++ L +LH II+ DLK NV+LD ++DF +
Sbjct: 112 QQVGKFKEP-QAVFYAAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMC 167
Query: 190 KLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFN 249
K + + +T + T Y+APE + D +++G++L E G+ P F+
Sbjct: 168 KEHMMD--GVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP----FD 221
Query: 250 GE 251
GE
Sbjct: 222 GE 223
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 17/205 (8%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFNLQC---GRALKSFNVECEMMKSIRHRNLIKVI 104
+IG+G + V RL + A++V + + E + + + + +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 105 SSCSNEEFKAL-VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPI 163
SC E + V+EY+ G L ++ + + R +++ AL YLH I
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 174
Query: 164 IHCDLKPSNVLLDDNMVAHLSDFSIAK--LLVGEDQSMTQTQTF-ATIGYMAPEYGREGR 220
I+ DLK NVLLD L+D+ + K L G+ T TF T Y+APE R
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTSTFCGTPNYIAPEILRGED 229
Query: 221 VSANGDVYSFGIMLMETFTGKKPTD 245
+ D ++ G+++ E G+ P D
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFD 254
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 13/213 (6%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
D + + +G G FG V++ G A K ++ E + M +RH L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ + + ++ ++ E+M G L + + + + + + M V L ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 273
Query: 161 APIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+H DLKP N++ L DF + L D + T T + APE
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEG 330
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
V D++S G++ +G P F GE
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP----FGGE 359
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 10/233 (4%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKGGF ++ D EV A K+ L + ++E + +S+ H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ +F +VLE SL + + + R + + +YLH +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 163
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H DLK N+ L++++ + DF +A + E + T Y+APE + S
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 221
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
DV+S G ++ GK P + E L+ N++ + V A+L+ +
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS- 105
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 106 ---SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
S EEF+ +V+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERMSYLLYQMLVGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G+++ E G +F G + W
Sbjct: 202 YKENVDIWSVGVIMGEMIKG----GVLFPGTDHIDQW 234
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 13/213 (6%)
Query: 42 DEFSENNLIGKGGFGSVYK-ARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNL 100
D + + +G G FG V++ G A K ++ E + M +RH L
Sbjct: 51 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 101 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ + + ++ ++ E+M G L + + + + + + M V L ++H
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 167
Query: 161 APIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGRE 218
+H DLKP N++ L DF + L D + T T + APE
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEG 224
Query: 219 GRVSANGDVYSFGIMLMETFTGKKPTDEIFNGE 251
V D++S G++ +G P F GE
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSGLSP----FGGE 253
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS- 105
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 106 ---SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
S EEF+ +V+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERMSYLLYQMLVGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G+++ E G +F G + W
Sbjct: 202 YKENVDIWSVGVIMGEMIKG----GVLFPGTDHIDQW 234
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 10/233 (4%)
Query: 49 LIGKGGFGSVYKARLGDGMEV-AVKVFN---LQCGRALKSFNVECEMMKSIRHRNLIKVI 104
+GKGGF ++ D EV A K+ L + ++E + +S+ H++++
Sbjct: 46 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 105 SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPII 164
+ +F +VLE SL + + + R + + +YLH +I
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNR---VI 161
Query: 165 HCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSAN 224
H DLK N+ L++++ + DF +A + E + T Y+APE + S
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGHSFE 219
Query: 225 GDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDANLLSQ 277
DV+S G ++ GK P + E L+ N++ + V A+L+ +
Sbjct: 220 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 272
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 67/257 (26%), Positives = 113/257 (43%), Gaps = 37/257 (14%)
Query: 50 IGKGGFGSVYKAR-LGDGMEVAVK-----VFNLQCGRALKSFNVECEMMKSIRHRNLIKV 103
+G+G +G V K R + G +AVK V + + R L ++ M+++ +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 71
Query: 104 ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL------NIMIDVASALEYLHF 157
+ E + +E M SL+K+ ++D Q + I + + ALE+LH
Sbjct: 72 YGALFREGDVWICMELM-DTSLDKFYKQ---VIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 158 GYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA----- 212
S +IH D+KPSNVL++ + DF I+ LV + + + YMA
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERIN 182
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHWVNDWLPISTLEVVDA 272
PE ++G S D++S GI ++E + P D LK V + P + A
Sbjct: 183 PELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-----QLPA 236
Query: 273 NLLSQEDIHFVAKEQCV 289
+ S E + F + QC+
Sbjct: 237 DKFSAEFVDFTS--QCL 251
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 85 FTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKHLH---S 137
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 138 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA +E+L S IH DL N+LL + V + DF +A+ + + + +
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 293
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA +E+L S IH DL N+LL + V + DF +A+ + + + +
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 41 TDEFSENNLIGKGGFGSVY--KARLGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSI 95
+D + +G G +G V K +L G E A+K+ + E ++K +
Sbjct: 20 SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN---IMIDVASAL 152
H N++K+ ++ LV+E G L + + F ++ IM V S
Sbjct: 79 DHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGT 134
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSI-AKLLVGEDQSMTQTQTFATI 208
YLH I+H DLKP N+LL+ + + + DF + A VG + T
Sbjct: 135 TYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG----KMKERLGTA 187
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
Y+APE R+ + DV+S G++L G P
Sbjct: 188 YYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 221
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA +E+L S IH DL N+LL + V + DF +A+ + + + +
Sbjct: 207 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 300
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERMSYLLYQMLXGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 4/97 (4%)
Query: 148 VASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFAT 207
VA +E+L S IH DL N+LL + V + DF +A+ + + + +
Sbjct: 209 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 208 IGYMAPEYGREGRVSANGDVYSFGIMLMETFT-GKKP 243
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 302
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 41 TDEFSENNLIGKGGFGSVY--KARLGDGMEVAVKVFNLQCGRALKSFNV---ECEMMKSI 95
+D + +G G +G V K +L G E A+K+ + E ++K +
Sbjct: 3 SDRYQRVKKLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 96 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN---IMIDVASAL 152
H N++K+ ++ LV+E G L + + F ++ IM V S
Sbjct: 62 DHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGT 117
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDD---NMVAHLSDFSI-AKLLVGEDQSMTQTQTFATI 208
YLH I+H DLKP N+LL+ + + + DF + A VG + T
Sbjct: 118 TYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG----GKMKERLGTA 170
Query: 209 GYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
Y+APE R+ + DV+S G++L G P
Sbjct: 171 YYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 204
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 47.8 bits (112), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 28/261 (10%)
Query: 14 GKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVK 72
G P ND +A + LE ++ L+G GGFGSVY R+ D + VA+K
Sbjct: 1 GAAPCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 55
Query: 73 VFNLQ----CGRALKSFNVECE--MMKSIRH--RNLIKVISSCSNEEFKALVLEYM-PHG 123
G V E ++K + +I+++ + L+LE P
Sbjct: 56 HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 115
Query: 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-H 182
L ++ + + R + V A+ + H + ++H D+K N+L+D N
Sbjct: 116 DLFDFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK 171
Query: 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA-NGDVYSFGIMLMETFTGK 241
L DF LL + T T Y PE+ R R + V+S GI+L + G
Sbjct: 172 LIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 242 KP---TDEIFNGEMTLKHWVN 259
P +EI G++ + V+
Sbjct: 228 IPFEHDEEIIRGQVFFRQRVS 248
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 28/261 (10%)
Query: 14 GKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVK 72
G P ND +A + LE ++ L+G GGFGSVY R+ D + VA+K
Sbjct: 1 GAAPCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 55
Query: 73 VFNLQ----CGRALKSFNVECE--MMKSIRH--RNLIKVISSCSNEEFKALVLEYM-PHG 123
G V E ++K + +I+++ + L+LE P
Sbjct: 56 HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 115
Query: 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-H 182
L ++ + + R + V A+ + H + ++H D+K N+L+D N
Sbjct: 116 DLFDFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK 171
Query: 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA-NGDVYSFGIMLMETFTGK 241
L DF LL + T T Y PE+ R R + V+S GI+L + G
Sbjct: 172 LIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 242 KP---TDEIFNGEMTLKHWVN 259
P +EI G++ + V+
Sbjct: 228 IPFEHDEEIIRGQVFFRQRVS 248
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 28/261 (10%)
Query: 14 GKRPSNDASMPLVAMWRTFSYLELCQATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVK 72
G P ND +A + LE ++ L+G GGFGSVY R+ D + VA+K
Sbjct: 1 GAAPCNDLHATKLAPGKEKEPLE-----SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 55
Query: 73 VFNLQ----CGRALKSFNVECE--MMKSIRH--RNLIKVISSCSNEEFKALVLEYM-PHG 123
G V E ++K + +I+++ + L+LE P
Sbjct: 56 HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 115
Query: 124 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVA-H 182
L ++ + + R + V A+ + H + ++H D+K N+L+D N
Sbjct: 116 DLFDFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELK 171
Query: 183 LSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGRVSA-NGDVYSFGIMLMETFTGK 241
L DF LL + T T Y PE+ R R + V+S GI+L + G
Sbjct: 172 LIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 242 KP---TDEIFNGEMTLKHWVN 259
P +EI G++ + V+
Sbjct: 228 IPFEHDEEIIRGQVFFRQRVS 248
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/254 (23%), Positives = 107/254 (42%), Gaps = 44/254 (17%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGRALKSFNVEC 89
ELC+ +IGKG F V + G + AVK+ F G + + E
Sbjct: 29 ELCE---------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA 79
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
+ ++H ++++++ + S++ +V E+M ++ +I +R + +
Sbjct: 80 SICHMLKHPHIVELLETYSSDGMLYMVFEFMD---------GADLCFEIVKRADAGFVYS 130
Query: 150 SA---------LEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQ 197
A LE L + + IIH D+KP VLL +++ L F +A + +GE
Sbjct: 131 EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGE-S 188
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP----TDEIFNGEMT 253
+ T +MAPE + DV+ G++L +G P + +F G +
Sbjct: 189 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK 248
Query: 254 LKHWVN--DWLPIS 265
K+ +N W IS
Sbjct: 249 GKYKMNPRQWSHIS 262
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/254 (23%), Positives = 107/254 (42%), Gaps = 44/254 (17%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKA-RLGDGMEVAVKV-----FNLQCGRALKSFNVEC 89
ELC+ +IGKG F V + G + AVK+ F G + + E
Sbjct: 27 ELCE---------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA 77
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 149
+ ++H ++++++ + S++ +V E+M ++ +I +R + +
Sbjct: 78 SICHMLKHPHIVELLETYSSDGMLYMVFEFMD---------GADLCFEIVKRADAGFVYS 128
Query: 150 SA---------LEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQ 197
A LE L + + IIH D+KP VLL +++ L F +A + +GE
Sbjct: 129 EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGE-S 186
Query: 198 SMTQTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP----TDEIFNGEMT 253
+ T +MAPE + DV+ G++L +G P + +F G +
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK 246
Query: 254 LKHWVN--DWLPIS 265
K+ +N W IS
Sbjct: 247 GKYKMNPRQWSHIS 260
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS- 105
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 106 ---SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
S EEF+ +V+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERMSYLLYQMLCGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E G +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS- 105
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 106 ---SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
S EEF+ +V+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E G +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS- 105
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 106 ---SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
S EEF+ +V+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E G +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 85 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 137
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 26 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 86 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 138
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 139 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 123
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 124 RHCH---NXGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 176
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 228
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 26 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 86 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 138
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 139 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 33 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 93 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 145
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 146 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVIS- 105
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 106 ---SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
S EEF+ +V+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLSQVI---QMELDHERMSYLLYQMLVGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E G +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 31 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 91 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 143
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 144 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 200
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 233
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 123
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 176
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 228
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 123
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 176
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 228
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 33 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 93 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 145
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 146 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 9 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 69 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 127
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 128 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 180
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 181 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 232
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 8 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 68 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 126
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 127 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 179
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 180 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 231
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 10 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 70 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 128
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 129 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 181
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 233
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 10 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 70 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 128
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 129 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 181
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 233
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 24 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 84 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 142
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 143 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 195
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 196 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 247
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 32 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 92 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 150
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 151 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 203
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 204 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 255
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 52 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 170
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 171 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 223
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 224 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 275
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 155
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 156 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 208
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 260
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 24 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 84 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 142
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 143 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 195
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 196 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 247
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 31/193 (16%)
Query: 39 QATDEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFNLQ-----C---GRALKSFNVEC 89
+ + ++S + +G G FG V+ A + EV VK + C L +E
Sbjct: 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 90 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS-LEKYLYSSNCILDIFQRLN----- 143
++ + H N+IKV+ N+ F LV+E HGS L+ + + +D RL+
Sbjct: 81 AILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAF-----IDRHPRLDEPLAS 133
Query: 144 -IMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQT 202
I + SA+ YL IIH D+K N+++ ++ L DF A L +
Sbjct: 134 YIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL----ERGKLF 186
Query: 203 QTF-ATIGYMAPE 214
TF TI Y APE
Sbjct: 187 YTFCGTIEYCAPE 199
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 32/226 (14%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMM- 92
L + +D + IG G FG R E VAVK ++ G + NV+ E++
Sbjct: 12 LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKY--IERGEKIDE-NVKREIIN 68
Query: 93 -KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----YSSNCILDIFQRLNIMI 146
+S+RH N+++ A+V+EY G L + + +S + FQ+L
Sbjct: 69 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL---- 124
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLVGEDQSMTQTQT 204
S + Y H + + H DLK N LLD + L F +K V Q + T
Sbjct: 125 --ISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKS---T 176
Query: 205 FATIGYMAPEY----GREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE +G+V+ DV+S G+ L G P ++
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFED 219
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 10 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 70 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 128
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 129 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 181
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 182 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 233
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 155
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 156 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 208
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 260
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 162
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 215
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 267
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 155
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 156 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 208
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 260
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 156
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 157 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 209
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 261
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 156
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 157 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 209
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 261
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 37 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 97 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 155
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 156 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 208
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 209 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 260
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 36/209 (17%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVI-- 104
+G G +GSV A G +VA+K + Q K E ++K ++H N+I ++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 105 ----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI-FQRLNIMIDVASALEYLHFGY 159
SS N LV+ +M L+K I+ + F I V L+ L + +
Sbjct: 92 FTPASSLRNFYDFYLVMPFM-QTDLQK-------IMGLKFSEEKIQYLVYQMLKGLKYIH 143
Query: 160 SAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG 219
SA ++H DLKP N+ ++++ + DF +A+ D MT GY+ + R
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT--------GYVVTRWYRAP 192
Query: 220 RV-------SANGDVYSFGIMLMETFTGK 241
V + D++S G ++ E TGK
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 39/225 (17%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 107 CSNEEFKALVLEYMPHGSLEKY--------LYSSNCILDIFQRLN------IMIDVASAL 152
+ P SLE++ L +N I L+ ++ + +
Sbjct: 92 ------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
++LH SA IIH DLKPSN+++ + + DF +A+ S T T Y A
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYYRA 193
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
PE N D++S G ++ E G +F G + W
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 156
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 157 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 209
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 261
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 38 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 98 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 156
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 157 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 209
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 210 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVS 261
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 130 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 182
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 107 CSN----EEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
+ EEF+ LV+E M +L + + LD + ++ + +++LH S
Sbjct: 130 FTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLYQMLCGIKHLH---S 182
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREGR 220
A IIH DLKPSN+++ + + DF +A+ S T T Y APE
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 221 VSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
N D++S G ++ E K +F G + W
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 32/226 (14%)
Query: 35 LELCQATDEFSENNLIGKGGFGSVYKARLGDGME-VAVKVFNLQCGRALKSFNVECEMM- 92
L + +D + IG G FG R E VAVK ++ G + NV+ E++
Sbjct: 12 LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKY--IERGEKIDE-NVKREIIN 68
Query: 93 -KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----YSSNCILDIFQRLNIMI 146
+S+RH N+++ A+V+EY G L + + +S + FQ+L
Sbjct: 69 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL---- 124
Query: 147 DVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLS--DFSIAKLLVGEDQSMTQTQT 204
S + Y H + + H DLK N LLD + L F +K V Q T
Sbjct: 125 --ISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP---KDT 176
Query: 205 FATIGYMAPEY----GREGRVSANGDVYSFGIMLMETFTGKKPTDE 246
T Y+APE +G+V+ DV+S G+ L G P ++
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTLYVMLVGAYPFED 219
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 57 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 175
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 176 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 228
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 229 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 280
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 50 IGKGGFGSVYKA-RLGDGMEVAVKVFN--LQCGRALKSFNVECEMMKSIRHRNLIKVI-- 104
+G G +GSV A G +VA+K + Q K E ++K ++H N+I ++
Sbjct: 50 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 105 ----SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYS 160
SS N LV+ +M L+K + F I V L+ L + +S
Sbjct: 110 FTPASSLRNFYDFYLVMPFM-QTDLQKIMGME------FSEEKIQYLVYQMLKGLKYIHS 162
Query: 161 APIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPEYGREG- 219
A ++H DLKP N+ ++++ + DF +A+ E T T Y APE
Sbjct: 163 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWM 217
Query: 220 RVSANGDVYSFGIMLMETFTGK 241
+ D++S G ++ E TGK
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGK 239
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 43 EFSENNLIGKGGFGSVYKA-RLGDGMEVAVKVFNLQ----CGRALKSFNVECE--MMKSI 95
++ L+G GGFGSVY R+ D + VA+K G V E ++K +
Sbjct: 52 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 96 RH--RNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCILDIFQRLNIMIDVASAL 152
+I+++ + L+LE P L ++ + + R + V A+
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAV 170
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVA-HLSDFSIAKLLVGEDQSMTQTQTFATIGYM 211
+ H + ++H D+K N+L+D N L DF LL + T T Y
Sbjct: 171 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 223
Query: 212 APEYGREGRVSA-NGDVYSFGIMLMETFTGKKP---TDEIFNGEMTLKHWVN 259
PE+ R R + V+S GI+L + G P +EI G++ + V+
Sbjct: 224 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 275
>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
pdb|2VD5|B Chain B, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
Length = 412
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 42 DEFSENNLIGKGGFGSVYKARLGD-GMEVAVKVFN----LQCGRALKSFNVECEMMKSIR 96
D+F +IG+G F V ++ G A+K+ N L+ G + F E +++ +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE-VSCFREERDVLVNGD 119
Query: 97 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 156
R + ++ + +E + LV+EY G L L + + ++ A++ +H
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 157 -FGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMAPE- 214
GY +H D+KP N+LLD L+DF + L + D ++ T Y++PE
Sbjct: 180 RLGY----VHRDIKPDNILLDRCGHIRLADFG-SCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 215 ------YGREGRVSANGDVYSFGIMLMETFTGKKP 243
G D ++ G+ E F G+ P
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 34/228 (14%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVK-VFN--------------LQCGR 80
EL ++ I G +G+V +G+ VA+K VFN C R
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 81 ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCI 135
L+ E ++ H N++ + + E A LV E M L + ++ +
Sbjct: 76 VLR----EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIV 130
Query: 136 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195
+ M + L LH A ++H DL P N+LL DN + DF++A+ E
Sbjct: 131 ISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR----E 183
Query: 196 DQS-MTQTQTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGK 241
D + +T Y APE + + + D++S G ++ E F K
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 39/225 (17%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 107 CSNEEFKALVLEYMPHGSLEKY--------LYSSNCILDIFQRLN------IMIDVASAL 152
+ P SLE++ L +N I L+ ++ + +
Sbjct: 92 ------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
++LH SA IIH DLKPSN+++ + + DF +A+ S T T Y A
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRA 193
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
PE N D++S G ++ E G +F G + W
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 39/225 (17%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 107 CSNEEFKALVLEYMPHGSLEKY--------LYSSNCILDIFQRLN------IMIDVASAL 152
+ P SLE++ L +N I L+ ++ + +
Sbjct: 93 ------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
++LH SA IIH DLKPSN+++ + + DF +A+ S T T Y A
Sbjct: 141 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRA 194
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
PE N D++S G ++ E G +F G + W
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 235
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/225 (24%), Positives = 89/225 (39%), Gaps = 39/225 (17%)
Query: 50 IGKGGFGSV---YKARLGDGMEVAVKVFNLQCGRALKSFNVECEMMKSIRHRNLIKVISS 106
IG G G V Y A L + + Q K E +MK + H+N+I +++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 107 CSNEEFKALVLEYMPHGSLEKY--------LYSSNCILDIFQRLN------IMIDVASAL 152
+ P SLE++ L +N I L+ ++ + +
Sbjct: 92 ------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 153 EYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGEDQSMTQTQTFATIGYMA 212
++LH SA IIH DLKPSN+++ + + DF +A+ S T T Y A
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRA 193
Query: 213 PEYGREGRVSANGDVYSFGIMLMETFTGKKPTDEIFNGEMTLKHW 257
PE N D++S G ++ E G +F G + W
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG----GVLFPGTDHIDQW 234
>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b
pdb|3SHE|A Chain A, Novel Atp-Competitive Mk2 Inhibitors With Potent
Biochemical And Cell- Based Activity Throughout The
Series
Length = 317
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMT 200
IM D+ +A+++LH S I H D+KP N+L + + V L+DF AK Q+
Sbjct: 114 IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNAL 167
Query: 201 QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
QT + T Y+APE + + D++S G+++ G P
Sbjct: 168 QTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 209
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 34/228 (14%)
Query: 36 ELCQATDEFSENNLIGKGGFGSVYKARLGDGMEVAVK-VFN--------------LQCGR 80
EL ++ I G +G+V +G+ VA+K VFN C R
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 81 ALKSFNVECEMMKSIRHRNLIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCI 135
L+ E ++ H N++ + + E A LV E M L + ++ +
Sbjct: 76 VLR----EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIV 130
Query: 136 LDIFQRLNIMIDVASALEYLHFGYSAPIIHCDLKPSNVLLDDNMVAHLSDFSIAKLLVGE 195
+ M + L LH A ++H DL P N+LL DN + DF++A+ E
Sbjct: 131 ISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR----E 183
Query: 196 DQS-MTQTQTFATIGYMAPEYGREGR-VSANGDVYSFGIMLMETFTGK 241
D + +T Y APE + + + D++S G ++ E F K
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase-Activated Protein Kinase 3
(Mk3)-Inhibitor Complex
pdb|3FXW|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase- Activated Protein Kinase 3INHIBITOR 2
COMPLEX
Length = 336
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 144 IMIDVASALEYLHFGYSAPIIHCDLKPSNVLL---DDNMVAHLSDFSIAKLLVGEDQSMT 200
IM D+ +A+++LH S I H D+KP N+L + + V L+DF AK Q+
Sbjct: 133 IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNAL 186
Query: 201 QTQTFATIGYMAPEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
QT + T Y+APE + + D++S G+++ G P
Sbjct: 187 QTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567
pdb|4HNI|B Chain B, Crystal Structure Of Ck1e In Complex With Pf4800567
pdb|4HOK|A Chain A, Crystal Structure Of Apo Ck1e
pdb|4HOK|C Chain C, Crystal Structure Of Apo Ck1e
pdb|4HOK|E Chain E, Crystal Structure Of Apo Ck1e
pdb|4HOK|G Chain G, Crystal Structure Of Apo Ck1e
pdb|4HOK|I Chain I, Crystal Structure Of Apo Ck1e
pdb|4HOK|K Chain K, Crystal Structure Of Apo Ck1e
pdb|4HOK|M Chain M, Crystal Structure Of Apo Ck1e
pdb|4HOK|O Chain O, Crystal Structure Of Apo Ck1e
pdb|4HOK|Q Chain Q, Crystal Structure Of Apo Ck1e
pdb|4HOK|S Chain S, Crystal Structure Of Apo Ck1e
pdb|4HOK|U Chain U, Crystal Structure Of Apo Ck1e
pdb|4HOK|W Chain W, Crystal Structure Of Apo Ck1e
Length = 296
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 50 IGKGGFGSVY-KARLGDGMEVAVKVFNLQCGRALK-SFNVECEMMKSIRHRNLIKVISSC 107
IG G FG +Y A + G EVA+K L+C + ++E + K ++ I I C
Sbjct: 17 IGSGSFGDIYLGANIASGEEVAIK---LECVKTKHPQLHIESKFYKMMQGGVGIPSIKWC 73
Query: 108 SNE-EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGYSAPIIHC 166
E ++ +V+E + SLE + + L + + S +EY+H S IH
Sbjct: 74 GAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 167 DLKPSNVLL----DDNMVAHLSDFSIAK----------LLVGEDQSMTQTQTFATIG-YM 211
D+KP N L+ N+V ++ DF +AK + E++++T T +A+I ++
Sbjct: 130 DVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188
Query: 212 APEYGREGRVSANGDVYSFGIMLMETFTGKKP 243
E R D+ S G +LM G P
Sbjct: 189 GIEQSRR------DDLESLGYVLMYFNLGSLP 214
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.322 0.136 0.401
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,549,064
Number of Sequences: 62578
Number of extensions: 388859
Number of successful extensions: 3420
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 792
Number of HSP's successfully gapped in prelim test: 304
Number of HSP's that attempted gapping in prelim test: 985
Number of HSP's gapped (non-prelim): 1153
length of query: 339
length of database: 14,973,337
effective HSP length: 99
effective length of query: 240
effective length of database: 8,778,115
effective search space: 2106747600
effective search space used: 2106747600
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 52 (24.6 bits)